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Summary of thesis 
 
 
Traditional clinical remedies are unable to address osteochondral defects adequately. 
Given the paucity of available alternatives, the author aims to harness the advances in 
stem cell and biomaterial research to create a biphasic osteochondral implant that caters to 
both cartilage and bone regeneration. The endeavor was driven by the hypothesis that a 
biomechanically competent biphasic scaffold that is seeded with hydrogel encapsulated 
Mesenchymal Stem Cells (MSC) would support osteochondral repair. Therefore the aim 
would be to select a suitable cartilage hydrogel and to engineer scaffolds which are 
mechanically compatible to the native osteochondral tissue. Moreover the design of a 
cartilage resurfacing membrane constituted an additional objective. Lastly, the feasibility 
of the assembled construct had to be validated in animal models. The investigation 
proceeded with a cartilage hydrogel selection. Consequently, fibrin was found to enhance 
MSC chondrogenesis, cellular growth and extracellular matrix synthesis in in vitro 3D 
osteochondral constructs. This bioactive hydrogel was coupled with rapid prototyped 
polycaprolactone – based scaffolds in the reconstruction of critically sized osteochondral 
defects in rabbits. These scaffolds were sufficiently porous and they mimicked the 
mechanical characteristics of bone and cartilage. In vivo findings indicated bone repair to 
be facilitated by the open architecture of the scaffolds while cartilage regeneration was 
reliant on the implanted MSC and matrix support. However the unsatisfactory healing at 
the cartilage surface suggested the inclusion of a membrane that would help to retain the 
seeded cells. In that light, the use of polycaprolactone - collagen electrospun meshes were 
explored. The synthetic membrane demonstrated MSC compatibility in the in vitro 
chondrogenic environment without inducing a hypertropic response. All these findings 
 xi
have prompted a large animal study with translational objectives. Osteochondral healing 
in the large animal was enhanced by the use of the implanted MSC within the biphasic 
scaffold and the electrospun mesh. However tissue healing was not just dependent on 
exogenous factors but also on the endogenous biomechanical features at the defect site. 
The research efforts have yielded a functional osteochondral implant with due attention 
given to the specific components and the concept was validated in the final preclinical 
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Chapter 1. Introduction  
 
 
1.1. Clinical background 
 
Osteochondral defects afflict cartilage and bone regions particularly so at the knee joint. 
This musculoskeletal aliment is attributed to osteonecrosis, osteochondrodritis dissecans, 
osteoarthritis, trauma and sports related injuries [11-12]. When left untreated, natural 
healing occurs and is often characterized by poor functional restoration which eventually 
deteriorates [18-19]. Current therapeutic interventions include the use of autografts, 
allografts and inert implants. These solutions are inadequate. The use of autografts is 
hindered by donor site morbidity while disease transmission is a concern for allografts 
[51]. Given the current limitations, alternatives in the field of tissue engineering are 
sought.    
       
1.2. Tissue Engineering 
The advent of tissue engineering has generated much excitement in medicine and science, 
attracting the attention of clinicians, researchers and even the general public. Tissue 
engineering can be defined as the endeavor to promote the regeneration of a specific tissue 
or organ through the use of biomaterials, cells and growth factors, with the aim of 
restoring normal tissue function which is lost due to congenial deformity, disease or 
trauma [81]. Hence the engineered graft must be able to recapitulate the appropriate 
structure, composition, cell signaling and functions of the original tissue [81]. To achieve 




Tissue engineered constructs generally consist of 3 components. They are scaffolds, cells 
and growth factors. Scaffolds provide an artificial Extracellular Matrix (ECM ) template 
required for cell attachment, proliferation and differentiation [93]. While the natural ECM 
is being deposited, the synthetic matrix degrades away, thus leaving behind the functional 
tissue. To facilitate growth, progenitor cells are incorporated into the scaffolds given their 
reparative capabilities. Molecular cues such as cytokines and growth factors are also 
included so as to assist or guide tissue development. These biosynthetic grafts can even be 
grown in bioreactors under mechanical stimulation. By manipulating these 3 key 
components, researchers tried to create substitutes for a myriad of tissues and organs. 
Examples would include skin [95], vasculature [96], tendon [98], bone [99] and cartilage 
[101]. One of the first commercially available tissue engineered product is Dermagraft ® 
(Advanced tissue sciences Inc, La Jolla, CA), which used in the treatment of diabetic foot 
ulcers. It comprised of allogeneic neonatal fibroblasts cultured on a polymeric mesh [102-
103]. Wu and colleagues achieved microvasculature growth on cocultures that consisted 
of endothelial progenitors and smooth muscle cells that were seeded onto porous 
polyglycolic acid – poly – L – lactic acid (PGA-PLA) scaffolds [104]. Unsatisfactory 
tendon healing warrants medical attention and Awad et al sought to resolve this problem 
by fabricating tendon implants with collagen composites seeded with Mesenchymal Stem 
Cells (MSC) [105]. Improved healing was observed during animal trials [105]. 
 
Bone and cartilage are popular subjects in the field of tissue engineering. Critically sized 
bone lesion often leads to non-unions [106]. Defect bridging can be achieved with an 
osteoconductive and osteoinductive 3D scaffold which induces the migration of 
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osteoprogenitor cells from the surrounding tissues. Given time, these cells would 
proliferate, differentiate and regenerate bone. This novel strategy is known as guided bone 
regeneration [107]. Cartilage defect is another major clinical challenge as the cartilage is 
avascular and lacking in self repair. To address this aliment, Brittberg et al introduced the 
Autologous Chondrocyte Implantation (ACI) which entails the isolation and expansion of 
chondrocytes from cartilage biopsies. A high density suspension of these autologous cells 
is subsequently injected back into the defect which is patched with a periosteal flap [108-
109]. The problem proves to be even more complicated in an osteochondral defect as both 
the cartilage and bone needs to be restored. To cater to the differing needs of the 2 tissues, 
Hollister et al experimented with a biphasic osteochondral implant [8]. The cartilage 
matrix comprised of a PLA sponge which was seeded with chondrocytes and it was 
coupled to a hydroxyapatite scaffold that served as a carrier for transfected gingival 
fibroblasts. Bone and cartilage formation was noted during subcutaneous implantation [8]. 
But even with these accomplishments, there is yet to be a clinically viable tissue 
engineering approach that aids osteochondral regeneration. This is because most of the 
proposed implants cannot be directly translated into medical products due to material, 
mechanical, structural and biological limitations. Biological compatibility stems from the 
material composition of the implant. Materials such as chitosan and hydroxyapatite are 
commonly used in the fabrication of osteochondral scaffolds but concerns were raised 
over the foreign body response elicited by chitosan moreover the slow resorption of 
hydroxyapatite leads to stress shielding of the repair tissue  [1, 9-10]. Mechanical 
competence is necessary as osteochondral constructs are exposed to high physiological 
loading at the knee joint. This criterion was not met when Tanaka et al employed collagen 
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cartilage matrices as the neo-tissue deteriorated under native stresses in the rabbit model 
[12]. This emphasized the need for animal modeling as the complex in vivo environment 
which interacts with the repair tissue cannot be fully recapitulated in cultures. Sherwood 
et al reported positive in vitro findings on his work with biphasic scaffolds but the final 
proof of concept in animals was lacking [26]. Despite of that, he recognized the 
importance of using porous scaffolds with interconnected pores [26]. This structural 
feature is critical in facilitating vasculature invasion in the bone region and nutrient 
transport via diffusion in the cartilage zone. This was in contrast with most of the 
osteochondral implants which were derived from foams. Pores in the foam based scaffolds 
may not be fully interconnected and this hampers tissue repair. These material, 
mechanical, structural and biological constraints have confounded researchers in their 
quest for a feasible tissue engineered osteochondral construct. Hence the author is mindful 
of these challenges and initiates an investigation guided by the hypothesis that a 
combination of MSC loaded hydrogel and biomechanically competent scaffolds would 
constitute a viable osteochondral implant that supports tissue regeneration. To validate 
this hypothesis, the following objectives were pursued. Firstly, a suitable cartilage 
hydrogel for MSC encapsulation must be selected. Moreover mechanically competent 
scaffolds with interconnected pores must be developed. A cartilage resurfacing membrane 
was also proposed and the feasibility of the construct was evaluated in medium and large 







Chapter 2. Literature Review 
 
 
2.1. Osteochondral biology 
 
An in depth understanding of osteochondral physiology is required for a clear prognosis of 
osteochondral defects. Articular cartilage covers the ends of long bones to form the joint 
surfaces and it fulfills 2 main functions. Firstly, it is a low friction bearing surface 
necessary for joint flexion [110].  Moreover, it effectively distributes the load between the 
femur and tibia. Normal joint functions are facilitated by the biomechanical interaction 
between cartilage and the underlying subchondral bone. During loading, the articular 
cartilage transmits the physiological stresses to the bone region [111]. Studies have shown 
that cartilage stiffness is positively correlated to that of subchondral bone as it provides 
the critical support [111]. Conversely, when cartilage health deteriorates, an uneven 
distribution of increased loading to the bone tissue occurs [112]. This triggers bone 
remodeling which in turn leads to a build up of high subsurface stress that further 
aggravates the condition of the cartilage [113]. Therefore articular cartilage and 
subchondral bone exist as an integrated unit and both tissues must be restored in order for 
an effective osteochondral repair to happen.  
 
 
2.1.1. Articular cartilage  
 
Articular cartilage is a resilient tissue that is subjected to compression, shear and 
hydrostatic pressure at the joint [114]. Compressive loads promote cartilage growth while 
enhancing the molecular exchange with the synovial fluid [115-116]. The tissue also 
serves as a smooth gliding surface through boundary, hydrostatic and elastohydrodynamic 
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lubrication [117-118]. These biomechanical capabilities are derived from the unique 
biology of cartilage that comprises of solid and fluid phases. Chondrocytes synthesize the 
solid matrix which consists mainly of collagen type II and aggrecan [119]. The network of 
crosslinked collagen fibers confers tensile and shear resistance to the tissue while the 
compressive resistance is derived from the electrostatic repulsion between the negatively 
charged aggrecan molecules [120-123]. External compression is also countered by the 
internal hydrostatic pressure attributed to the compressed fluid phase that consists of water 
and dissolved electrolytes such as Na+, Ca2+ and Cl-. During tissue deformation, fluid flow 
is impeded by the ECM, thus resulting in a built up of internal pressure [124].   
 
Articular cartilage is divided into 4 zones : superficial, middle, deep and calcified. These 
differ in composition, structure and mechanical properties. The topmost superficial zone 
has a high water and collagen content which declines towards the calcified region. 
Aggrecan content increases from the articulating surface and peaks at the middle zone 
[119]. An acellular sheet of collagen known as lamina splendens is located on the 
superficial zone. The parallel alignment of collagen fibrils along the articulating surface 
switches into an oblique and random pattern in the middle zone. These fibrils are 
subsequently oriented perpendicular to the joint surface in the calcified cartilage. The 
parallel arrangement of the collagen fibers helps to resist tensile forces at the superficial 
zone [125], while the perpendicular orientation counters the shear stresses at the calcified 
layer [125-126]. Cellular variations are also observed across the 4 zones. Chondrocytes 
alter their morphology from a flatten shape in the superficial zone to a rounded shape in 
the middle zone. A columnar arrangement of cells which exhibit high synthetic activity is 
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observed in the middle zone [126]. Upon descending into the calcified region, the 
chondrocytes diminish in size with a reduced metabolic activity [127].  
 
2.1.2. Bone  
 
Bone tissue can be categorized either as cortical or trabecular bone. Cortical bone 
envelops the flexible trabeculae network. While torsion and bending are resisted by the 
dense cortical tissue, the elastic trabecular struts help to distribute the compressive stresses 
[128]. Trabecular tissue can be found in the subchondral region of the osteochondral 
tissue. Bone develops via intramembranous or endochondral ossification and it comprises 
of water, organic and inorganic components (8, 22, 70% of the wet weight respectively) 
[128-129]. The organic matrix contains mainly collagen type I which confers tensile 
resistance while the compressive strength stems from an inorganic matrix of calcium 
phosphate complexes and crystalline hydroxyapatite [128, 130]. Tissue remodeling and 
maintenance are conducted by a cellular array of osteoblast, osteocyte, osteoclast and 
osteoprogenitors. Osteoblasts secrete a collagenous osteoid matrix that subsequently 
mineralizes with the accumulation of hydroxyapatite [128, 131]. These cells originate 
from osteoprogenitors which reside in bone canals, endosteum and periosteum [128, 132]. 
During matrix deposition, some of these osteoblasts are entrapped within the new matrix 
and they become osteocytes which extend processes to form gap junctions with the other 
neighboring cells [133]. Researchers have postulated that this network of osteocytes 
facilitate strain-related responses, microdamage repairs, revitalization of dead tissues and 
mineral exchange [133-136]. Bone resorbing osteoclasts play an important role in bone 
physiology. During bone remodeling, osteoclasts synergize with osteoblasts within a 
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Basic Multicellular Unit (BMU) [128] and the former would resorb bone at the cutting 
cone while the trailing osteoblasts would deposit bone [137]. During maturation, collagen 
fibrils are deposited in an orderly fashion resulting in the formation of lamellar bone. 
However woven bone develops with asynchronous deposition that occurs during the initial 
phase of bone healing [138]. 
 
2.2. Osteochondral defects.  
Osteochondral defect encompasses bone bruises, osteochondritis dissecans and 
osteoarthritis. Trauma such as sports injury exposes the articulating joint to excessive 
loading which either triggers tissue bruising or the loosening of a fragment of 
osteochondral tissue in a condition known as osteochondritis dissecans [113, 139-140]. 
Osteochondral degeneration also occurs during osteoarthritis. During the initial stages, 
fissures form on the articular cartilage. These clefts enlarge and deepen with the 
destruction of cartilage while exposing the underlying subchondral bone. Bleeding soon 
occurs with the development of bone necrosis [141-142]. The symptoms indicative of 
osteochondral abnormalities would include chondrocyte necrosis, proteoglycan loss, 
osteocyte death, microfractures in the cancellous bone and even the collapse of the 
subchondral bone [113, 143-144]. When left untreated, inadequate natural healing occurs 
as the low cell density of the avascular cartilage limits self repair [145]. While 
subchondral penetration allows the influx of native progenitor cells and growth factors 
from the bone marrow into the wound site, the initial hyaline cartilage repair soon 
degenerates into a mechanically inferior fibrocartilage. A probable reason for this would 
be an inadequate supply of reparative cells [146]. Due to the inability to withstand 
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repetitive loads, tissue failure eventually occurs [79]. This was proven in several animal 
models. Jackson et al observed osseous resorption, tissue collapse with the formation of 
large lesions in the critically sized osteochondral defects in goat models [147]. Smaller 
defects fare better with complete healing as reported by Conveny [148]. However the 
outcome is generally far from satisfactory and medical intervention is warranted.    
 
2.3. Conventional Therapies  
When the osteochondral region suffers an insult and begins to degenerate, medical 
treatment is required. At the initial stages, non-surgical treatments are prescribed which 
include physiotherapy, glucosamine supplementation and pain relief [51, 149]. But these 
are palliative and they do not result in direct tissue restoration. To resolve this condition, 
osteochondral grafts from autogenous or allogenous sources are required. In mosaicplasty, 
healthy osteochondral grafts are transferred from low load bearing areas in the knee to the 
defect. However, given the limited availability of donor cartilage, defects larger than 6 – 8 
cm2 cannot be treated. Besides the issue of donor site morbidity, mismatches in articular 
surface curvature and poor graft integration also complicates the procedure [150]. 
Allografts harvested from cadavers may be utilized to treat large defects (> 4 cm2). To 
facilitate successful outcomes, advanced instrumentation is required to duplicate the 
native cartilage contour while a complete preservation of the graft is crucial for tissue 
viability. Beyond these constraints, disease transmission, immuno-responses, shortfall in 
tissue banks are also valid concerns [51]. When all these alternatives are exhausted, 
prosthetics are employed. Though joint articulation is restored, these prostheses loosen 
and they undergo wear and tear over time [125, 151]. Thus most of the conventional 
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therapies are deemed inadequate in the treatment of osteochondral defects and novel 
solutions are desperately sought.      
        
2.4. Tissue engineering approach  
The shortcomings in the current treatments for osteochondral defects call for innovative 
solutions. Hence initiatives are taken to tissue engineer functional implants through the 
use of cells, biomaterials and growth factors. ACI was an early attempt in restoring 
cartilage defects that are larger than 2 cm in diameter. Cartilage biopsy is first taken from 
a low load bearing region of the affected knee. Chondrocytes are extracted from this tissue 
and expanded via cell culture [152]. In the second open knee surgery, a periosteal patch is 
harvested, sewn over the defect and a suspension of the cultured chondrocytes is injected 
into the site [152]. Though promising, this procedure does not address the bone defect 
directly.   
 
There are various tissue engineering attempts to regenerate both the cartilage and bone in 
the osteochondral defect, however there is yet to be a Food and Drug Administration 
(FDA) approved product. Susante et al experimented with an osteochondral implant 
consisting of a top fibrin layer which served as the cartilage phase and a hydroxyapatite 
bony graft [153]. The bone phase was not seeded with cells but xenogenous chondrocytes 
were encapsulated in the overlying fibrin gel. The investigators rationalized the use of 
xenogenous cell lines as they reasoned that chondrocytes were immuno-protected by a 
surrounding pericellular matrix [153]. The final construct was tested in an in vivo model 
and promising results were obtained with the development of neocartilage with bone 
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growing and maturing within the hydroxyapatite graft. However over time, the repair 
cartilage degenerated as the fibrin matrix disintegrated [153]. Jiang et al had a similar 
problem when he implanted a biphasic osteochondral construct at the weightbearing 
region in the medial condyle of a pig [22]. Repair cartilage was found to be thinner than 
the native cartilage as the Poly Lactic-co-Glycolic Acid (PLGA) scaffold might have 
lacked the mechanical resistance to withstand physiological loading. Zhou et al 
experimented with osteochondral implants comprising of MSC seeded Poly Glycolic Acid 
(PGA) scaffolds [154] and the Green Fluorescent Protein (GFP) labeled MSC was found 
to reconstitute both the new cartilage and bone in the osteochondral site. Though 
promising, these finding were derived from a non weightbearing site [154]. Niederauer et 
al achieved effective osteochondral repair at load bearing sites in goats via fiber reinforced 
PLGA scaffolds which were seeded with chondrocytes [2]. However as the defects were 
not critically sized, spontaneous healing resulted in the similarity between the 
experimental and control groups. All these reports suggest the need for a robust 
scaffolding system, tested in an effective animal model which mimics chronic clinical 
anomalies.      
 
Besides the use of cells and scaffolds, molecular cues can also be manipulated to achieve 
regeneration. Sellers implanted a Bone Morphogenetic Protein (BMP) laden collagen 
sponge in the rabbit osteochondral defect and she observed significant healing [155]. This 
promising outcome was primarily attributed to the accelerated repair of the subchondral 
bone in the presence of BMP which in turn provided the crucial biomechanical support 
required for cartilage healing. Insulin-like Growth Factor 1 (IGF-1) was also 
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experimented as it enhances chondrocyte survival and it activates the Sox9 gene which is 
a critical molecular switch in the chondrogenic differentiation cascade of MSC [156]. In 
view of these exciting findings, one can conclude that a functional osteochondral implant 
would eventually be derived from competent cells, well designed scaffolds, suitable 
biomaterials and potent growth factors.  
 
2.4.1. Cell based therapies 
 
Implanted cells play a restorative role in osteochondral repair [31, 61]. This is especially 
so for the cartilage defect as the omission of exogeneous cells could lead to unfavorable 
outcomes [31]. In an osteochondral construct, the candidate cells can be differentiated 
cells (osteoblast and chondrocytes) or progenitor cells. Chondrocytes are commonly used 
but its application is hampered by several concerns. Firstly, chondrocytes are highly 
differentiated and they have a limited capacity for expansion [157-158]. Moreover these 
cells dedifferentiate during 2D culturing and they lose the capacity to secrete the key 
cartilaginous ECM such as collagen type II and aggrecan. More importantly, Wakitani et 
al has expressed reservations on the efficacy of chondrocytes for bone repair as their 
osteogenic response was slow [159]. To circumvent this limitation, osteoblasts or other 
cell sources are required to complement the use of chondrocytes so as to aid bone 
regeneration. This tedious approach can be simplified through the use of stem cells that 
are capable of reconstituting both cartilage and bone effectively. These progenitor cells 
are known to be capable of both self – renewal and differentiation as they form the basic 
cellular building blocks [160]. Hence they possess an immense reparative potential for 
clinical exploitation. There are several classes of stem cells and one of them is the 
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Embryonic Stem Cell (ESC). This pluripotent cell is capable of forming countless tissues 
and its use for cartilage regeneration was also being investigated [156]. However its 
clinical use is discouraged on ethical grounds and the risk of teratomas [161]. To avoid 
these contentions, adult stem cells prevalent in mature tissues are sought as alternatives 
and one of them is the MSC.  
 
Role of MSC in osteochondral repair 
 
MSC was first isolated by Friendenstein when he retained the adherent cell fraction from 
bone marrow cultures [162]. Besides bone marrow, MSC are also found in peripheral 
blood, perichondrium, periosteum, skin, muscle, growth plate and fat tissues. Depending 
on the environmental cues, this multipotential cell is capable of differentiating into 
osteoblast, chondrocyte, adipocyte and myoblast [70]. The use of MSC for 
musculoskeletal repair is attractive because of various inherent advantages. Firstly, the 
routine harvest of bone marrow that is rich in MSC can be conducted via a minor non-
invasive procedure [163]. Subsequently, the isolated progenitors can be readily expanded 
[164]. Moreover MSC do not express cell surface markers that T cells recognize in 
immuno-rejection [165]. More importantly, MSC is capable of differentiating into 
osteoblasts and chondrocytes that are needed for cartilage and bone healing [92]. 
Therefore the usage of MSC does away with the need for invasive multisite biopsies that 
are required to isolate both cell types. Moreover donor site morbidity is also avoided. 
Upon recognizing these advantages, Im et al experimented with a modified ACI procedure 
which uses MSC instead of chondrocytes and he noted the formation of neocartilage in the 
animal models at 14 weeks [158]. Comparative studies between mature chondrocytes and 
MSC have suggested a predominant fibrocartilage repair with chondrocytes but hyaline 
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regeneration and improved host cartilage integration with MSC [4, 166]. Wakitani et al 
reasoned that during an osteochondral injury, potent cytokines were released and they 
primarily target the MSC and not chondrocytes [159]. His opinion was based on the poor 
response of chondrocytes especially so at the bone region where bone substitution was 
slow [159, 167-169]. Conversely, MSC was able to assist bone healing by progressing 
rapidly through the chondrogenic lineage to hypertrophy and subsequently the 
hypertrophic tissue was vascularized and remodeled into bone [170]. In order to prove the 
reparative role of MSC, Tatebe et al implanted labeled MSC into the osteochondral defect 
of rabbits [171]. It was discovered that the chondrocytes and osteoblasts located in the 
regenerated tissues originated from the labeled cells. Interestingly, when Lee injected 
labeled MSC into the joint space of pigs, cell migration into the cartilage defect site was 
observed and it promoted healing [172].  
     
2.4.2. Scaffold based techniques : Biphasic and monophasic 
 
Scaffolds 
Scaffolds are increasingly being recognized as an important component required for the 
repair of osteochondral defects and their effectiveness is dependent on various factors. 
Osteochondral scaffolds must be porous so as to allow vasculature invasion which is 
necessary for bone regeneration. Conversely cartilage is an avascular tissue, hence the 
scaffold has to be highly porous so as to facilitate nutrient transport via diffusion. The 
porous implant would not only support tissue in growth but also host tissue integration. 
However these porous matrices retain cells poorly when harnessed as cellular delivery 
vehicles. To arrest cell loss, seeding via hydrogel encapsulation is widely employed. This 
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constitutes a “micro matrix within a macro scaffold” approach. The scaffolding system           
provides a 3D environment which mimics the natural physiological state for cell 
attachment and tissue in growth. It was discovered that chondrocytes dedifferentiate and 
become fibroblastic when they are maintained on a 2D surface, but they regain their 
chondrocytic phenotype in 3D scaffolds [54, 173]. As the native osteochondral region is 
exposed to high levels of physiological loads ranging from 20 – 800% of the body weight, 
the scaffold must be able to shield the immature tissue from excessive stress [174-175]. In 
view of all these demands, the osteochondral scaffold must possess the following features 
: 
 
1. Porous. It must be sufficiently porous with large interconnected pores so as to 
facilitate tissue in growth and nutrient exchange [30, 176].  
2. Biocompatibility. It must not elicit an adverse host reaction but support the 
integration between the repair and host tissue. 
3. Biomimetic. It must be able to modulate cellular behavior and enhance the 
regenerative process.     
4. Biodegradable. The gradual degradation of the scaffold would permit load 
bearing on the regenerated tissue as it remodels. 
5. Mechanical competence. It must be able to withstand in vivo loads so as to 
protect the neotissue.  
 
In order to achieve optimal results in all these aspects, careful thought is given to the 




Osteochondral functional restoration is dependent on the biological and biomechanical 
properties of the implanted scaffold. These should mimic the native characteristics of 
cartilage and bone. Bone is a well vasculatized tissue while cartilage is avascular, hence it 
is heavily reliant on diffusion for molecular transport. Bone biology is influenced by the 
significant inorganic content which comprises mainly of calcium phosphate and 
hydroxyapatite [128]. On the other hand, cartilage physiology is affected by the organic 
matrix and high water content. These fundamental compositional differences result in 
different mechanical behaviors. Trabecular bone is stiffer than cartilage and it has an 
instantaneous compressive Young’s modulus of 4.4 – 229 MPa, while that of cartilage 
was found to be 1.36 – 39.2 MPa [177-179]. The yield stress for trabecular bone and 
cartilage are 0.85 – 13 MPa and 5 MPa respectively [178, 180]. During loading, the 
cartilage tissue deforms more than the stiff osseous tissue, resulting in different strains in 
the osteochondral region [181].  
 
In view of these inherent dissimilarities, a biphasic approach can be adopted with 
customization of a dual scaffold phase with respect to the unique material, structural and 
mechanical requirements suited for the regeneration of cartilage and bone. The biphasic 
construct comprised of the top cartilage component and an underlying osseous phase [8-9, 
12, 22]. In the current work, biphasic does not refer to two distinct phases of composite 
materials as described in the biomechanical modeling of cartilage by Mow et al, Mak et al 
and Disilvestro et al [182-185]. A biphasic osteochondral scaffold can comprise of 2 
separate units which are combined at the point of application. An example would be the 
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bilayered scaffold that Schaefer et al devised using a PGA cartilage mesh and a 
PolyLactic-co-Glycolic Acid / Poly Ethylene Glycol (PLGA /  PEG) bone matrix [17]. 
After cell seeding and induction, these discrete units were combined for coculturing. 
Furthermore a biphasic scaffold can also be built as an integrated construct with a 
transition zone between the 2 phases. This was demonstrated in Harley et al’s an 
integrated bilayer scaffold that was fabricated via liquid cosynthesis which allowed the 
interdiffusion of materials from the cartilage and bone phases thereby creating in a gradual 
transition zone [52, 181]. To enhance regeneration, materials with biomimetic properties 
are preferred. Barbero et al found that he was able to direct the differentiation of 
chondrocytes down an osteogenic lineage with a high expression of collagen I and bone 
sialoprotein by maintaining the cells on a ceramic substrate [186]. Conversely, the 
chondrogenic phenotype with the expression of collagen II and GAG can be promoted by 
plating the chondrocytes onto collagen coated surfaces [186]. Hence chondrogenic and 
osteogenic differentiations can be modulated through cell substrate interactions. In line 
with these findings, Tanaka et al attempted to repair an osteochondral lesion by 
implanting collagen and Tri Calcium Phosphate (TCP) into the cartilage and bone defects 
respectively [12]. Bone regeneration occurred in the resorbing ceramic but cartilage repair 
deteriorated because the collagen gel was too soft [12]. Mechanical compatibility is 
crucial in the design of osteochondral scaffolds. Niederauer et al was able to achieve 
better cartilage restoration at the load bearing sites of the goat model when he implanted 
scaffolds of comparable stiffness to the native cartilage [2]. The same principle also 
applies to design of the bone matrix. This was shown by Schlichting et al when he tested 
stiff and soft scaffolds in the subchondral bone defects of sheep [187]. The stiff matrix 
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assisted osseous healing but bone sclerosis occurred when the soft scaffold was used as it 
was not able to provide adequate support at the defect site [187]. Cartilage and bone 
scaffolds of different mechanical properties are fabricated so as to mimic the 
physiological biomechanics of the osteochondral tissue. Oliveira et al used this approach 
in the development of a chitosan hydroxyapatite bilayer scaffold [9]. The chitosan matrix 
served as the cartilage phase and it has a Young’s modulus of 2.9 MPa while the stiff 
hydroxyapatite bone scaffold has a higher modulus of 153 MPa [9]. In addition to that, the 
2 phases also differed structurally. The cartilage scaffold was more porous than the bone 
matrix as cartilage growth was solely dependent on diffusion for nutrient exchange while 
bone development was facilitated by vasculature. Sherwood et al was able to incorporate 
this structural variation in an integrated biphasic matrix which was 90% porous in the 
cartilage region, 55% porous in the bone phase and there was an intermediate zone with a 
gradual transition in porosity [26]. The inherent advantage of the biphasic design given 
the flexibility in varying the material, structural and mechanical properties of the 2 phases 
so as to assist cartilage and bone repair is an appealing strategy which many investigators 
have exploited (table 2.1).  
 
Monophasic approach 
A monophasic osteochondral scaffold is defined as a single homogeneous matrix 
consisting of both cartilage and bone phases. This approach encompasses the use of a 
bone scaffold without a cartilage matrix. Mixed and inconsistent outcomes were reported 
with monophasic scaffolds. Schreiber et al was able to achieve hyaline cartilage repair 
with a monophasic PGA matrix, but the results were compromised by the unsatisfactory 
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restoration of bone [42]. This constraint can be partially resolved through the inclusion of 
osteogenic induced cells. Alhadlaq et al encapsulated osteogenic induced rat MSC in the 
bone phase of the Poly Ethylene Glycol Diacrylate (PEGDA) matrix [49]. Osteogenesis 
and chondrogenesis occurred in the monophasic construct when it was implanted into 
subcutaneous sites. Cao and co-workers seeded osteoblasts into monophasic 
Polycaprolactone (PCL) scaffolds and after 50 days of coculturing, mineralized nodules 
were observed in the osseous compartment [54]. On the other hand, Guo et al reported 
satisfactory bone and cartilage healing at the osteochondral defect of the sheep model 
when he used an MSC seeded TCP scaffold [44]. In these studies, the cartilage region was 
reinforced by an artificial matrix but researchers such as Kandel et al deemed that the 
cartilage scaffold was redundant [53]. He seeded chondrocytes onto a ceramic scaffold 
and implanted it into sheep. After 9 months, the repair cartilage was found to be deficient 
in collagen II and compressive strength [53]. This mirrors the inconsistent outcomes in 
ACI and Lee et al reasoned that it was due to the poor mechanical integrity of the repair 
cartilage which was attributed to the omission of the cartilage matrix during the cell 
transplantation procedure [188].    
 
Biphasic vs Monophasic     
The biphasic approach in designing an osteochondral scaffold excels over that of 
monophasic as the cartilage and bone phases can be individually customized in terms of 
the material, structural and mechanical aspects so as to assist the regeneration of the 
specific tissues. The monophasic scaffold can be optimized in these 3 areas but it would 
be difficult to engineer a single matrix that would mimic the different biological features 
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of cartilage and bone. These design concepts were put to the test in Niederauer et al’s goat 
implantation study [2]. He found that a better histological score was achieved through the 
use of the biphasic scaffolds moreover overall healing was enhanced when bioceramics 
were incorporated into the bone matrix [2]. A probable reason for this could be that these 
bioactive components accelerated the regeneration of the subchondral bone which was the 
supporting substratum for the overlying cartilage. Beyond compositional considerations, 
the biphasic scaffold can be engineered to recapitulate native deformation through the 
coupling of a flexible cartilage phase to a stiff bone matrix. According to 
mechanotransduction theories, such an arrangement exposes the reparative cells to a low 
strain in the bone region which supports osteogenesis and an elevated strain in the 
overlying cartilage zone that promotes chondrogenesis [189]. This postulation was 
validated by the experimental observation that a strain of 10% stimulates 
Glycosaminoglycan (GAG) synthesis in chondrocytes while a reduced strain of 0.1% 
enhances alkaline phosphatase (ALP) activity and ECM production in osteoblasts [190-




No. Cartilage phase Bone phase Comments Reference 
1 PLGA scaffold (12 MPa stiffness) 
Reinforced PLGA scaffold (32 MPa stiffness) 
Reinforced PLGA scaffold (32 MPa stiffness) 
Reinforced PLGA scaffold (32 MPa stiffness) 
PLGA scaffold (12 MPa stiffness) 
Reinforced PLGA scaffold (48 MPa stiffness) 
PLGA scaffold with bioglass (0.3 MPa stiffness) 
PLGA scaffold with calcium sulfate (1080 MPa 
stiffness) 
- Biphasic and monophasic 
- Poor histological scoring for 
monophasic implants. 
- The use of bioceramics 
enhanced the overall 
osteochondral repair. 
- A cartilage scaffold with 
comparable stiffness to the 





2 3% type 1 atelo – collagen gel  TCP matrix (75% porosity, 200 µm pore size) - Biphasic 
- Fibrocartilage increased in 
the cartilage defect. The 
collagen gel might be 
biomechanically 
incompatible with respect to 




3 PGA scaffold (97% porosity) PLGA - PEG scaffold (85% porosity) - Biphasic 
- The 2 distinct phases were 
separately induced but were 
sutured together prior to 
coculturing. 
- An increase in GAG was 




4 Collagen - GAG scaffold (98% porosity, 653 
µm pore size, 30 kPa stiffness)  
Collagen - GAG - Calcium phosphate scaffold 
(85% porosity, 56 – 1085 µm pore size, 762 kPa 
stiffness, 85.2 kPa compressive strength) 
- Integrated biphasic 
- Integration between the 2 
phases was achieved through 
liquid cosynthesis which 





5 Chitosan matrix (74.6% porosity, 20 - 600 µm 
pore size, 2.9 MPa stiffness) 
Hydroxyapatite scaffold (59.3% porosity, 50 – 
500 µm pore size,  153 MPa stiffness) 
- Integrated biphasic  
- l mm thick transition zone.   
- Seeded with induced cells. 
Chondrogenesis and 
osteogenesis occurred in the 











No. Cartilage phase Bone phase Comments Reference 
6 PLA scaffold  Hydroxyapatite scaffold (50% porosity, 300 – 
800 µm pore size) 
- Integrated biphasic  
- A PGA film which served as 
a cell barrier was sandwiched 




7 PLGA matrix (85% porosity, 250 – 400 µm 
pore size) 
PLGA - TCP matrix (85% porosity, 250 – 400 
µm pore size) 
- Integrated biphasic 
- Implanted at the 
osteochondral defect in the 
pig model. Bone regeneration 
occurred in the unseeded 




8 PLGA - PLA matrix (90% porosity) PLGA - TCP matrix (55% porosity, 1.6 – 2.5 
MPa compressive strength) 
- Integrated biphasic 
- A gradient in material 
composition and porosity was 




9 PCL scaffold (65% porosity, 300 - 580 µm 
pore size)  
PCL scaffold (65% porosity, 300 - 580 µm pore 
size)  
- Monophasic 
- Seeded with chondrocytes 
and osteoblasts prior to 




10 PEGDA hydrogel PEGDA hydrogel - Monophasic 
- Seeded with chondrogenic 
and osteogenic induced rat 
MSC. Stratified tissue layers 
were observed after 




11 PGA scaffold  PGA scaffold  - Monophasic 
- Unsatisfactory bone repair in 






No. Cartilage phase Bone phase Comments Reference 
12 TCP scaffold (70% porosity, 450 µm pore 
size,  4 – 6 MPa compressive strength) 
TCP scaffold (70% porosity, 450 µm pore size,  
4 – 6 MPa compressive strength) 
- Monophasic 
- Seeded with MSC prior to 
implantation.  
- Cartilage repair with 





13  No scaffold Collagen hydroxyapatite matrix 
  
- Monophasic 
- Chondrocytes were seeded 
onto the scaffold. 
- A viable cartilage tissue 
developed during in vitro 




14 No scaffold Calcium polyphosphate matrix (37% porosity) - Monophasic 
- Seeded with chondrocytes 
and precultured for 8 weeks 
before implantation. The 
repair cartilage has a low 





15 No scaffold PLA scaffold (92% porosity) - Monophasic 
- A chondrogenic induced cell 
pellet was press coated onto 
the PLA scaffold. 
- A low compressive strength 








2.4.3. Classes of scaffolds and fabrication techniques.  
 
 
There are 5 categories of scaffolds : injectable matrices, foams, electrospun meshes, 
textiles and Rapid Prototyped (RP) scaffolds. The classification is based on the production 
approach and since there is a close interplay between fabrication methods and scaffold 
characteristics, these 5 classes of matrices have varying properties. The manufacturing 
procedures and associated applications are summarized in table 2.3. As each category 
would have an unique set of strengths and weaknesses, an in depth understanding is 





Injectable matrices comprise of liquefied polymers, hydrogels and ceramic paste. 
Liquefied matrices can be readily shaped or injected into surgical sites via minimally 
invasive procedures and they adopt the shape of the defect upon solidification [20]. 
Hydrogels provide a 3D environment which is important for cellular development as 
demonstrated by the maintenance of the chondrocytic phenotype, moreover therapeutic 
agents can be easily incorporated into the injectable material via simple mixing prior to 
application [50, 192]. An example would be fibrin glue which has been evaluated by 
Catelas et al as a carrier for Transforming Growth Factor Beta 1 (TGF-β1) and it was also 
advocated by Silverman et al as a possible injectable tissue engineered cartilage matrix 
[20, 193]. Despites of these outstanding advantages, Risbud et al has expressed concern 
that some of these matrices lack mechanical strength and suggested the complementary 
use of solid porous scaffolds [194].  That proves to be strategic as the injectable matrix 




Foams possess a sponge-like architecture and they are conventionally produced via phase 
separation, porogen and solvent removal. Table salt is a common porogen that is added to 
the biomaterial during the fabrication process. Subsequent salt leaching results in a porous 
matrix, hence porosity and pore size can simply be controlled by adjusting the salt content 
and particle size [73]. However due to porogen agglomeration, architectural features such 
as pore shape and interconnectivity are poorly modulated [196]. The removal of porogens 
and solvents located far from the exterior surface poses a concern, especially so when the 
solvents are cytotoxic. Moreover during solvent evaporation, the pores are frequently 




This unique matrix consists of electrospun fibers of nanometer dimensions which 
physically mimic the structural dimensions of naturally occurring ECM and they can be 
arranged either in an orderly or random fashion [72]. Electrospun meshes have a high 
surface area to volume ratio which is favorable towards cell attachment and tissue growth 
[72]. This unique topography enhanced the attachment and survivability of HTB-94 
chondrocyte like cell line [197]. Interestingly, chondrocytes cultured on PCL electrospun 
meshes were found to undergo redifferentiation in the absence of growth factors and the 
nanometer topology could have played a significant role [198]. In order to harness the 
mechanical stability of synthetic polymers and the bioactivity of natural materials, 
composite meshes are explored. One example would be the blend of poly (L – lactide – co 
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– ε - caprolactone) and collagen I as reported by Kwon et al [96]. Compositional 
optimization was required as cell attachment and proliferation improved with the increase 
in the collagen I content which was offset by a decline in mechanical strength. This is 
because during electrospinning, parameters such as material additives and deposition 
voltage influence the fiber dimensions. The mean diameter of poly (L-lactide-co-ε-
caprolactone) electrospun fibers decreased with the inclusion of collagen type I [96]. Such 
dimensional alterations influence cell behavior as witnessed by Li et al [199]. Li et al 
discovered that bovine chondrocytes adopted different morphologies when seeded on 500 
nm and 15 µm PLA elecrospun meshes. Differences in cell proliferation and ECM 
synthesis were also reported [199]. As the electrospun fibers are loosely piled up, the 
resultant matrix is highly porous with interconnected pores [72]. Li et al was again able to 
exploit this advantage by seeding MSC onto an electrospun PCL mesh and after 21 days 
of in vitro chondrogenic induction, progenitor cells were found to infiltrate into the porous 
structure and underwent chondrogenesis, resulting in a construct with a stratified cell 
orientation which resembled that of native cartilage [200]. The porous architecture of the 
electrospun mesh also allows it to be harnessed as permeable membrane required for the 
resurfacing of osteochondral defects. Nutrient diffusion can occur across the porous 
membrane from the synovial space to the repair site. This role is currently fulfilled by the 
autologous periosteal flap whose use is frequently accompanied by cartilage hypertrophy 
[87]. As the cartilage patch seals the osteochondral defect so as to arrest the leakage of 
transplanted cells, the electrospun mesh must have restrictive pores so as to function as a 







Textiles are used in the tissue engineering of bone, cartilage, cardiovasculature, bladder 
and liver [201-203]. This versatile scaffold can be broadly divided into 2 categories : 
woven and non-woven textiles. Both categories are highly porous with a high surface to 
volume ratio hence promoting cell attachment and proliferation. Unfortunately textiles are 
unable to withstand mechanical compression hence they may not be suited for the 
regeneration of load bearing tissues [56].  
 
RP scaffolds      
The RP technique is centered on the computer aided construction of the individual layers 
via material deposition which are subsequently stacked to form the intended 3D object 
[56]. RP was initially employed in the production of implant templates and intricate 
anatomical models required for operative planning [84]. Complex anatomies can be 
readily reproduced as patient data derived from Computed Tomography (CT) and 
Magnetic Resonance Imaging (MRI) are used as a digital input for RP design and 
fabrication [56]. Similarly RP scaffolds can be customized to fit an implantation site and 
this advantage is uncommon among other conventional methods. Being a highly accurate 
and controllable process, scaffolds with interconnected pores and complicated details can 
be consistently produced. Such standards are not only enforceable within a single scaffold 
but also for different batches during scaled up production [204]. This is difficult with 
other fabrication modes especially so if there is a heavy reliance on personnel expertise 
which results in varying outcomes among operators [205]. A comparative study between 
RP and foam based scaffolds was conducted by Malda et al with the objective of selecting 
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the optimal matrix for cartilage implants [77]. These scaffolds were seeded with 
chondrocytes and cultured for 35 days. It was found that the RP construct exhibited 
superior cell distribution and ECM deposition as the well connected pore network assisted 
cartilaginous development while the poorly interconnected pores in the foam hampered 
cell survival and growth [77]. Woodfield et al also modified the RP matrix by altering the 
lay down pattern at each deposition layer so as to control the scaffold porosity, pore 
geometry and mechanical strength [59]. This flexibility was further enhanced by the non-
reliance on solvents and porogens. The use of toxic solvents is a safety concern as 
complete removal is difficult [56].  
 
There are various RP processes available for tissue engineering applications (table 2.2). 
But among these techniques, the author’s group has deemed the Fused Deposition 
Modeling (FDM) approach to be versatile as the feed material is not restricted to photo-
curable polymers that are required in Stereolithography (SLA) [39]. Powder material must 
be removed from Selective Laser Sintering (SLS) and Three Dimensional Printing (3DP) 
scaffolds, but this is unnecessary in FDM. The ease of automation in FDM excels over the 
tedious lamination procedure in laminated object manufacturing [84]. Despite of its 
strengths, there are drawbacks in the FDM technique and one of which is the need for feed 
filaments of precise dimensions. Furthermore operational requirements such as extrusion 
temperature limit the spectrum of biomaterials suitable for processing. Three dimensional 
deposition is an alterative RP method which does not require preformed filaments as the 



























Techniques Description  
Stereolithography  
(SLA) 
The tracing of lasers across resin filled vats which polymerizes the curable 
material found within the trace paths [39].   
Selective Laser Sintering 
(SLS) 
A bed of heat fusible powder material is sintered in a defined pattern using lasers. 
The bonded layers are subsequently supported by the surrounding unprocessed 
powder which has to be extracted out at the end of the process [43].   
Three Dimensional 
Printing  (3DP) 
An ink jet printer setup ejects liquid binder onto a layer of powdered material. 
This binder bonds the powder at precise positions giving rise to the desired 
architecture of the 3D object [61].  
Laminated object 
manufacturing  
Lasers cut out profiles on heat activated adhesive coated paper. These profiles are 
subsequently stacked and laminated to form the desired object [84].  
Fused Deposition 
Modeling (FDM) 
As preformed thermoplastic filament is fed into a temperature controlled extruder, 
the incoming feed material drives the preceding liquefied material which is 
extruded onto a movable platform [86].      
Three dimensional 
deposition 
Filaments are deposited using a syringe system and the extrusion is assisted by a 
plunger or air pressure. The feed material need not be of defined dimensions as 
required in FDM [59].  
 







Category Fabrication technique Tissue engineering applications in bone and cartilage 
Injectables  Gelation of polymers or ceramics via 
polymerization or chemical reactions. 
- Self hardening injectable calcium phosphate was used 
as a bone filler of osteochondral defects created in 
rabbits [31]. 
 
- Collagen I gel enmeshed in a 3D polyethylene woven 
textile was used to deliver basic Fibroblast Growth 
Factor (FGF) to the osteochondral defects in rabbits 
[46]. 
 
- Photopolymerizable PEG based hydrogel was used to 
encapsulate rat MSC. Bone and cartilage development 
occurred under osteogenic and chondrogenic 
induction respectively [49].  
 
Foams  Foams are sponge like structures 
which can be fabricated via solvent 
leaching, gas foaming, vacuum drying, 
salt leaching, porogen removal, 
thermally induced phase separation 
and casting [55-57].       
- PLA sponge was fabricated by Schek et al via solvent 
evaporation and salt leaching. The matrix was 
developed as the cartilage phase of an osteochondral 
implant [8]. 
   
- Sintered calcium polyphosphate foam was implanted 
into osteochondral defects in sheep. Bone in growth 
was observed in the bony region [53]. 
 
- Gotterbarm fabricated a biphasic scaffold comprising 
of freeze dried collagen sponge (cartilage phase) and 




Matrices are fabricated via 
electrospinning whereby an electrical 
field is applied to the polymer solvent 
solution. This creates a force which 
exceeds the surface tension of the 
polymer solution, resulting in the 
ejection of an electrically charged 
polymer jet that undergoes bending 
and elongation. Solvent evaporates 
from this polymer stream before it 
reaches a grounded collection device 
as nanometer polymer fibers [72-73]. 
Mechanical properties are dependent 
on fiber orientation [83].  
 
- Shields and co workers observed the infiltration of 
chondrocytes in electrospun collagen II meshes [89]. 
 
- PCL electrospun meshes were seeded with rat MSC 
and subjected to osteogenic induction under dynamic 
in vitro culturing. Cell proliferation, osteogenesis and 


















2.4.4. Scaffolding materials 
The functional characteristics of the scaffold are derived from its inherent material 
properties. Therefore the first step in scaffold design is material selection which has to be 
accompanied by an insight of material strength, chemistry and degradation kinetics. The 
criteria in gauging the material suitability is as listed : 
 
1. The resorption rates of biodegradable materials must match that of tissue in growth 
so that there would be sufficient mechanical strength to shield the neo-tissue from 
excessive loads. A controllable degradation would allow for the maintenance of 
open pore channels which facilitates tissue in growth [56, 204].  
2. Physiologically compatible material strength [204].  
3. Surface chemistry which promotes cell adhesion, proliferation and migration[206].  
Category Fabrication technique Tissue engineering applications in bone and cartilage 
Textiles  Subdivided into woven and non-
woven meshes. Regular woven textiles 
are formed via knitting, braiding and 
embroidery, while non – woven 
meshes consist of an agglomeration of 
polymer fibers.  
- A non-woven PGA mesh was seeded with 
chondrocytes and implanted into in vivo osteochondral 
defects. Significant healing was observed as compared 
to untreated defects [42]. 
 
- Fukuda sprayed coated a 3D polyethylene woven 
fabric with hydroxyapatite to form an osteochondral 
scaffold [46].  
                                 
RP 
scaffolds 
A 3D model of the intended object is 
created via computation. This model is 
digitally sectioned and the data from 
each section guides the layer by layer 
construction of the scaffold. 
Fabrication can be accomplished via 
SLA, SLS, 3DP, 3D deposition, 
laminated object manufacturing and 
FDM. 
         
-      Woodfield et al fabricated a honeycomb scaffold using 
3D deposition. Chondrocytes which were seeded into 
the porous matrix, proliferated and secreted 
cartilaginous ECM [59]. 
 
- A biodegradable burr hole cover designed for 
cranioplasty was built using FDM. During clinical 





4. Flexibility in material processing which allows for a variety of shapes and sizes of 
scaffolds to be constructed [56].  
5. Availability, affordability and sterility [54, 207]. 
6. An absence of toxicity and the inability to provoke immunological responses either 
from the release or metabolism of degradation products [208].  
7. Regulatory approval and acceptance [32]. 
 
The advancement of material science has introduced a wide spectrum of biomaterials. In 
the following discussion, these materials can be divided into 4 main classes : 
decellularized tissue matrices, natural polymers, synthetic polymers and ceramics (table 
2.4).   
 
Decellularized tissue matrices 
Decellularized tissues can be potentially harnessed as scaffolding materials as they retain 
a portion of their original native characteristics. An example would be the Devitalized 
Bone Matrix (DBM) which is osteoconductive and osteoinductive as it harbors BMP in a 
collagenous meshwork [13, 209].  Kasten et al found that DBM excels over 
hydroxyapatite and calcium phosphate in terms of cell growth and osteogenesis when he 
evaluated the suitability of these materials as osseous implants [13]. The inherent presence 
of growth factors is an advantage because they would promote better tissue restoration for 
the subchondral bone and cartilage [14]. Lyophilized cartilage chips are also 
decellularized tissue matrices that can be used in osteochondral regeneration. When 
Peretti et al created cartilagous constructs comprising of cartilage chips and fibrin seeded 
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chondrocytes, he observed a synergistic interaction between the cells and decellularized 
chips. Furthermore the lyophilized tissue conferred stiffness to the implant as it aided 
volume and mass retention [6-7]. Despite of these advantages, concerns such as limited 
availability and pathogen transfer hamper the widespread use of these allogenous derived 
materials [41].  
 
Natural polymers 
Natural polymers are readily available and they are well received in the medical 
community. One example would be hyaluronan which can be used as an injectable 
hydrogel for lip augmentation and recontouring [50]. Being immunologically inert and 
completely biodegradable, it can be used as a cellular delivery vehicle to assist healing in 
osteochondral defects [29]. Solchaga et al suspected that the degradation of this natural 
polymer facilitates the vascularization, endochondral formation and host tissue integration 
[101, 210-213]. However hyaluronan has a short residence due to its high solubility and 
rapid resorption, thus esterified forms are recommended for extended implantation periods 
[32]. Chitosan is another natural material with potential osteochondral regenerative 
applications and it can be complemented with calcium phosphate to promote bone healing 
[50]. However the usage of chitosan is hampered by its chemoattraction on neutrophils 
which provokes a foreign body response [10]. The use of natural polymers could also 
replicate the native physiological conditions. For instance, it was found that load 
transmission via fluid pressurization occurs in both cartilage and agarose [214]. Benya et 
al exploited this similarity by compressing chondrocytes which were embedded in agarose 
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so as to elucidate the effects of loading on cartilage physiology [215]. However there is a 
limited use of agarose as an implant material given its poor bioresorption [216].                   
Collagen is an ubiquitous substance in the human body and it is found in bone and 
cartilage. When a comparison is made between bovine collagen type I and synthetic 
polymers, Garnde et al noted that collagen excels in terms of chondrocyte adhesion and 
ECM synthesis. This advantage stems from the fact that there is a regulatory feedback 
between the natural substrate and chondrocyte [67]. Moreover collagen can be remodeled 
and degraded as it is easily recognized by enzymes and this turnover not only creates 
space for the growing tissue but also stimulates new collagen deposition [67, 111]. Gelatin 
is derived from denatured collagen but it lacks antigenic properties [217]. Xia et al was 
able to use a chitosan – gelatin composite scaffold to engineer an elastic cartilage implant 
which exhibited chondrocytic lacuna, GAG deposition and a stiffness that approximated 
to that of native auricular cartilage [27].                  
               
Fibrin is a naturally derived polymer employed in the native healing of vascularized 
tissues. During clotting, fibrinogen which is a monomeric form of fibrin is cleaved by 
thrombin (a serine protease). These molecules associate to form fibrin polymer chains 
which lengthen and thicken. The agglomeration of these chains constitutes a 3D matrix 
[218-219]. The polymerization is assisted by factor XIII, a protransglutaminase which 
cross links and stabilizes the clot. During degradation, fibrin is broken down by the 
proteolytic enzyme plasmin. But the process is influenced by the presence of aprotonin 
(fibrinolysis inhibitor), the degree of fibrin cross linking and host response [220]. Fibrin is 
a clinically approved tissue adhesive which can be used to achieve traumatic wound 
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closure, hemostasis and healing [220]. It is popular given the availability of commercial 
kits that are well known for their stringent quality controls [218]. Besides conventional 
surgical applications [220], fibrin can also be used as a matrix and cell seeding agent in 
tissue engineering applications. Bensaid et al seeded MSC into bone coralline scaffolds 
via fibrin [221]. Paletta et al found the exogenous fibrin clot to be effective for 
osteochondral repair as it accelerates the healing response [21]. Moreover the implanted 
fibrin matrix restored the geometry of the articulating surface while promoting the repair 
of underlying subchondral bone [21]. Despite of these encouraging findings, Paletta et al 
cautioned that fibrin degrades rapidly and it lacked the mechanical competence to support 
osteochondral healing at critical load bearing sites. To resolve this constraint, Silverman 
and coworkers advocated a higher fibrinogen content when encapsulating chondrocytes as 
that would slow down the degradation process, allowing for the deposition of 
cartilaginous ECM [20]. The composition of the fibrin matrix not only affects mechanical 
performance and degradation kinetics, but it also influences cell response. Cox et al 
reported fluctuations in cell proliferation, migration and cytokine expression when he 
adjusted the fibrinogen and thrombin contents of encapsulating matrices [222].  
 
Alginate is a polysaccharide consisting of (1→ 4)-linked β-D-mannuronate (M block) and 
C-5 epimer α-L-guluronate (G block) (Figure 2.1). The G blocks form stable cross links 
with divalent cations so as to constitute 3D networks, hence a high G block content would 
result in a rigid matrix. On the other hand, gels with high M block content would be soft 
and elastic [223]. Besides being used in the production of absorbable wound dressings, 
alginate can be employed as a delivery agent for Deoxyribonucleic Acid (DNA), proteins 
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and cells. Alginate was used to encapsulate cells in osteochondral implants [79, 224]. 
Cohen et al achieved uniform chondrocyte seeding on PGA-PLA non woven textiles with 
alginate [225]. But the use of alginate is constrained by immunogenicity as inflammatory 
agents were detected in unpurified grades [32, 226-227]. Poor biodegradability is also a 
concern. When Silverman et al attempted to tissue engineer cartilage, he observed non-
uniform growth as pockets of neocartilage were separated by undegraded alginate even 
after 3 months of animal implantation. Despite of this, the slow degradation kinetics was 
exploited by Marignissen et al when he improved the shape retention of collagen matrices 
through the addition of alginate as it delayed the degradation process [228]. In addition to 
these limitations, poor cell attachment is frequently encountered with alginate matrices. 
Lawson et al noted that MSC does not attach nor proliferate readily in alginate [229]. 
Mierisch et al had the same problem when he implanted chondrocytes encapsulated within 
alginate into an osteochondral defect. The bioinertness of the hydrogel resulted in cell 
death at the implant site [80]. Hence additives such as collagen, TCP and fibronectin were 
recommended so as to improve the cellular response of alginate [229-230]. Though 
alginate and fibrin are widely used in the encapsulation of chondrocytes, the findings 
cannot be directly applied to MSC because these progenitor cells undergo chondrogenesis 
upon induction and the process is influenced by the environmental cues. Hence additional 
studies are required to elucidate the effects of hydrogel encapsulation on MSC seeded 
within osteochondral constructs.  














There is a drive towards the development of synthetic materials given the constraints 
associated with the use of natural polymers such as the difficulty in securing large 
quantities with reproducible quality [67]. Moreover the risk of pathogen transfer from 
animal sources is also a concern [231]. This is not the case with synthetic polymers as 
they can be mass produced with strict quality controls [232]. Furthermore the properties of 
these materials can be tailored to suit applications. For example Malda et al altered the 
ratio of the co-polymers poly ethylene glycol terephthalate and poly butylene terephthalate 
so as to derive a polymer with comparable mechanical properties to the articular cartilage 
[77]. An alteration in molecular weight would also yield a similar effect [233]. Synthetic 
polymers commonly used in osteochondral regenerative work can be classified on the 
basis of biodegradability. PGA, PCL, PLGA and PLA are biodegradable polymers. The 
non – biodegradable polymers would include Polyurethane, Poly Tetrafluoethylene 
(PTFE), PEGDA, Poly Methyl Methacrylate (PMMA) and Poly Ethylene Oxide (PEO). 
Biodegradable polymers are rather appealing as they facilitate tissue remodeling at the 
Figure 2.1. Molecular 
formula of alginate. 
Monomer (A), chain 
conformation (B) and 







implant site while the non-biodegradable counterparts are usually applied in conceptual 
studies.  
 
Some of the synthetic polymers are photopolymerizable and they can be used in the 
creation of implants with complex shapes [234-235]. Alhadlaq et al recognized this 
advantage and used photopolymerizable PEGDA in the fabrication of a human condylar 
shaped biphasic osteochondral construct[49]. This biocompatible polymer was capable of 
maintaining the phenotype of chondrogenic and osteogenic induced MSC which were 
entrapped in 2 distinct layers. Elisseeff et al attempted to recreate the cartilage and bone 
regions of the osteochondral tissue by encapsulating goat MSC in PEGDA [236]. He 
noted cell proliferation with an accumulation of collagen II and GAG in the cartilage layer 
while the bone phase became opaque with calcium deposition [236]. Despite of this 
promising outcome, Salinas et al caution against the use of Poly Ethylene Glycol (PEG) 
based hydrogels as these bioinert materials are unable to maintain the viability of MSC 
which is adherence dependent for survival and function [237].    
 
PLGA is a versatile synthetic copolymer comprising of PLA and PGA. The percentage 
content of PLA determines material rigidity while biodegradability is largely influenced 
by that of PGA [3]. Hence the co-polymer ratio can be adjusted to suit various 
applications [2]. The applications of PLGA ranged from common surgical sutures to the 
scaffold that was used in the high profile attempt in the tissue engineering of a human ear 
[5]. PLGA can be used in the fabrication of bone implants as it exhibited superior 
osteoblast adhesion as compared to PLA and tissue culture polystyrene [238]. Niederauer 
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et al tested a PLGA based biphasic osteochondral implant and found it to be supportive of 
tissue repair [2].  
 
PCL (figure 2.2) is a semi-crystalline linear aliphatic polyester which belongs to the 
family of poly (ω-hydroxy esters). It has a low glass transition temperature of – 60 C, a 
melting point of 60 C and a high decomposition temperature of 350 C [146]. PCL is a 
slow degrading polymer which is completely metabolized beyond a period of 24 months 
[239]. Degradation begins with random hydrolytic chain scission of ester linkages, 
resulting in the reduction of viscosity and molecular weight. Once the molecular weight 
declines to about 5000, mass loss proceeds with fragmentation and intracellular 
degradation. The by products are metabolized either via the tricarboxylic acid (TCA) 
cycle or eliminated through direct renal secretion [240]. PCL can be used to fabricate long 
residence implants as it degrades slowly. An example would be the Capronora system 
which is a one year implantable contraceptive device that is available in Europe and 
United States. In addition to that, FDA approval was also granted for other numerous PCL 
medical and drug delivery devices [240]. Regulatory acceptance has further encouraged 
the use of PCL as a scaffolding material. Studies with MSC [70, 94], osteoblasts [233, 
240], chondrocytes [241], cardiomyblasts [242] and periosteal cells [243] were conducted. 
The material was found to support cell attachment, proliferation and tissue development. 
In bone research, cell seeded PCL scaffolds exhibited extensive ECM secretion and 
mineralization under in vitro settings [243-244]. These constructs facilitated osseous 
integration, bone formation and vascularization when they are transplanted into bone 
defects [70, 99, 243]. Mechanical competence was also highlighted for these PCL 
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implants [70]. Cao et al has evaluated the use of PCL matrices as cartilage implants and he 
found them to be supportive of cartilaginous growth [54]. The use of the polymer can be 
complemented with other materials such as hydroxyapatite [64], TCP and PLGA [233] so 






Ceramics are promising substitutes for bone grafting as they are osteoconductive and 
osteoinductive [13, 37]. They would include hydroxyapatite, bioactive glass and calcium 
phosphate. As most ceramics are brittle, they are usually complemented with other 
biomaterials such as polymers for tissue engineering applications [245]. Malafaya et al 
have adopted this strategy by using a chitosan hydroxyapatite composite to fabricate the 
bone phase of a biphasic implant [34]. When Hollister et al implanted an osteochondral 
construct with a hydroxyapatite bone region, he noted vascularized osseous in growth 
within 4 weeks. Despite of its popularity, the use of hydroxyapatite has its distracters. One 
disadvantage is the minimal resorption which leads to long term stress shielding for the 
regenerating bone [1]. However the bioresorbability of hydroxyapatite can be improved 
by adding in TCP [246].  
 
TCP is a degradable ceramic which does not elicit inflammatory reactions [74]. It is 
commonly used as a filling or coating material in reconstructive bone surgery and it is 
{― O― (CH2)5―C ―}n 
O
Figure 2.2. Molecular formula of PCL. 
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usually blended with hydroxyapatite or polymers in order to strengthen the brittle ceramic 
as its compressive strength is only 5% of cortical bone [74-75]. As TCP resorbs rapidly, 
its short residence as a scaffold implant may not allow for sufficient bone formation [75]. 
On the contrary, Uemura et al noted that the rate of bone formation superseded that of 
ceramic resorption and eventually the compressive strength of the regenerated bone was 
equivalent to that of cancellous bone at 6 months [1]. During aqueous dissolution, TCP 
releases calcium and phosphate ions. At saturation point, these ions reprecipitate as 
hydroxyapatite crystals on the available surfaces which subsequently bind and concentrate 
the cytokines hence enhancing bone growth through an osteoinductive mechanism [13, 37, 
74]. The affinity for growth factors was demonstrated by De Bruijin et al when he 
implanted calcium phosphate constructs treated with BMP antibodies [76]. Osteoinduction 
was inhibited as compared to non-treated samples. The opinion reinforced by the 
observation of bone development in hydroxyapatite / TCP composites implanted at 
intramuscular and subcutaneous sites [247]. These results suggest that TCP can be harness 
as a bone scaffolding material and a carrier of growth factors such as BMP [13]. 
Furthermore TCP is incorporated into polymeric scaffolds so as to buffer the acidic by 
products which are released during polymer degradation [248]. The author’s group has 
blended TCP into PCL and found composite material to enhance ALP activity and ECM 
synthesis in bone constructs [249]. Moreover the PCL - TCP composite scaffold supported 
the growth of neo-cortical and well vascularized cancellous bone [250]. These findings 
agree with those of Fini et al when he observed that the addition of TCP enhanced bone 




Bioactive glass and coralline materials are alterative ceramics with potential tissue 
engineering applications. Hench introduced the bioactive glass to the medical community 
in the 1970s and it was found to induce ectopic bone formation in canine models [37, 40, 
251-252]. Niederauer et al exploited this advantage by adding bioglass to the bone phase 
of osteochondral scaffolds [2]. Bioactive glass resorbs in physiological fluids and the 
degradation rate is dependent on the composition and morphology of the ceramic particles 
[58]. Biocoralline material is another exciting avenue in bone research. These are coral 
derived ceramics and in a recent osteochondral implantation study conducted by Vago et 
al, complete matrix resorption was noted after 4 months with new cartilage and bone 
formation [11]. Moreover a well defined tidemark was observed between the 2 tissues and 
the neocartilage displayed a columnar orientation of chondrocytes. Vago et al suggested 
that the crystalline architecture, porosity and the biocoralline features enhanced cellular 
invasion, proliferation and vascularization [11]. These opinions were shared by Kreklau et 
al when he experimented with a biphasic osteochondral construct engineered using 
biocoral and PGA mesh [62]. The porous coralline material provided good anchorage for 









Decellularized tissue matrices 
Cartilage chips Y   Assist volume retention of in vivo 
constructs. 
 Synergistic interaction with 
chondrocytes.  
 [6-7] 
DBM  Y  Osteoconductive and osteoinductive   [13-14] 
Natural polymers 
Fibrin Y Y  Degrades easily.  
 Consists of fibrinogen, thrombin and 
factor XIII. 
 [20-21] 
Alginate Y Y  Purity is necessary for biomedical 
applications.  
 Helps to maintain the phenotype of 
chondrocytes. 
 [23-25] 
Gelatin Y   Comprises of denatured collagen. 
 Non - antigenic  
 Promotes cell adhesion, differentiation 
and proliferation.  
 [24, 27] 
Hyaluronan Y Y  Esterified forms for extended 
implantation periods.  
 Immunologically inert. 
 [28-31] 
Chitosan Y Y  Chemically similar to 
glycosaminoglycans. 
 Chemoattraction on neutrophils. 
 [27, 32-34] 
 
Collagen Y Y  Can be remodeled. 
 Cross-linking slows down the 
degradation process. 
 [35] 
Silk Y Y  Slow biodegradation with high 
structural integrity.    
 [35, 37] 
Synthetic polymers 
Polyurethane Y   Non biodegradable material.   [38] 
PTFE Y   Used as a tissue engineered 
pseudoperichondrium.  
 [66] 
PGA Y   Degrades rapidly.  
 Postulated that the degradation 
products promote proteoglycan 
synthesis. 
 [4, 28, 67] 
PCL Y Y  FDA approval for drug delivery 
devices. 
 Slow degradation.  






Y   The ratio of the 2 polymers can be 
varied to achieve suitable mechanical 
properties and degradation kinetics. 
 [77] 
PEGDA Y Y  A photopolymerizing hydrogel suited 
for minimally invasive implantation.  
 Non biodegradable  
 [49, 78] 
















PLGA Y Y  Comprises of PLA and PGA. 
 Polymer ratio can be altered to control 
biodegradation.  
 [2-5] 
PLA Y Y  Potential osteoconductivity. 
 More hydrophobic than polyglycolic 
acid.  
 [8, 15-16] 
PMMA  Y  Used as a bone cement.  [47] 




Hydroxyapaptite  Y  Minimal resorption. 
 Complemented with tricalcium 
phosphate 
 [1] 
Bioactive glass  Y  Degradation influenced by the 
composition and morphology of the 
glass particles. 
 Induce ectopic bone formation. 
 [37, 58] 
Coralline 
derivatives 
Y Y  Aragonite crystalline structure  
 Highly porous.  
 [11, 62] 
TCP Y Y  Rapid bioresorption.  
 Buffers acidic degradation of polymers 




2.4.5. Material selection  
The efficacy of the osteochondral implant is dependent on the scaffolding material. Hence 
an in depth understanding of the advantages and disadvantages of the selected material is 
required as shown in table 2.5. From the 4 main material classes, candidates 
demonstrating potential in osteochondral tissue engineering applications would include 
fibrin, alginate, collagen, PCL and TCP. A combination of these materials would harness 
the strengths while compensate the inherent weaknesses. An example would be the fibrin 
alginate composite [224]. The degradation of fibrin is arrested by the addition of alginate, 








































Materials Concerns and considerations 






- Limited availability and pathogen transfer is a concern for this 
























- Bioactive hydrogel that can be used for both bone and cartilage 
tissue engineering applications [21, 45]. Degradation is 
dependent on the fibrinogen content [20]. 
 
 
- Helps to maintain the chondrocytic phenotype of chondrocytes, 
but it is bioinert [68, 79-80].  
 
- Dissolves easily at physiological temperatures if it is not cross-
linked [72]. 
 
- Highly soluble and resorbs rapidly [32]. 
 
- Provokes foreign body response [10]. 
 
- Found commonly in the human body. Can be remodeled and 
degraded by enzymes [67]. 
 




























- Slow degrading polymer which was used to fabricate clinically 
approved calvarial bone plugs [63]. 
 
- Degrades rapidly [4]. 
 
- A commonly used scaffolding material, but Meinel et al 
cautioned that the polymer generates inflammatory response 
[100]. 
 
- The strength and degradation kinetics of the co-polymer can be 
adjusted by modulating the polymers ratio [2, 82].     
  
 











2.5. Micro Computed Tomography (CT) 
Tissue analysis usually entailed intensive specimen preparation and tedious sectioning. As 
tissue loss or distortions may occur during the destructive histological procedure, a loss of 
key information pertaining to tissue distribution is likely. Hence many are hesitant in 
using histological analysis for scarce samples since other assays are not possible once they 
are sectioned. Non-destructive techniques are preferred and that would include micro CT. 
CT is a popular approach in the study of fragile and rare specimens such as priceless 
fossils and ancient Egyptian mummies. Besides providing 2D data, micro CT allows 3D 
visualization with close ups on specific Region of Interest (ROI). These visualizations are 
accompanied by reliable quantitative measurements without extensive specimen 
preparations [253-254]. The first micro CT imager was built primarily for the 
understanding of bone physiology as it was able to unveil the structural characteristics of 
the trabecular bone such as mean isotropy, trabeculae thickness and separation [254-256]. 
These parameters affect bone strength. The radiographical method effectively replaces 
conventional histomorphometry that requires specimen sectioning [257]. With these 














- Resorbs poorly resulting in stress shielding [1]. 
 
- Dissolves readily when in contact with biological fluids [40]. 
The particulate form lacks mechanical strength and 
cohesiveness when large amounts are used [68].  
 
- Processed from limited natural resources [11]. 
 
- Osteoconductive ceramic employed used as a bone filler. Can be 
blended with polymers to enhance mechanical strength. Affinity 




advantages in mind, researchers begun to exploit the technology to achieved goals in 
osteochondral tissue engineering. The author’s group has harnessed micro CT in the 
evaluation of bone in growth within osteochondral implants [258-259]. Regenerated bone 
can be visualized simply by applying specific thresholds to the ROI. More importantly, 
healing can be quantified by measuring the volume of the regenerated bone which is 
compared to the native tissue [259-260]. Besides bone analysis, micro CT is also an 
effective tool in scaffold design as it is capable of providing 3D visualization of the 
structural intricacies. Guldberg et al recognized the versatility of this technique and 
employed it in the optimization of poly (L-lactide-co-DL-lactide) foams [261]. 
Architectural parameters derived from the scans were correlated back to the porogen 
content used. These measurements would include scaffold porosity, strut thickness, 
surface to volume ratio and interconnectivity. The thorough assessment allows the 
consistency of the manufacturing process to be monitored and controlled. Other 
biomedical researchers have also recognized the potential of this imaging technique and 
have applied it to vasculature imaging, soft tissue studies, finite element modeling and 















The inability of conventional medical therapies to arrest osteochondral degradation calls 
for innovative solutions. One of them is tissue engineering. Biomedical researchers 
envision the use of biological constructs which promote osteochondral regeneration, 
thereby restoring joint functionality. The advancement in stem cell research and 
biomaterial innovation contributes to the fulfillment of the vision. The investigation aims 
to harness this synergy, with the intention of engineering a biphasic scaffold system which 
acts as a biologically viable osteochondral implant with specific phases that cater to 
cartilage and bone restoration. The work was driven by the hypothesis that a combination 
of MSC loaded hydrogel and biomechanically competent scaffolds would constitute a 
viable osteochondral implant that supports tissue regeneration. 
 
In order to prove the hypothesis, the following areas have to be addressed : 
1. Selection of a hydrogel matrix which promotes cartilage development. 
2. Biomechanical competence of the scaffolds 
3. Proof of principle in a rabbit model. 
4. Development of a synthetic periosteal substitute for the resurfacing of the 
articulating joint. 
5. Evaluation of the developed osteochondral construct (consisting of a periosteal 
substitute and a biphasic scaffold that is seeded with hydrogel encapsulated MSC) 
in a preclinical large animal model.  
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3.2. Four research stages 
 
3.2.1. An optimum cell encapsulation matrix that supports cartilage growth   
MSC seeded scaffolds are used to support osteochondral regeneration. Hydrogels would 
assist cell retention in these porous scaffolds, moreover they exert a biomimetic influence 
on the chondrogenic differentiation of MSC, thus affecting the eventual cartilage growth. 
Fibrin and alginate were found to demonstrate potential in this aspect, hence composites 
of these biomaterials were evaluated. The influence of these encapsulating hydrogels on 
MSC chondrogenesis and neocartilage growth in an osteochondral environment are of 
interest.  
 
The objective would be to derive a suitable hydrogel matrix for the encapsulation of MSC 













3.2.2. Tissue engineering of an osteochondral implant in a rabbit model.  
The knee joint is a complex environment where physiological stresses and molecular 
signaling occur. These intricate interactions cannot be fully replicated in an in vitro setting 
thus necessitates animal modeling. The following work seeks to examine the regenerative 
potential of the biphasic implant in a critically sized osteochondral defect that is created in 
the rabbit model. The construct comprises of a cartilage zone and an underlying bone 
phase. This study would address the following questions : 
 
1. Are PCL-TCP and PCL suitable scaffolding materials in promoting the restoration 
of the osteochondral bone? 
2. Does the fibrin PCL composite support better cartilage regeneration than the 
fibrin matrix? 
3. Is the implantation of MSC necessary for osteochondral repair? 
 
To answer these queries, histological and radiographic analyses of the repair tissue are 
conducted. Attention is also given to the restoration of the underlying bone stratum which 
influences cartilage healing. 








3.2.3 A synthetic substitute for the periosteal flap 
A periosteum autograft is used to patch the cartilage defect in conventional ACI so as to 
retain the implanted cells at the required site. But there are concerns as the autograft tends 
to undergo hypertrophy. A tissue engineering alternative based on the use of PCL – 
collagen electrospun meshes is being proposed here. The patching of the defect site with a 
porous mesh would not only help in cell retention, but that would also facilitate the 
diffusion of nutrients from the synovial space. The synthetic mesh must complement 
cartilage regeneration without invoking tissue hypertrophy. Moreover, it should be 
mechanically competent so as to withstand physiological loading. The key aspects would 
be : 
 
1. The optimum composition of the PCL – collagen electrospun mesh. 
2. Mechanical properties of the mesh. 
3. Biocompatibility in the chondrogenic environment. 











3.2.4 Evaluation of the developed osteochondral construct in a preclinical animal 
model 
The biphasic osteochondral construct assisted cartilage and bone regeneration in the rabbit 
model. Though the preliminary results were promising, cartilage resurfacing was 
unsatisfactory. Moreover the findings from the rabbit study cannot be directly 
extrapolated onto humans due to the complicated immunoresponse and physiology in 
higher level organisms. Hence a large animal study is proposed so as to elucidate the 
clinical feasibility of the osteochondral implant. A pig knee model is selected because of 
the similar anatomy and biomechanical loading with respect to the human joint. The final 
phase of the investigation is centered on the efficacy of the biphasic osteochondral implant 
that is coupled with an electrospun membrane in supporting tissue repair in critically sized 
osteochondral defects. The points of interest are: 
 
1. The ability of the implant to promote cartilage and bone regeneration under high 
physiological loading. 
2. Improvement in cartilage repair via the use of an electrospun patch. 
3. The requirement of the implanted MSC for osteochondral healing in large 
animals.  
4. Endogenous factors which will influence the reparative outcome.   






Chapter 4. Optimization of fibrin based hydrogels for 





A potential use of Mesenchymal Stem Cells (MSC) in regenerative medicine is the 
restoration of osteochondral defects. Viable osteochondral implants can be engineered by 
seeding MSC via hydrogels into load bearing scaffolds. These hydrogel matrices have a 
profound influence on the differentiation of MSC into chondrocytes thus affecting 
cartilage growth. This investigation is the first known attempt to compare the effects of 
fibrin and fibrin alginate composites on the chondrogenic differentiation of MSC and the 
resultant development of neocartilage in a biphasic osteochondral construct. It was found 
that the encapsulating matrices determined the initial mesenchymal condensation that 
preceded chondrogenic differentiation. MSC entrapped within fibrin was found to 
agglomerate earlier than those in the fibrin alginate composites. The fibrin encapsulated 
cells differentiated into chondrocytes as indicated by the deposition of aggrecan and 
collagen II. As the alginate content increased from 0.3 to 0.6%, chondrogenic 
differentiation declined with a reduction in collagen II and aggrecan expressions. When 
fibrin and fibrin alginate 0.3% were tested in the cartilage phase of biphasic osteochondral 
constructs, it was noted that fibrin supported better cartilage development. It was highly 
cellular with superior levels of Glycosaminoglycan (GAG) and collagen II as compared to 
the fibrin alginate 0.3%. The later was found to be fragmented and partially calcified. 
These findings support the use of fibrin in cartilage repair as it facilitated MSC 






Scaffolds play a crucial role in the tissue engineering of osteochondral implants as they 
act as delivery vehicles for cells and growth factors while providing a temporary 
supportive stratum for tissue growth. These artificial matrices shield immature tissue from 
excessive stresses occurring at the articulating joints. Peak forces ranging from 20 – 800% 
of the body weight were reported during the course of daily activities at the human knee 
joint [174-175]. Besides being mechanically competent, scaffolds should also be porous 
so as to facilitate tissue in growth, nutrient exchange and host tissue integration. Cartilage 
being avascular is dependent solely on diffusion for molecular transport. Therefore 
cartilage scaffolds have to be highly porous so as to promote diffusion. This has however 
led to the problem of poor cell retention when open and sparse scaffolds were seeded. The 
issue could be addressed by using hydrogel matrices which effectively encapsulate and 
retain cells. Hydrogels are crosslinked polymeric matrices with a dry mass of only 0.5 – 
20 % (of the total mass) with water constituting the remaining weight. This high water 
content helps to maintain cellular viability through the diffusion of hydrophilic nutrients 
and metabolites. Moreover foreign body reaction is kept to a minimal due to the low dry 
mass [266]. Unfortunately most hydrogels are not load bearing. But a complementary 
system could be formed when hydrogels are combined with mechanically resilient porous 
scaffolds. The scaffold would provide the necessary physical support while the hydrogel 
would assist in cell retention and biomimetic interactions. The author proposed using this 




Hydrogels can be derived from synthetic and natural sources but the later is preferred 
given the inherent biocompatibility. Natural hydrogels would include fibrin and alginate 
which are widely used in tissue engineering. Fibrin contains factor XIII which enhances 
MSC proliferation and migration [267]. The author’s lab group attempted to tissue 
engineer calvarial bone implants by seeding MSC into porous PCL scaffolds. During the 
seeding process, the use of fibrin minimized cell loss [244]. Sams et al encouraged the use 
of fibrin in delivery of chondrocytes as it promoted collagen II expression [45]. However 
as fibrin disintegrates, it releases the entrapped cells which later dedifferentiate [224]. In 
order to stabilize the fibrin matrix, Perka et al added alginate to fibrin [224]. Alginate has 
been used widely in the encapsulation of chondrocytes as the cells secrete a functional 
pericellular ECM within alginate which enable them to undergo mechanotransduction 
similar to that in the native cartilage [268-269]. The application of alginate has been 
hampered by the lack of biodegradability and biocompatibility, moreover cellular 
overgrowths and fibrosis were noted in clinical trials [270]. The use of highly purified 
alginate may alleviate these concerns [270]. Studies were done by Leddy and coworkers 
to compare the effects of fibrin and alginate on the chondrogenic differentiation of human 
adipose derived stem cells [24]. The cells distributed uniformly in alginate while 
cartilaginous ECM was more prevalent in fibrin. This would suggest the use of fibrin 
alginate composites in place of alginate hydrogels. 
 
The proposed work aimed to compare the use of fibrin and fibrin alginate composites in 
the encapsulation of MSC for the regeneration of cartilage tissue. Similar studies have 
been conducted with chondrocytes [224] but not with progenitor cells which would have a 
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profound application in future regenerative medicine. The findings based on chondrocytes 
could not be directly extrapolated onto MSC as chondrocytes are mature differentiated 
cells, while MSC undergoes chondrogenic differentiation upon induction and the process 
is influenced by the environment. This comparative study seeks to select hydrogels which 
would complement macro scaffolds so as to form the cartilage phase of the osteochondral 
implant. A biphasic osteochondral coculture would be carried out so as to mimic the in 
vivo conditions whereby cartilage regeneration occurs in close proximity to bone growth, 
thus providing key insight into the suitability of the hydrogel.  
 
The objectives of present research were : 1. Screen fibrin based hydrogels in their ability 
to support the chondrogenic differentiation of MSC. 2. Create the cartilage phase of an 
osteochondral implant by using the selected hydrogels to encapsulate MSC within a macro 
porous scaffold. In vitro cartilage growth would be evaluated in this biphasic 
osteochondral construct. The objectives would be fulfilled via a two-stage investigative 
effort. Firstly, MSC would be encapsulated within fibrin, Fibrin Alginate 0.3% and 0.6% 
(FA0.3 and FA0.6). Cell viability, gene and protein expressions of key chondrogenic 
markers in these hydrogel constructs would be compared against that of standard MSC 
pellet cultures under chondrogenic induction. Matrices that facilitate chondrogenic 
differentiation would be used to encapsulate MSC in honeycombed Polycaprolactone 
(PCL) scaffolds. These scaffold hydrogel constructs would be cultured for 28 days under 
chondrogenic induction. Meanwhile bone constructs comprising of porous 
Polycaprolactone - Tri Calcium Phosphate (PCL-TCP) scaffolds, MSC and fibrin were 
maintained under osteogenic induction for a similar time frame. After 28 days of separate 
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induction, the cartilage and bone phases were integrated together using fibrin glue and 
cocultured for a further 28 days. Neo-cartilage growth would be examined via histology, 
immunochemistry and complemented by the quantification of DNA, GAG and collagen II.                        
 
                            
 
Figure 4.1. The experimental design for the evaluation of hydrogels as a cartilage matrix for an 
osteochondral implant. In stage 1, MSC chondrogensis in fibrin, FA0.3 and FA0.6 were compared 
against that of the standard MSC pellet cultures. The hydrogels which supported chondrogenic 
differentiation were subsequently used to seed MSC into the cartilage phase of the biphasic constructs 
in stage 2. Cartilage development was later assessed in this in vitro osteochondral environment.     
 Stage 1 : Evaluation under chondrogenic induction 
 
1. MSC encapsulated in fibrin  
2. MSC encapsulated in fibrin alginate 0.3% (FA0.3) 
3. MSC encapsulated in fibrin alginate 0.6% (FA0.6) 
4. MSC pellet as control 
Stage 2 : Evaluation of the cartilage phase in an in vitro biphasic environment 
MSC seeded into a PCL scaffold via 





for 28 day 
Bone Phase 
Cartilage Phase 
MSC seeded into a PCL-TCP scaffold 






4.3. Materials and Methods 
 
4.3.1. Reagents and chemicals 
Unless otherwise stated, all reagents used in this study were purchased from Sigma 
Aldrich (St Louis, MO). High glucose Dulbecco’s Modified Eagle’s Medium (high 
glucose DMEM) and Low glucose Dulbecco’s Modified Eagle’s Medium (low glucose 
DMEM) were from Gibco BRL (Grand Islands, NY). All labware consumables were 
purchased from Becton-Dickinson (Franklin Lakes, NJ).        
 
4.3.2. MSC isolation and expansion 
Bone marrow was aseptically aspirated from the iliac crest of 3 human donors who were 
undergoing elective orthopaedic procedures. Patient consent was granted and the work 
was approved by the Hospital Institutional Review Board. Upon collection, the bone 
marrow was plated out in low glucose DMEM, 10% Fetal Bovine Serum (FBS, 
Invitrogen, Carlsbad, CA) and 100 U/ml Penicillin Streptomycin (Invitrogen, Carlsbad, 
CA) on 75 cm2 flasks and incubated at 37˚C in 5% CO2, 95% air and 99% relative 
humidity. The unattached cells were removed after 24 hours via repeated Phosphate 
Buffered Saline (PBS) washings. The adherent MSC was cultured with media changes on 
every third day. When the cultures were confluent, they were passaged with 0.25% trypsin 
(Invitrogen, Carlsbad, CA). The enzymatic treatment was quenched in the presence of 





4.3.3. Hydrogel encapsulation and chondrogenic induction  
Passage 3 MSC was encapsulated in fibrin, FA0.3 and FA0.6. A final concentration of 30 
mg/ml of fibrin and 5 U/ml thombin (Baxter, Austria) was used in all groups. Alginate 
was purchased from Novamatrix (Gaustadalleen, Norway). For the fibrin encapsulated 
group, MSC was mixed in fibrin and pipetted at a volume of 2.5 µl to a corner of a well in 
a 48 well plate. Gelation followed when 2.5 µl of thrombin was added to the fibrin cell 
mix. MSC was mixed in the fibrin alginate composites and the suspension was pipetted at 
a volume of 5 µl into a bath of thrombin (5U/ml) and calcium chloride (102mM) so as to 
initiate polymerization. These hydrogel cell pellets were rinsed in sterile DI water prior to 
culturing. Each of these fibrin and fibrin alginate pellets encapsulates 0.2 million cells 
each. They were compared against standard MSC pellet cultures (without hydrogels) 
formed by centrifuging aliquots of 0.25 million MSC at 150g for 10 mins in 15 ml 
polyprolene conical tubes. The cell constructs were maintained in the chondrogenic media 
containing  10-7 M dexamethasone, 1% ITS+ premix (Biomedical Diagnostics, Ann 
Arbor, MI), 50 µg/ml ascorbic acid, 1 mM sodium pyruvate (Invitrogen, Carlsbad, CA),  4 
mM proline, 1% L-Glutamine (Invitrogen, Carlsbad, CA),  100 U/ml Penicillin-
streptomycin (Invitrogen, Carlsbad, CA) and high glucose DMEM. Chondrogenic 
induction was achieved with 10 ng/ml of Transforming Growth Factor Beta 1 (TGF-β1, 
Peprotech, Rocky hill, NJ) while uninduced samples were maintained in the absence of 






4.3.4. Biphasic Osteochondral Construct 
PCL and PCL-TCP macro scaffolds that were used to create the biphasic osteochondral 
construct were built via Fused Deposition Modeling (FDM). PCL was purchased from 
Birmingham Polymers (Pelham, AL) while TCP was obtained from Shanghai Rebone 
Biomaterials (Shanghai, China). PCL-TCP was derived by blending PCL with TCP in a 
ratio of 4 : 1. The scaffolds were cut into 2 mm cubes prior to use. 0.8 million MSC were 
encapsulated in either fibrin or FA0.3 and seeded in a final volume of 20 µl into the 
porous PCL scaffolds. The fibrin concentration was 30 mg/ml for both groups. Gelation 
was achieved either with the addition of 5 U/ml thrombin or in a bath of 5 U/ml thrombin 
with 102 mM calcium chloride for the fibrin and fibrin alginate constructs respectively. 
These cartilage constructs were initially cultured for 28 days in the chondrogenic media 
that was supplemented with TGF-β1. Bone constructs were created by mixing 0.125 
million MSC in a 12.5 µl fibrin (30 mg/ml) thrombin (5 U/ml) suspension which was later 
pipetted into porous PCL-TCP scaffolds. The bone phase was subjected to osteogenic 
induction for 28 days in a media containing 10-8 M dexamethasone, 50 µM ascorbic acid, 
10 mM β-glycerophospate, 10% FBS, 100 U/ml Penicillin Streptomycin and high glucose 
DMEM.  
 
After 28 days of separate chondrogenic and osteogenic induction, the cartilage and bone 
constructs were positioned against each other and joined with a 100 µl fibrin (30 mg/ml) /  
thrombin (5 U/ml) mix. The biphasic osteochondral construct was cocultured for another 
28 days in 2% FBS, 50 µg/ml ascorbic acid, 10mM β-glycerophosphate, 100 nM 
dexamethasone, 40 µg/ml L-proline, 10 µg/ml sodium pyruvate, 1% ITS+ premix, 100 
Chapter 4. 
 62
U/ml Penicillin Streptomycin and high glucose DMEM. MSC from only 1 patient was 
selected for this second stage.                                 
 
4.3.5. Fluorecein Diacetate (FDA) and Propidium Iodide (PI) staining  
Cell viability in the MSC hydrogel pellets was evaluated using FDA – PI staining at 7 and 
28 days time points. Media was first aspirated from the cultures and the pellets were 
rinsed in PBS before being incubated in a 20 µg/ml FDA solution (Invitrogen, Carlsbad, 
CA) for 15 mins at 37˚C under dark conditions. The fluorescent dye was aspirated and the 
samples were washed in PBS. This was followed by a second incubation in a 20 µg/ml PI 
solution (Invitrogen, Carlsbad, CA) for 2 mins at room temperature under dark conditions. 
After which the PI solution was aspirated and the samples were washed with PBS before 
being viewed with an Olympus IX81 confocal microscope (Japan).         
 
4.3.6. RNA extraction and real time PCR     
Gene expression of key chondrogenic markers was analyzed after 28 days of in vitro 
culture. The results were normalized to that of the standard MSC pellets. The pellets were 
washed with PBS before being digested with 0.25% collagenase II (Invitrogen, Carlsbad, 
CA) at 37˚C for 2 hours. The cells were collected by centrifugation and RNA was 
extracted using the RNeasy Mini kit (Qiagen, Chatsworth, CA). Total RNA was measured 
using the NanoDrop (Nanodrop Technologies, Wilmington, DE). Reverse transcription 
was achieved with 100 ng of RNA via the iScriptTM cDNA synthesis kit (Biorad, 
Hercules, CA). Real time PCR was performed using the SYBR green system (7500 real 
time PCR system, ABI, Foster city, CA). A total of 3 replicates from every hydrogel 
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group for each MSC donor were analyzed. Amplifications for cDNA samples were carried 
out at 50˚C for 2 mins, 95˚C for 10 mins, followed by 40 cycles at 95˚C for 15 seconds 
and 60 ˚C for 1 minute. Primer sequences are as shown on table 4.1. The level of target 
gene expression was normalized to GAPDH and calculated using the 2-∆∆Ct method.           
 
4.3.7. Histology and immunohistochemistry             
The MSC hydrogel pellets (28 days time point) and biphasic osteochondral constructs (56 
days time point) were evaluated via histology and immunohistochemistry. The samples 
were fixed overnight in 10% neutral buffered formalin. The MSC hydrogel pellets were 
dehydrated, embedded in paraffin and 5 µm sections were taken from the center. The 
biphasic cocultures were subjected to cryosectioning (18 µm thickness). As the 
osteochondral constructs comprised of polymeric scaffolds which stuck poorly to the glass 
slides, voids were left behind where once the scaffold struts were found. De-paraffinized 
and hydrated sections were immersed in 0.5% alcian blue in 0.1 M HCl for 30 mins for 
alcian blue staining.  Hematoxylin and Eosin (HE) staining was similarly achieved by 
soaking the sections in Gill’s hematoxylin and counterstained with Eosin. Mineralized 
tissue in the osteochondral constructs were stained using von Kossa (counter stained with 
Target gene Ascension 
No. 
Forward Reverse Size 
Aggrecan NM_001135 5’ – ACT TCC GCT GGT 
CAG ATG GA – 3’ 
5’ – GGT GAT GAT CTG GCA 
CGA GA – 3’ 
111 bp 
Sox 9 NM_000346 5’ – CAG TAC CCG CAC 
TTG CAC AA – 3’  
5’ – CTC GTT CAG AAG TCT 
CCA GAG CTT – 3’ 
69 bp 
Collagen II NM_033150 5’- GGC AAT AGC AGG 
TTC ACG TAC A – 3’ 
5’- CGA TAA CAG TCT TGC 
CCC ACT T – 3’ 
79 bp 
Collagen X NM_000493 5’ – CAA GGC ACC ATC 
TCC AGG AA – 3’ 
5’ – AAA GGG TAT TTG TGG 
CAG CAT ATT – 3’ 
70 bp 
 
GAPDH NM_002046 5’ – ATG GGG AAG GTG 
AAG GTC G – 3’ 
5’ – TAA AAG CAG CCC TGG 
TGA CC – 3’ 
70 bp 
Table 4.1. Real time PCR Primer sequences. 
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Alcian blue) and Alizarin red. The hydrated cryosections were incubated in 1% silver 
nitrate for 30 mins under the exposure of UV light and treated with 5% sodium thiosulfate 
for von Kossa staining. 2% Alizarin red solution (pH 4.1 –  4.3) was used to stain for 
calcium deposits in the samples. Immunohistology was conducted using collagen I 
(Dilution factor 1 : 500), collagen II (Chemicon, Temecula, CA. Dilution factor 1 : 500), 
collagen X (Quartett, Berlin, Germany. Dilution factor 1:25), aggrecan (Abcam, 
Cambridge, MA. Dilution factor 1:100) and Sox 9 (Santa Cruz, Santa Cruz, CA. Dilution 
factor 1:250) primary antibodies. Isotype controls (Dakocytomation, Glostrup, Denmark) 
were included. Endogenous peroxidase was blocked with hydrogen peroxide. Antigen 
retrieval for collagen I, II and X staining was performed by treating the sections with 
pepsin (Labvision, Fremont, CA) for 20 mins. For aggrecan and Sox 9, antigen retrieval in 
the paraffin sections was achieved by boiling in 10 mM citrate buffer. Biotinylated goat 
anti mouse and rabbit were used as secondary antibodies (Labvision, Fremont, CA) for 30 
mins reaction at room temperature. Streptavidin peroxidase was administered for 45 mins 
with the use of 3, 3’ diaminobenzidine as a chromogenic agent. Counterstaining was done 
with Gill’s hematoxylin, after which the sections were dehydrated before being 
coverslipped. The sections were viewed with a Leica DM IRB microscope.     
 
4.3.8. Quantitative assays 
Cartilage development in the biphasic osteochondral construct was quantified on the basis 
of cellularity, GAG and collagen II content. PicoGreen® (Invitrogen, Carlsbad, CA), 
Dimethymethylene Blue (DMMB) and Enzyme-Linked Immuno Sorbent Assay (ELISA, 
Chondrex, Redmond, WA) quantitative methods were used to measure these respective 
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components. After 56 days of in vitro culturing, 3 biphasic constructs from each hydrogel 
group were sampled. After washing in PBS, the cartilage phase was excised with a scalpel 
and digested in 1 mg/ml pepsin and 0.1 mg/ml pancreatic elastase. The enzymatic 
treatment was facilitated with a homogenizer. Once the samples were solubilized, they 
were centrifuged and the supernatant was kept aside.  DNA content was measured via the 
PicoGreen® DNA quantification kit with the help of a Tecan micro-plate reader 
(Männedorf, Switzerland). GAG measurements were derived from DMMB absorbance 
readouts which were compared against that of chondroitin-6-sulfate standards. The 
amount of collagen II presented in each sample was measured in accordance to the 
Chondrex ELISA kit protocol.                 
 
4.3.9. Statistical Analysis 
3 replicates per donor were used for each experimental group. The results were expressed 
in mean ± standard deviation and compared using student t-test. The difference was 












4.4.1. Cell seeding and viability  
MSC were uniformly distributed in the hydrogels on day 0 (figure 4.2). When these cell 
hydrogel pellets were exposed to chondrogenic induction, cellular condensation was 
observed in both the MSC pellet and fibrin group at day 7 but that was only noticeable in 
the alginate composites at day 28 (figure 4.2 J and K). Cell viability appeared to be the 
highest in the MSC pellet and fibrin group even with considerable cell death occurring at 















 Figure 4.2. MSC chondrogenesis within the hydrogel matrix. MSC was encapsulated in fibrin (A, E and I), FA0.3 
(B, F and J) and FA0.6 (C, G and K). The samples were subjected to FDA-PI staining and confocal imaging at 7 
(D- G) and 28 (H – K) days. The MSC pellet (D and H) was employed as a control.   
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4.4.2. Chondrogenic differentiation in the hydrogels 
When the MSC pellet cultures were exposed to chondrogenic reagents, they differentiated 
into chondrocytes which formed lacunaes as shown in figure 4.3A. These cells secrete a 
dense surrounding ECM which stained positively with Alcian blue for GAG (figure 4.3E). 
This was similarly observed in fibrin and FA0.3, but as the alginate content increased to 
0.6%, tissue growth became sparse with widely scattered cells and it stained poorly with 
Alcian blue. The presence of Sox 9 was noted in all samples (figure 4.3I - L). Sox 9 is an 
important molecular switch in the signaling pathway which regulates the chondrogenic 
differentiation of MSC. Sox 9 gene expression of the induced fibrin group was equivalent 
to that of the MSC pellet (figure 4.4A). The immunostaining of aggrecan for the hydrogel 
groups agreed with that of Alcian blue (figure 4.4M - P). There was no significant 
difference in aggrecan gene expression between the induced MSC pellet and fibrin group. 
Collagen I, II and X depositions were observed in the MSC pellet, fibrin and FA0.3. 
FA0.3 stained strongly for collagen I and the fibrin cell pellet registered the strongest 
staining for collagen II and X.  Moreover the real time PCR results indicated that the 
fibrin group experienced high collagen II and X gene expressions (figure 4.4C and D). 
Collagen II staining was stronger than that of collagen I for the induced MSC pellet and 
fibrin group. Cells encapsulated in FA0.6 exhibited limited chondrogenesis as shown by 
the sparse ECM which did not contain collagen II. This observation was supported by the 
dismal chondrogenic gene expressions in FA0.6. On close inspection, the pericellular 
matrix of the cells entrapped in FA0.6 stained positively for aggrecan (figure 4.3P) but 
this important cartilage marker was absented in the extracellular region. The uninduced 
MSC pellet and the uninduced hydrogel encapsulated MSC were negative controls which 
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failed to undergo chondrogenic differentiation given the absence of the key gene and 
protein markers. This was not the case for the chondrogenic induced MSC pellet which 
was employed as a positive control.  
 
The findings from this initial work indicated that MSC can be successfully differentiated 
into chondrocytes when encapsulated in fibrin and FA0.3. The cells formed distinctive 
lacunes in the pellets.  Moreover there were comparable gene and protein expressions of 
Sox 9, aggrecan and collagen II for the induced MSC pellet and fibrin group. 
Consequently, the fibrin and FA0.3 matrices were selected for the encapsulation of MSC 
within porous PCL scaffolds which would constitute the cartilage phase of the 
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Figure 4.3. Chondrogenic induction of hydrogels encapsulated MSC at day 28. The cell morphology was 
compared against MSC pellets using HE (A – D), alcian blue (E – H), immunostaining against Sox9 (I – L), 
aggrecan (M – P), collagen I (Q – T), II (U – X) and X (U1 – X1).  MSC chondrogenesis occurred in fibrin 
and FA0.3, with the secretion of key chondrogenic markers such as Sox 9, aggrecan and collagen II. 
However, there was poor differentiation in FA0.6. During chondrogenic differentiation, collagen I and X were 
noted in the MSC pellet, fibrin and FA0.3 groups.     
Figure 4.4. Real time gene expression analysis of Sox9 (A), aggrecan (B), collagen II (C) and collagen X (D) 
in the chondrogenic induced MSC hydrogel pellets. The results were normalized to that of the MSC cell pellet. 
* indicates significant difference in expressions between MSC cell pellet and the other groups (p < 0.05). N is 












4.4.3. Cell seeding of the biphasic osteochondral construct 
The use of hydrogels assisted the retention of MSC in the porous scaffolds during the 
seeding process. Moreover the cells were uniformly distributed in both the bone and 
cartilage phases (figure 4.5). When the 2 phases were fused together with fibrin glue for 
coculturing, they bonded well without any signs of delamination. A scalpel blade was 






Figure 4.5.  In vitro biphasic osteochondral constructs.  MSC was seeded into the PCL cartilage scaffold 
in either fibrin (A and D) or FA0.3 (B and E). These were coupled to a PCL – TCP bone scaffold that 
was seeded with MSC via fibrin after 28 days of separate chondrogenic and osteogenic inductions. The 
photomicrographs were taken at day 0.  
 
Cartilage phase 
PCL scaffold with fibrin 
Cartilage phase 
PCL scaffold with FA0.3 
Bone phase 





4.4.4. Tissue development in the biphasic environment  
Gross morphological differences were observed between fibrin and FA0.3 cartilage 
phases. Dense cartilaginous tissue developed in the fibrin group which stained strongly 
with alcian blue (figure 4.6G). Chondrocyte lacunes were found in the neocartilage that 
formed a distinctive boundary with the bone phase (figure 4.6A, C and D). This separation 
was less obvious for FA0.3 which has a fragmented neocartilage morphology that was 
pockmarked by void spaces (figure 4.6B, E and F). The FA0.3 cartilage construct stained 
positively for aggrecan (4.6H). Mineralization occurred in the bone phase of the 
osteochondral constructs as indicated by von Kossa staining (figure 4.6I). The boundary 
between the cartilage and bone regions in both groups was even marked by a mineralized 
front as shown in figure 4.6J. Interestingly, a portion of the FA0.3 cartilage phase was 
found to be calcified (figure 4.6K and L) and this might be due to a probable bone tissue 
invasion. The bone and cartilage zones were well integrated in both groups except at the 
voids located in the FA0.3 cartilage phase. Similar to aggrecan, collagen II was only 
localized to the cartilage phase of the 2 osteochondral constructs as shown in figures 4.7B 
and E. Collagen II staining was observed for the dense neocartilage that developed in the 
fibrin group and it clearly demarcated the bone and cartilage regions. Collagen I was 
prevalent throughout the osteochondral constructs for the 2 groups and it was not 
restricted to the bone phase. A faint presence of collagen X was noted for the cartilage 








Figure 4.6. Biphasic osteochondral constructs after 28 days of coculturing. The cartilage phase comprised either 
of fibrin (A, C, D, G, I and J) or FA0.3 (B, E, F, H, K and L) hydrogels. Tissue morphology was observed with 
HE (A – F), Alcian blue (G – H), Von Kossa Alcian blue (I and K) and Alizarin red (J and L) stains.  C and D 
are the close up images of the boxed regions in A, while E and F are the close up images in B. Gaps and holes in 
the sections were attributed to the scaffold struts.  A clear cartilage bone phase boundary with good fusion was 
observed in the fibrin group and it was accompanied by dense cartilaginous growth which stained positively with 
Alcian blue for GAG. Furthermore, mineralization occurred solely within the bone phase of the fibrin group (I 
and J). Similar observations were made for FA0.3, but the cartilaginous tissue was fragmented, pockmarked (F) 
and a portion of it was calcified (K and L).   
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Negative controls were omitted in this second part of the study because the uninduced 
MSC pellet and hydrogel encapsulated cells did not demonstrate chondrogenesis in the 
preceding study. Hence neocartilage would not develop in the uninduced biphasic 
cocultures. Moreover naked MSC seeding into the biphasic construct was not practical as 
they drained out from the porous scaffolds. Currently there are no hydrogels that are 
accepted as the gold standard for cell seeding procedures, hence a positive control was 





Figure 4.7. Immunostaining of the biphasic constructs against collagen I (A and D), 
collagen II (B – E) and collagen X (C and F). The arrowheads are positioned at the cartilage 
bone boundary with the red arrowhead in the bone phase and white arrowhead in the 
cartilage phase. Collagen I was detected throughout the fibrin and FA0.3 biphasic 
constructs (A and D), while collagen II was only localized to the cartilage phase. A faint 
presence of collagen X was observed in the cartilage regions. Negative staining was 
obtained with the isotype controls.     
 
















4.4.5. DNA, GAG and collagen II content 
The DMMB assay indicated a higher total GAG content in the cartilage phase when fibrin 
was used to encapsulate the MSC. This superiority was due to the higher cellularity in 
fibrin as indicated by the high DNA content which off set the low GAG / DNA ratio 
(figure 4.8). Collagen II deposition was better for the fibrin group. This advantage was 
attributed to the higher cellularity and superior collagen II deposition per cell in the fibrin 
matrix. These findings supported the observation that the neocartilage was denser for the 
fibrin group as it was more cellular and had a greater amount of cartilaginous ECM as 







































                           
A B 
C D 
E Figure 4.8. GAG (A), collagen II (B) and 
cellularity (C) of the cartilage phase after 28 
days of coculturing. GAG and collagen II 
measurements were also normalized to DNA 
as shown in D and E. There was significant 
difference between fibrin and FA0.3 in each 
graph (p < 0.05). N = 3.   
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4.5. Discussion  
The effective use of MSC in cartilage repair is dependent on the differentiation of MSC to 
chondrocytes which would synthesize the essential cartilage ECM. But for this to happen, 
there must be an initial aggregation of MSC resulting from cell proliferation or migration 
[271-272]. Once these progenitor cells condense together, lineage determination happens 
[273]. During mesenchymal condensation, cell to cell contacts are established via cell 
surface molecules such as the Neural Cell Adhesion Molecule (NCAM) [274]. When 
these contacts are formed, cells will signal to each other and activate the chondrogenic 
differentiation program which leads to the expression of cartilage markers such as 
collagen II. Goldring et al proposed that cellular agglomeration could be influenced by the 
surrounding environment [275] and his claim was verified when Tacchetti et al cultured 
chick limb bud mesenchymal cells in carboxymethylcellulose [274]. A delay in cell 
condensation was noted as compared to the controls maintained in normal media. This 
was accompanied by a reduction in the number of progenitor cells which differentiated 
into chondrocytes [274]. Similarly, the cellular interaction with the encapsulating fibrin 
and fibrin alginate matrices have resulted in the differences in MSC chondrogenic 
differentiation as observed in this experiment. 
 
Early MSC condensation was observed for the MSC pellet and fibrin group at day 7. This 
was mirrored by an equivalent Sox 9, collagen II and aggrecan gene expressions in both 
groups as the cells differentiated into chondrocytes. The ECM secreted by the cells 
entrapped within fibrin stained positively for aggrecan and collagen II (figure 4.3N and 
V). In the biphasic osteochondral environment, the fibrin cartilage phase was found to be 
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more cellular and it contained higher levels of GAG and collagen II as compared to 
FA0.3. Cell survival and proliferation was better in the fibrin matrix moreover it favored a 
superior collagen II deposition per cell. Fibrin is able to support cartilage development 
because its degradation kinetics, biochemical and biological properties. Fibrin degrades 
readily within days to weeks via fibrinolysis and as it degrades, the entrapped MSC would 
be free to migrate towards each other and agglomerate. Cell migration is further enhanced 
by the chemotactic properties of fibrin and its degraded fragments [276]. Moreover MSC 
are adherence dependent cells which interact with the fibrin matrix via RGD sequences 
presented on the α chains and C-terminal peptides located on the β and γ chains [277-278]. 
Furthermore, a detailed compositional analysis of fibrin revealed traces of fibronectin, 
TGF-β1 and Fibroblast Growth Factor (FGF) [222]. These bioactive components 
influence cell proliferation, mesenchymal condensation and chondrogenic differentiation. 
Catelas et al reported that fibrin possessed an intrinsic binding affinity for TGF-β1 [193]. 
Under inductive conditions, TGF-β1 could have been localized and maintained in close 
proximity to the entrapped MSC, hence promoting chondrogenesis. 
 
Alginate was added to fibrin with the intention of stabilizing the hydrogel matrix but this 
has led to the unsatisfactory outcome in MSC chondrogenic differentiation and cartilage 
growth. Firstly, cellular agglomeration was delayed in the induced FA0.3 and 0.6 samples. 
When the alginate content was increased from 0.3 to 0.6%, the gene expressions of Sox 9, 
collagen II and aggrecan decreased. This was coupled with the absence of collagen II and 
the low aggrecan secretion in FA0.6. When MSC was encapsulated in a lower 
concentration of alginate (FA0.3), the cells differentiated into chondrocytes and they 
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synthesized both collagen II and aggrecan. This hydrogel was subsequently used to seed 
cells into the porous cartilage scaffold of an osteochondral construct. After 56 days of in 
vitro culturing, the FA0.3 cartilage phase was found to be pockmarked by voids, thus 
lacking in physical integrity required for load resistance. These empty spaces occurred in 
the FA0.3 cartilage region because MSC condensed within discrete pockets which were 
segregated from each other. While chondrogenesis and ECM synthesis took place in each 
cluster, there was limited bridging and interaction between them. Thus fibrin alginate 
encapsulation did not support MSC chondrogenic differentiation and cartilage growth. 
This might be due to the inability of alginate to facilitate cell mobility and interaction 
[279]. Alginate encapsulation is commonly used to maintain chondrocytes in their 
differentiated state, but these cells proliferate poorly within the polysaccharide hydrogel 
[280]. A possible reason could be that the encapsulated cells are confined to their 
positions as alginate degrades slowly, hence they are unable to migrate and signal to each 
other via cell to cell contacts [281]. Lin et al recognized the problem and instead of 
encapsulating chondrocytes within alginate, he seeded the cells onto lyophilized alginate 
slabs. Cell migration, clustering and proliferation were observed with this alternative 
technique [282]. When Lawson et al experimented with MSC, he noted that the cells 
attached and expanded poorly in alginate [229]. He reasoned that the lack of bioactivity in 
alginate as the attributing cause which could be resolved by the supplementation with 
collagen I, TCP and RGD ligands [229, 283].  
  
For the osteochondral tissue to function effectively, cartilage must be firmly anchored 
onto the underlying bone substratum. This was a concern for Schaefer et al when his bone 
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and cartilage constructs bonded poorly via surgical suturing as both phases were matured 
after 4 weeks of isolated culture [17]. This problem did not surface in the current 
experiment as fibrin might have facilitated good fusion. There were no signs of 
delamination except at the voids presented in the FA0.3 cartilage construct (figure 4.7E). 
In the fibrin group, a clear cartilage bone boundary was observed as aggrecan (figure 
4.6G) and collagen II (figure 4.7B) were only restricted to the cartilage construct which 
was opposed by a mineralized front that formed in the bone phase (figure 4.6J). There was 
no hypertropic or calcified tissue in the fibrin cartilage phase despite of the presence of 
collagen X. Mineralized tissue was however located in the FA0.3 cartilage phase. This 
might be due to cartilage hypertrophy or the invasion of osteoblasts into the pores found in 
the fragmented neocartilage. Calcification was noted in the bone region which comprised 
of a porous PCL-TCP scaffold that was seeded with MSC using fibrin. Other researchers 
have used fibrin to seed cells into bone scaffolds. Arnold et al created a bone implant by 
using a Poly Lactic-co-Glycolic Acid – Tri Calcium Phosphate (PLGA-TCP) composite 
scaffold that was seeded with a fibrin suspension containing human periosteal cells [248]. 
Preosseous growth within the implant was marked by an increase in alkaline phosphatase 
activity and osteocalcin content [248]. When Schantz et al implanted a porous PCL 
scaffold into rabbit calvarial defects, he noted good mechanical integration with the host 
bone. The excellent result was attributed to the presence of MSC that was seeded into the 
implant using fibrin [244]. 
                                                                                    
Collagen I and X were detected in the induced MSC pellet, fibrin and FA0.3 groups. 
Furthermore collagen I was also observed in both the cartilage and bone phases of the 
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osteochondral construct. The prevalence of collagen I might be due to various reasons. 
Tuan et al discovered that some MSC remained undifferentiated during chondrogenesis 
and they produced a matrix of collagen I [273]. In conjunction, Nöth and Tuli reported the 
expression of collagen I in their cartilage constructs, developed using MSC [60, 284]. The 
presence of collagen I in the cartilage phase of the osteochondral construct would suggest 
the occurrence of fibrocartilage which could arise because of the prolonged in vitro 
culture. The culturing conditions might not have duplicated all the in vivo factors required 
for the development of hyaline cartilage. The positive detection of collagen X in the first 
stage of the study would suggest hypertrophy. However Mwale and Rucklidge cautioned 
against the use of collagen X as the sole marker for cartilage hypertrophy as monolayer 
undifferentiated MSC also expressed collagen X [285] and this protein was found to be 
localized on the articulating surface of normal rat pups [286]. 
 
Several biomaterials were evaluated in the preceding literature review with fibrin and 
alginate deemed as suitable candidates for the MSC encapsulation. But this initial 
selection process was limited despite the non exhaustive list of materials given the 
advancement in material science. Hence the presented findings would only advocate fibrin 
as a better hydrogel than fibrin alginate for the encapsulation of MSC in the cartilage 
phase of the biphasic construct, but that did not suggest fibrin as the best-off solution as 






4.6. Conclusion  
A comparative study was conducted so as to evaluate the suitability of fibrin and fibrin 
alginate composites in supporting the chondrogenic differentiation of MSC required for 
the development of cartilage in a biphasic osteochondral construct. The current data 
showed that MSC differentiated poorly into chondrocytes when encapsulated in FA0.6 as 
they underwent late condensation as compared to the fibrin group where early cell 
clustering was observed. After 28 days of chondrogenic induction, the expression of Sox 
9, collagen II and aggrecan were found to be equivalent in both the fibrin group and MSC 
pellet. When fibrin and FA0.3 were tested in the biphasic osteochondral environment, a 
dense cartilaginous growth was found in the fibrin cartilage phase. Quantitative assays 
showed the neocartilage to be highly cellular with superior levels of GAG and collagen II. 
On the other hand, the neocartilage of the FA0.3 construct was found to be fragmented 
with a portion of it being calcified. Osteoblast invasion was likely. The overall findings 
supported the use of fibrin as the encapsulating matrix for the cartilage phase in an 















The current investigation sought to evaluate the efficacy of biphasic osteochondral 
implants in the repair of critically sized medial condyle defects in the rabbit model. Fibrin 
was used to seed MSC into the cartilage phase as established in the previous study. 
Moreover PCL and PCL – TCP scaffolds were proposed as implants, thus prior 
architectural and mechanical characterizations were carried out. 2 groups of biphasic 
constructs were subsequently examined. Group 1 consisted of a fibrin matrix which served 
as the cartilage phase and PCL as the bone phase. Group 2 comprised of a PCL cartilage 
scaffold and an underlying PCL – TCP bone scaffold. These constructs were seeded with 
autologous MSC. It was discovered that the fibrin matrix of group 1 was unable to support 
long term cartilage repair as it was neither load bearing nor stable at the in vivo site. 
However an improved outcome was noted when a supportive PCL scaffold was used to 
complement the fibrin matrix (group 2). MSC implantation was necessary for cartilage 
repair and it accelerated bone restoration. There was considerable reconstitution of the 
subchondral bone for both groups as the volume of the mineralized bone approached that 
of native bone at 6 months. This favorable outcome was attributed to the structural and 













The effectiveness of an osteochondral implant is determined by its ability to satisfy the 
biomechanical and biological demands at the native site. Contact stresses experienced at 
the human knee joint were reported to be 0.2 – 8 times that of body weight [174-175]. The 
compressive loads are transmitted by the mechanically resilient hyaline cartilage to the 
underlying trabecular bone. The instantaneous compressive Young’s modulus and yield 
strength of articular cartilage are 1.36 – 39.2 MPa and 5 MPa respectively [177, 180], 
while the trabecular bone has a compressive stiffness of 4.4 – 229 MPa [178-179] and 
yield strength of 0.85 – 13 MPa [178]. These loads and parameters must be factored into 
the design of the cartilage and bone phases of the osteochondral construct.   
 
During osteochondral repair, vascular networks extend from the host bone into the defect 
site so as to facilitate bone growth. This is coupled with the migration of native progenitor 
cells and cytokines from the surrounding tissue. Such events which influence the 
reparative process cannot be recapitulated under in vitro settings, thus animal studies are 
warranted. Animal studies employ critically sized defects as spontaneous healing does not 
result in adequate tissue repair. Shapiro et al has shown that in his rabbit experiments as 3 
mm diameter osteochondral defects underwent progressive deterioration when left 
untreated [287]. Lietman et al reasoned that this was due to the lack of subchondral bone 
support [288].            
 
Tissue engineering researchers have experimented with various biomaterials in the design 
of bone and cartilage implants, in particular PCL and TCP have demonstrated potential. 
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When porous PCL scaffolds were seeded with human periosteal cells and implanted 
subcutaneously into nude mice, osteoid production with endochondral bone formation was 
found within the matrix [99]. Such promising findings have advocated the use of PCL 
cranial implants [63]. Cartilage research on the PCL scaffold was also initiated when 
Hutmacher et al implanted chondrocytes into subcutaneous sites via this biodegradable 
matrix [241]. Subsequently, elastic cartilage grew within the implants without any 
inflammatory response or fibrous in growth. Hutmacher’s results were further validated 
by Cao et al’s in vitro work which demonstrated chondrocyte viability and ECM synthesis 
within the porous PCL scaffold [54]. As most PCL is neither osteoconductive nor 
osteoinductive, bioactive ceramics can be blended into the polymer so as to support 
applications in regenerative bone medicine. TCP was chosen as it was commonly used as 
an osteoconductive bone filler.  
 
A rabbit study was initiated so as to evaluate the biphasic osteochondral construct. PCL 
and PCL –TCP scaffolds were proposed as implants. Prior to the animal study, 
architectural and mechanical characterizations were conducted on these scaffolds. 2 
groups of osteochondral implants were investigated in the rabbit model (figure 5.1). The 
first group comprised of a cartilage fibrin matrix and a PCL bone scaffold. The second 
group was designed with a PCL cartilage scaffold and an underlying PCL – TCP bone 
matrix. Autologous MSC was seeded into the implants via fibrin and a comparison was 
































Figure 5.1. Experimental design of the rabbit study. MSC was seeded into the biphasic constructs which 
were implanted into the critically sized osteochondral defects located at the medial condyle of the rabbit 
model. Group 1 comprised of a cartilage fibrin phase and a PCL bone scaffold. Group 2 consisted of a 
cartilage PCL matrix and a PCL – TCP bone scaffold. Cell free implants were included as controls.      
OR 
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5.3. Materials and Methods 
 
 
5.3.1. Reagents and chemicals 
Unless otherwise stated, all reagents used in this study were purchased from Sigma 
Aldrich (St Louis, MO). Low glucose DMEM was from Gibco BRL (Grand Islands, NY). 
All labware consumables were purchased from Becton-Dickinson (Franklin Lakes, NJ).        
 
5.3.2. Scaffold fabrication 
The PCL and PCL – TCP scaffolds were built using the FDM 3000 (Stratasys, Eden 
Prairie, MN). PCL was acquired from Birimingham Polymers (Pelham, AL) while TCP 
was purchased from Shanghai Rebone Biomaterials (Shanghai, China). The PCL – TCP 
composite was derived by blending PCL and TCP in a ratio of 4 : 1. The 2 scaffolds have 
a laydown pattern of 0 / 60 / 120º as shown in figure 5.2. Both scaffolds were built with an 
intended Road Width (RW) and Fill Gap (FG) of 406 and 711 µm respectively. A 4 mm 
diameter and 3 mm thick PCL scaffold was used in group 1. As for group 2, a 4 mm 
diameter and 2.5 mm thick PCL scaffold was coupled with a 4 mm diameter and 3 mm 
thick PCL - TCP scaffold. Prior to use, the scaffolds were rendered hydrophilic through a 
3 hour treatment in 5 M NaOH at 37 ºC and sterilization was achieved by 70% ethanol 








5.3.3. Scaffold characterization   
The PCL and PCL – TCP scaffolds were loaded onto a Skyscan in vivo 1076 Micro 
Computed Tomography (micro CT) scanner (Belgium) for data acquisition at a resolution 
of 35 µm. A modified Feldkamp algorithm provided by Skyscan was employed in data 
reconstruction. The evaluation of architectural features was subsequently accomplished 
with MIMICS (Materialize, Belgium). 
 
The compressive behavior of the scaffolds was elucidated with an Intron 4302 set up 
(Norwood, MA) that was equipped with a 1 kN load cell. The tester was controlled by the 
Series IX Automated Materials Tester software (version 7.43). The scaffolds were 
compressed at a rate of 1 mm / min up to a strain of 60% in the Z direction. Compressive 
Young’s modulus and compressive yield strength were subsequently derived from the 
stress-strain curves. Young’s modulus was calculated as the slope of the initial linear 
Figure 5.2. The design of the RP scaffold. The matrices were built with a 0/60/120˚ 
laydown pattern. Road width (RW), fill gap (FG) and layer gap (LG) are as shown on the 
side view. The intended RW and FG were 406 and 711 µm respectively for the PCL and 












region of the curve (without the toe region), while compressive yield strength was 
measured at the yield point or at the end of the linear portion. 5 samples per scaffold were 
tested and evaluated.      
 
5.3.4. Scanning Electron Microscopy (SEM) 
Scaffold morphology was examined via SEM using a Quanta 200F set up (FEI, Hillsboro, 
Oregon). Before imaging, the scaffold specimens were gold coated for 90 seconds under a 
10 mA current using a JFC 1600 auto fine coater (JEOL, Tokyo, Japan). 
 
5.3.5. Bone marrow aspiration, MSC isolation and culturing 
Approval for the animal work was granted by the institutional animal care and use 
committee of the National University of Singapore. New Zealand white rabbits were 
procured for the procedure. The animals were anaesthetized and bone marrow was 
aspirated from the iliac crest region. MSC was isolated from the bone marrow and 
cultured as described in the materials and methods of chapter 4. Only passage 2 MSC was 
used in the experiment. 
 
5.3.6. Implant preparation with fibrin encapsulation 
Passage 2 MSC was mixed in thrombin and pipetted into sterile PCL and PCL – TCP 
scaffolds. Gelation was achieved with the addition of fibrin. 1 million cells were seeded 
into the PCL scaffold of group 1 and both implant phases of group 2. The cartilage and 




5.3.7. Surgical implantation 
Skeletally mature rabbits were anesthetized, intubated and disinfected. A medial 
parapatellar incision was made on the knee joint so as to expose the medial femoral 
condyle, following that a 4 mm diameter defect which reaches to a depth of 5.5 mm was 
drilled on the medial femoral condyle. In group 1, the pre - seeded PCL scaffold was 
positioned in the bone defect and a fibrin suspension containing 1 million cells was 
pipetted into the cartilage zone. In group 2, the osteochondral construct comprising of cell 
seeded PCL – TCP and PCL scaffolds were press fitted into the osteochondral defect. 
Controls without implanted cells were included for each group. Wound closure was 
accomplished with bioabsorbable sutures, the animal was returned to its enclosure and 
monitored till full recovery. The rabbits were allowed to move freely without constraint 
within the cages and they were euthanized at 3, 6 and 9 months post operation. The knee 
joints were excised and kept for analysis.  
 
5.3.8. Histology 
The harvested samples were fixed in 10% neutral buffered formalin. Decalcification in 
30% formic acid, ethanol dehydration and paraffin embedding followed. 5 µm sections 
were taken from the centre of the defect site and stained with Toluidine blue for GAG 
deposition. General morphological analysis was aided by HE staining. 
 
5.3.9. Micro CT analysis of in vivo samples 
The samples were loaded onto a Skyscan in vivo 1076 micro CT scanner (Belgium) for 
data acquisition at a resolution of 35 µm. After reconstruction, the data was loaded onto 
Chapter 5. 
 91
MIMICS for analysis. A cylindrical Region of Interest (ROI) which corresponds to the 
original defect location was used to isolate the regenerated bone on the CT scans. 
Topographical bone growth pattern was evaluated by sectioning the ROI radially (core, 
inner and outer shells) and laterally (top, mid and bottom) as shown in figure 5.3. 12 
femoral medial condyles from age-matched unoperated rabbits were used as controls. The 
volume of mineralization with respect to that at the native site was presented as the degree 












          
5.3.10. Indentation of the repaired cartilage 
The Young’s modulus of the repaired cartilage in group 2 was measured via indentation 
test, conducted using an Instron 5848 micro tester (Norwood, MA). Thawed samples were 
fixed onto Petri-dishes using PMMA dental cement (Meliodent, Heraeus Kulzer, 











Lateral and radial sections
Regenerated 
bone isolated at 
the defect site.  
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Germany). A 1.6 mm diameter porous plane ended indenter (Captan Permaflow, CA) was 
positioned perpendicularly to the cartilage surface and after a tare load, 5 stepwise 
consecutive 10 µm displacements were compressed into the cartilage at a rate of 1 µm/s. 
Data was recorded at each step over a period of 150 – 300 s. The equilibrium load was 
recorded at full relaxation (load fluctuations < 0.005 N over the final 60 s). Cartilage 
thickness at the test site was measured with a customized needle probe system. A fine 
needle was lowered into the cartilage at a constant rate and the applied load jumped when 
the needle contacted the subchondral bone. Hence cartilage thickness could be read off 
from the displacement versus load graph. 4 sets of measurements were taken for each 
sample. The Young’s modulus (E) of the cartilage was derived from the following 
equation taken from Hayes et al [36] and it was compared against that of the native 
cartilage. 








5.3.11. Statistical analysis 
The results were expressed in mean ± standard deviation and compared using student t-
test. The difference was considered significant when p < 0.05.  
 
 
E = P (1 – ν2) / 2auκ 
Where : 
 
P  =  Equilibrium load 
ν  =  Poisson ratio. A value of 0.2 was adopted for rabbit cartilage. 
a  =  Radius of indenter 
u  =  Applied displacement 
κ  =  Theoretical scaling factor, dependent on ν and a / hc [36]. 






5.4.1. Mechanical and architectural properties of scaffolds 
The PCL and PCL – TCP scaffolds were designed with similar RW and FG inputs, 
however they differed architecturally as shown in figure 5.4. and table 5.1. This was due 
to the difference in the material properties of PCL and PCL – TCP. The PCL structure was 
more sparse and open as compared with the dense PCL – TCP scaffold (figure 5.4A and 
B). The centre to centre strut spacing was same for both scaffolds (figure 5.4C and E), but 
the measured FG in PCL – TCP was smaller than that of PCL. This was due to the thicker 
PCL – TCP struts which in turn lowered the scaffold porosity. Even though the scaffolds 
have different porosities, their pore spaces were 100% interconnected. The PCL - TCP 
scaffold was much stiffer than the PCL counterpart, but the later has higher yield strength. 
Despite of that, the compressive strengths of the 2 scaffolds were of the same order of 
magnitude. The FDM scaffolds yield when the struts delaminate and that was determined 
































Figure 5.4. Characterization of PCL (A, C and D) and PCL – TCP (B, E and F) scaffolds. SEM images 
revealed a more open structural for the PCL matrix. From the micro CT measurements, the centre to centre 
strut distance was similar for both scaffolds as shown in C and E but the strut diameter differed (D and F). 
Compressive Young’s modulus (G) and compressive yield strength (H) of the matrices are as shown with 
significant difference between the 2 scaffolds (p < 0.05).   
A B C 
D E F 
G H
Table 5.1. Architectural characterization of PCL and PCL-TCP scaffolds. 
Architectural properties PCL PCL-TCP 
Measured LG (µm) 502 ± 60 1058 ± 53 
Measured RW (µm) 462 ± 110 636 ± 96 
Measured FG (µm) 513 ± 60 478 ± 43 
Porosity (%) 65 ± 4 35 ± 3 
Interconnectivity (%) 100 100 
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5.4.2. Bone repair 
There was considerable mineralization in the osteochondral defect at 3 months for both 
groups and it approached that of native bone at 6 months (figure 5.5). Bone in growth was 
accompanied by mineralization as shown by the HE staining (figure 5.6). At 3 months, the 
experimental and control subgroups of group 2 did not differ significantly in 
mineralization however the presence of the implanted cells seemed to enhance it. This was 
also observed in group 1. However the trend ceased at 6 months as the degree of 
mineralization was equivalent across all groups. The similarity at 6 months would suggest 
that the porous structure of the scaffolds was conducive for bone repair as it facilitated 
bone in growth from the surrounding tissue. Furthermore, the porous bone implants 
entrapped the hematoma that formed during the coring of the defect. The hematoma was 
rich in growth factors, cytokines and it triggered the migration of the native progenitor 










 Figure 5.5. The degree of mineralization within the defects of groups 1 and 2 
(relative to native site). N is indicated in the brackets. Sample groups bearing the 





Figure 5.6. Bone regeneration in groups 1 (A – D1) and 2 (E – H1). The evaluation was based on HE (A – 
D and E – H) and micro CT analysis (A1 – D1 and E1 – H1) at 3 and 6 months. In the micro CT models, 
bone is denoted by white while scaffold and soft tissue are denoted by red.  
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Bone mineralization in the PCL scaffold appeared to be higher than that of PCL – TCP at 
3 months. This could be attributed to the higher porosity of the PCL scaffold (65%) which 
promoted bone and vascular in growth. However mineralization was similar for both 
scaffolds at 6 months. Bone repair could have proceeded slowly in the PCL – TCP 
scaffold but it was enhanced over long term by the bioactive TCP.  
 
The lateral and radial sections of the ROI displayed a “bottom to top” and “out to 
inwards” growth pattern. This trend was observed for groups 1 and 2, experimental and 
control, across all time points. A possible explanation would be that vascularization and 
progenitor cell migration originated from the periphery of the defect. Moreover bone 
growth at the boundary was enhanced by the superior nutrient and oxygen transport.  
Figure 5.7. Outward to inward and bottom to top bone growth. The growth pattern in group 2 control at 3 months is 
as shown by the degree of mineralization in the lateral (A) and radial (B) sections. This was observed for all other 
samples at both time points. There is no significant difference between the sections which share the same alphabet 


















The bone repair which occurred at the defect site was accompanied by tissue maturation. 
This took place across all groups. At 3 months, the regenerated bone comprised mainly of 
woven bone (figure 5.8A) which was gradually replaced by mature lamellae bone (figure 






































Figure 5.8.  Bone remodeling at the defect (A – C) and native sites (D and E) as 
shown by the HE staining. Woven bone (A) was observed at the bone defect of the 
experimental and control subgroups of groups 1 and 2 at 3 months. At 6 months post 
surgery, tissue remodeling occurred with the formation of lamellae bone (B) and bone 
resorption lacunae as shown in C. These features were similarly observed in the 







5.4.3. Cartilage repair 
When the cell seeded fibrin matrix was implanted into the cartilage defect of group 1, 
neocartilage developed within the site and it integrated well with the host cartilage (figure 
5.9C). The repaired tissue stained positively with Toluidine blue for GAG. However the 
chondrocyte orientation in the developing tissue differed from that of mature native 
cartilage (figure 5.9D and B). At 6 months, the neocartilage deteriorated as it became 
thinner with a fissured integration zone (figure 5.9E). Only 2 out of 6 samples exhibited 
excellent tissue repair bearing a notable tidemark and an orderly chondrocyte alignment 
(figure 5.9G). A MSC seeded PCL – fibrin construct was implanted at the cartilage defect 
of group 2. At 3 months, neocartilage developed within the construct which integrated 
well with the host cartilage. However at 6 months, variable results were obtained. Most of 
the samples exhibited excellent cartilage regeneration, but unsatisfactory outcomes were 
noted in some specimens, as characterized by a fibrillated surface with cracks occurring at 
the integration zone (figure 5.10C and D). At 9 months, the defect site of group 2 was 
covered by a layer of mature cartilage as indicated by the regular cell arrangement and 
tidemark (figure 5.10F). A generally smooth articulating surface that was disrupted by 
protruding PCL struts was noted in the 6 and 9 months samples of group 2. GAG was 
presented in the repaired cartilage of group 2 experimental at all time points. The absence 
of the implanted MSC at cartilage defect site has led to the occurrence of fibrous growths 
in both groups. These were devoid of GAG across all time points (figure 5.9 and 5.10). 
Hence the implanted MSC played a crucial role in cartilage regeneration. A comparison of 
the experimental results of groups 1 and 2 revealed an initial cartilage repair which was 
followed by the mixed outcomes at 6 months. The 6 months results of group 1 were more 
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adverse as fibrillated cartilage and poor host integration were found in most of the 
samples as compared to group 2.  
Figure 5.9. Cartilage repair in group 1. HE (A – I) and Toluidine blue (J – L) stainings are as shown. The 
experimental (C – G, K and L) and control (H and I) results were compared against that of native cartilage (A, 
B and J).  At 3 months in the experimental group, a layer of neocartilage (C) developed with random cell 
orientation (D) as compared to the native tissue (B). After 6 months, thinning of the repair cartilage (E) and 
fissuring of the integration zone (circled) was observed, moreover the cartilage became fibrillated (F). 
Excellent cartilage repair occurred in only 2 out of 6 specimens (G). When the implanted MSC was omitted, 
fibrous tissue developed within the cartilage defect site at 3 (H) and 6 (I) months time points. GAG depositions 
as observed with Toluidine blue staining in native cartilage (J), 3 (K) and 6 (L) months experimental 
specimens. The integration with the host cartilage was circled and there was poor integration at 6 months.  The 









Figure 5.10. Cartilage repair in group 2. HE (A – H) and Toluidine blue (I – K) staining are as shown. The 
integration with the surrounding cartilage was circled. At 3 months, extensive neocartilage formed within the 
PCL scaffold (A) which integrated well with the host cartilage (B). This satisfactory repair persisted for most of 
the samples at 6 months, however a minority of the samples exhibited cracks at the integration zone (circled in 
C) and fibrillated surfaces with the exposure of the scaffold struts (D). At 9 months, the defect site was 
resurfaced by a layer of smooth articular cartilage (E) which bonded well with the host cartilage and it possessed 
a regular cell alignment as that of mature cartilage (F). Fibrous tissue developed in the cartilage defect at 3 (G) 
and 6 (H) months in the absence of the implanted MSC. GAG deposition in 3, 6 and 9 months experimental 
samples are as shown in I, J and K respectively. The control samples stained negatively for GAG (results not 








Functional restoration occurs when the regenerated cartilage is as mechanically competent 
as the native tissue. The indentation tests showed an increase in the Young’s modulus of 
the repaired cartilage of group 2 over the 6 months period (figure 5.11). Moreover the 
results at the later time point approximated to that of the native cartilage. This functional 
restoration was absented in the group 2 controls as the Young’s modulus remained a low 


















Figure 5.11. The Young’s modulus of the repaired cartilage in group 2. The results 
were compared against that of native cartilage. Sample size is indicated within the 
brackets. # indicates significant difference when compared against native cartilage 
(p < 0.05). * indicates significant difference between experimental and control 





The PCL-based scaffolds evaluated in this study possessed several key features that 
facilitated osteochondral regeneration. Firstly the pore sizes of the PCL (502 x 513 µm) 
and PCL – TCP (1058 x 478 µm) scaffolds were sufficiently large. The porosities of PCL 
and PCL – TCP scaffolds were 65 and 35% respectively. Kühne et al reported that bone in 
growth occurred in 500 µm but not in 200 µm pores of coralline hydroxyapaptite implants 
[289]. Large pores would allow vasculature invasion which accompany bone growth [37]. 
Conversely, cartilage is an avascular tissue that is solely dependent on diffusion for 
molecular transport [24], hence cartilage scaffolds have to be highly porous so as to 
promote cell survival. Allemann and coworkers have noted a decline in chondrocyte 
cellularity and ECM deposition when the pore size fell below 5000 µm2 [30]. The use of 
porous osteochondral scaffolds would also facilitate host tissue integration hence 
stabilizing the graft at the load bearing site. Besides being porous, the pore spaces within 
the PCL and PCL – TCP scaffolds were 100% interconnected, hence there were no dead 
end spaces such that tissue survival and growth were impossible. 
 
TCP was added to the composite scaffold with the aim of improving the osteoconductivity 
of the implant and moreover it acts as a buffer against the acidic by-products released 
during PCL degradation. The addition of the ceramic has also indirectly altered the 
scaffold architectural features. The viscosity of the molten PCL – TCP was higher than 
PCL and this affected the extrusion process in FDM as thicker PCL – TCP filaments were 
deposited, which in turn reduced the scaffold porosity. As the porosity declined, the 
resultant compressive stiffness of the scaffold increased as dictated by the Power law 
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[290]. However this increment was not solely due to the structural change but also an 
alteration of the intrinsic material properties as postulated by Heidemann et al when he 
noted an increase in the stiffness of particle filled polymers [243].  
 
The medial condyle is load bearing region of the knee and it is selected as the defect site 
so as to model the actual medical conditions observed in patients. In order for the new 
osteochondral tissue to be load bearing, the subchondral bone has to be regenerated. From 
the present findings, the mineralized volume at the bone defect was 30 – 70% that of the 
native bone at 3 months. A slower rate of mineralization was noted for PCL – TCP as it 
was not as porous as PCL. However mineralization in both scaffolds was equivalent and 
approximated to that of native bone at a later stage. This promising outcome at 6 months 
was attributed to various factors. Firstly, the porous implants have large interconnected 
pores which did not hinder bone in growth. Despite being less porous, the PCL – TCP 
scaffold excelled in bioactivity and osteoconductivity, thus favoring a high level of bone 
growth over time. The stiffness of the PCL scaffold (27.7 MPa) was within that of the 
trabecular bone (4.4 – 229 MPa), while the stiffness of the PCL – TCP scaffold (191.7 
MPa) coincided with the upper stiffness range of cancellous bone [178-179]. These 
scaffolds also possessed adequate yield strength relative to trabecular bone. Being 
mechanically competent, the bone implants were able to resist the physiological stresses 
while providing physical support for the developing tissue. The health of the overlying 
cartilage was determined by the condition of the subchondral bone. Favorable cartilage 
repair observed in the experimental groups was partly due to the successful restoration of 
the bone region. Wei et al discovered that cartilage stiffness was inversely correlated to 
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the volume fraction of the subchondral bone [177]. Computer stimulations have also 
demonstrated that stresses experienced at the cartilage were dependent on the stiffness of 
the underlying bone [291]. Therefore the increased deformability of the subchondral bone 
would not just undermine the structural support of cartilage but also result in a build up of 
stresses in cartilage which eventually leads to fatigue failure [292]. Such concerns 
surfaced in Chu et al’s attempt to repair osteochondral defects with a chondrocyte seeded 
PLA mesh [293]. Cartilage restoration was poor as subchondral bone repair was 
unsatisfactory even after 1 year. This was because the PLA mesh was not of sufficient 
mechanical strength [293].  
 
There are 2 commonly reported strategies in cartilage regeneration. Some researchers 
chose to use immature cartilaginous constructs that integrate well with the host, which are 
inherently biomechanically deficient as they are not fully developed. Conversely a mature 
cartilage graft is mechanically competent but it bonds poorly with the surrounding tissue 
and as a result it breaks down eventually at the load bearing site [4, 294-295]. With these 
considerations in mind, the author proposed an alternative approach of using an immature 
construct that is reinforced by a supportive scaffold system, hence encouraging both tissue 
integration and early biomechanical functionality.  
 
Cartilage repair occurred in both groups 1 and 2 as a layer of neocartilage developed from 
the MSC encapsulated within the fibrin matrix. This validated the previous in vitro 
findings that demonstrated the ability of the fibrin hydrogel in supporting MSC 
chondrogenesis and cartilage growth. However marked cartilage deterioration was 
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discovered at 6 months when fibrin was the sole scaffold. Van Susante et al encountered 
the same problem [153]. The hyaline cartilage which was developed from a chondrocyte 
seeded fibrin matrix, gradually degraded due to the disintegration of fibrin. This was even 
more obvious at load bearing sites when Patella et al tried to repair canine cartilage 
defects with exogenous fibrin clots [21]. The unloaded regions were resurfaced with a 
cartilage tissue that was more cellular and organized than the loaded sites as the 
mechanical stresses disrupted the hydrogel matrix hence affecting the chemotactic and 
mitogenic activities within the repair zone. This limitation can be resolved by reinforcing 
the fibrin matrix with a porous PCL scaffold. The strength and stiffness of the polymeric 
scaffold matched that of the native hyaline cartilage. Moreover as it degrades slowly, the 
PCL scaffold served as a supportive substrum for the development and maturation of 
cartilage at the defect site. Hence there was superior cartilage repair in group 2 as 
compared to group 1 at 6 months.                                                           
 
Bioabsorbable implants must not degrade prematurely during osteochondral recovery as 
neotissues are not fully weight bearing. The time period required for adequate restoration 
must be factored into the design of osteochondral scaffolds. Clinicians recommend 6 
months of abstinence from sports after ACI procedures [296]. Bentley and Peterson 
reported that the newly repaired cartilage needs 2 years to mature [297-298]. A 2 year in 
vitro degradation test conducted by the author’s group have shown a decline in the 
stiffness of PCL and PCL – TCP scaffolds to 20 and 50 MPa respectively, while the yield 
strength was reduced to 2.8 and 0.8 MPa respectively [299]. During the initial 6 months, 
the yield strength of the scaffolds remained constant. The unique degradation profile of 
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these PCL – based scaffolds would enable the implants to provide the necessary support 
during the healing and maturation at the osteochondral defect. Furthermore the timely 
degradation of the polymeric scaffolds would facilitate the transfer of the stress bearing by 
the scaffolds to the regenerated tissues [56].  
 
The implanted MSC played an important role in osteochondral repair. At 3 months, the 
controls seemed to experience a lower degree of mineralization as compared to the 
experimental groups. But interestingly, bone mineralization was equivalent after 6 
months. A likely reason would be that the implants were situated in the bone marrow 
region which was rich in native MSC. These cells migrated to the defect site hence 
resulting in a significant level of bone repair at 6 months. From these findings, MSC 
implantation might accelerate bone healing over short term, thus allowing early load 
bearing at the defect site. The implanted MSC played an indispensable role in cartilage 
regeneration. Fibrous tissue developed at the cartilage zone in the absence of the 
implanted MSC. This occurred because the host tissue was unable to supply a sufficient 
number of native progenitor cells required for cartilage repair. Tatebe et al had similar 
conclusions with regards to the requirement of the implanted MSC for the repair of bone 
and cartilage [171]. The use of unseeded osteochondral scaffolds has resulted in 
satisfactory bone repair but poor cartilage restoration. Cell labeling studies have shown 
that most of the chondrocytes and osteoblasts at the repair site originated from the 
implanted MSC [171]. However these donor cells were gradually replaced by the native 




The efficacy of the osteochondral implants was gauged against the controls. Cell free 
implants were included as negative controls, but the empty osteochondral defect was 
omitted because it has been established by several researchers that self repair deteriorates 
over time in the rabbit model. Shapiro et al conducted a comprehensive study to evaluate 
the efficacy of osteochondral self healing in rabbits [287]. 3 mm diameter defects were 
created and evaluated over 12 months. The defect site was initially repopulated with the 
native MSC which differentiated into chondrocytes and osteoblasts. After 6 months, the 
tidemark and underlying subchondral bone were re-established. However at this time 
point, the neocartilage was found to degenerate with an increasing occurrence of 
fibrillation, hypocellularity, proteoglycan loss and vertical fissuring [287]. Chondrocyte 
death was also observed and the deterioration progressed from the superficial to the deep 
layers of the cartilage. These observations were similarly reported by Lietman et al and 
Wakitani et al [288, 301]. The general opinion was that the subchondral bone was restored 
but the cartilage defect was filled with fibrous tissue which stained poorly for GAGs 
[301]. Wei et al measured the stiffness of the neocartilage and found it to be about 30% 
that of the native cartilage [302]. Shapiro et al hypothesized that the failure of self healing 
stemmed from the poor biochemical reconstitution of the new cartilage and its inferior 
physiochemical bonding to the host cartilage [287]. The neocartilage was unable to 
withstand mechanical stress and it was displaced by micro motion. Therefore the untreated 
rabbit osteochondral defect did not heal by itself and this was evident at 6 months. As this 
was well reported, the untreated control was omitted since reference could be taken from 
literature. On the other hand, the positive control in this rabbit study would ideally be the 
autograft. But the osteochondral defect was critically sized, hence transplantation would 
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not be clinically feasible since graft harvesting would created similarly sized defects that 
heal poorly. Moreover this would influence the experimental outcome if practiced in the 
animal model. Given the absence of these controls, the characteristics of the regenerated 
tissue were compared against that of the native site in the unoperated animals. The 
restoration process is quantified as the volume of bone in growth within the defect was 
normalized to that of the native subchondral bone while the Young’s modulus of the 
neocartilage was compared against that of the native cartilage. 
 
The osteochondral repair in group 2 was promising. However the surface continuity of the 
repaired cartilage was compromised by the protruding struts of the PCL scaffold and the 
surface was also fibrillated in a few samples. This might be due to the direct contact 
between the top of the cartilage implant and the opposing surface. Abrasion at that region 
might have resulted in the loss of the implanted cells and immature cartilage, hence 
constituting a major concern in the repair of large defects. The author proposed the use of 
an overlying membrane which helps to retain the implanted MSC at the defect and prevent 











Biphasic osteochondral implants were characterized and evaluated in an animal model. 
The in vivo findings have revealed a high degree of bone mineralization which 
approximated to that of native bone at 6 months. Bone growth was assisted by the porous 
PCL and PCL – TCP scaffolds which were mechanically competent. Bone development 
was initially slow in the less porous PCL – TCP scaffold, but it was enhanced by TCP 
over long term. Hyaline cartilage repair occurred in both implants, but the PCL – fibrin 
combination was more promising as compared to fibrin alone because the PCL matrix was 
load bearing and it did not degrade rapidly. The implanted MSC might have accelerated 
bone repair over short term but bone regeneration could proceed solely with the native 
progenitor cells. This was however not the case for the cartilage restoration as the native 
















Chapter 6. Resurfacing of the cartilage defect with a 
PCL – collagen electrospun mesh. 
 
 
6.1. Abstract  
The author sought to address the inconsistent cartilage repair in the preceding rabbit study 
by proposing a cartilage resurfacing membrane which would prevent the leakage of the 
transplanted MSC from the defect site. This cell loss was likely to have compromised the 
healing process in the rabbit model. A polycaprolactone – collagen electrospun mesh was 
proposed as a novel alternative to the conventional periosteal graft in Autologous 
Chondrocyte Implantation (ACI). This was the first known attempt in designing a 
cartilage patch by using a mechanically resilient Polycaprolactone (PCL) mesh that was 
enhanced with bioactive collagen. PCL – collagen 10, 20 and 40 % electrospun meshes 
(Coll-10, 20 and 40) were evaluated and it was discovered that collagen retention could 
only be achieved in Coll-20 and 40. Furthermore Coll-20 was stiffer and stronger than 
Coll-40 and it satisfied the mechanical demands at the cartilage implant site. When seeded 
with Mesenchymal Stem Cells (MSC), the cells adhered on the surface of the Coll-20 
mesh and they remained viable over a period of 28 days, however they were unable to 
infiltrate through the dense meshwork. Cell compatibility was also noted in the 
chondrogenic environment as the MSC differentiated into chondrocytes with the 
expression of Sox9, aggrecan and collagen II. More importantly, the mesh did not induce 
a hypertrophic response from the cells. The current findings supported the use of Coll-20 





In the previous rabbit study, the MSC seeded biphasic osteochondral constructs which 
consisted of a PCL cartilage scaffold and a PCL – TCP osseous phase supported tissue 
regeneration. However cartilage healing was inconsistent due to the probable leakage of 
the transplanted MSC into the joint space during articulation. The full reparative potential 
can only be realized when the implanted cells are retained at the defect site. Therefore the 
scaffold implant can be further complemented with a cartilage patch which seals the 
defect site. An autologous periosteal patch is commonly used to achieve this goal in ACI 
procedures as it is readily available and it serves as a source of mesenchymal progenitor 
cells and growth factors which promote cartilage repair [303]. Unfortunately there are 
concerns. Gooding et al noted that cartilage hypertrophy occurred in a staggering 36.4% 
of the patients who received periosteal grafts during ACI as compared to none with 
synthetic membranes [87]. When the study was repeated in the sheep model, the use of the 
graft resulted in a 45 – 70% increase in the density of the subchondral bone [88]. This 
occurred because the periosteal flap stimulated bone remodeling and stiffening which 
would eventually led to the degeneration of the overlying cartilage via a build up of 
stresses. A probable explanation for these occurrences would be the expression of 
Vascular Endothelial Growth Factor (VEGF) by the periosteum. This growth factor 
induces vasculature invasion which encourages bone development [304]. In view of these 





A PCL – collagen I tissue engineered graft was proposed as a membrane covering over 
cartilage defects that were treated with MSC. The electrospun mesh was selected because 
of its porous and permeable architecture which facilitates molecular transport between the 
defect site and the synovial space while preventing the leakage of the implanted MSC. 
Furthermore, the patch would also prevent the opposing articulating surface from coming 
into direct contact with the repair site thereby inflicting abrasive damage on the immature 
cartilaginous tissue. PCL – collagen blends containing 10, 20 and 40% collagen I would 
be evaluated for this application (figure 6.1). The selection process would be based on 
their collagen retention rates and mechanical properties. MSC – mesh compatibility in an 


























Figure 6.1. Schematic layout of the investigation. 3 compositions of PCL 
collagen electrospun blends were evaluated. They were subjected to 
collagen retention and mechanical assessment. After which the selected 
mesh was seeded with MSC in order to gauge the cell response to the 
synthetic membrane.  
Collagen retention 
Mechanical characterization 
MSC – mesh compatibility 
in the in vitro chondrogenic 
environment  




1. PCL – collagen 10% (Coll-10) 
2. PCL – collagen 20% (Coll-20) 
3. PCL – collagen 40% (Coll-40) 
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6.3. Materials and Methods 
 
 
6.3.1 Reagents and chemicals 
Unless otherwise stated, all reagents used in this study were purchased from Sigma 
Aldrich (St Louis, MO). High glucose Dulbecco’s Modified Eagle’s Medium (high 
glucose DMEM) and low glucose Dulbecco’s Modified Eagle’s Medium (low glucose 
DMEM) were from Gibco BRL (Grand Islands, NY). All labware consumables were 
purchased from Becton-Dickinson (Franklin Lakes, NJ).        
 
 
6.3.2. Fabrication of the PCL – Collagen electrospun meshes 
PCL collagen composites were prepared by dissolving PCL (Birmingham Polymers, 
Pelham, AL) and bovine collagen type I (Symatase, Chaponost, France) in  1, 1, 1, 3, 3, 3 
fluoro 2-propanol (HFP) (Fluka, Buchs, Switzerland). PCL and collagen were mixed in 9 : 
1, 4 : 1 and 3 : 2 ratios in HFP so as to constitute the PCL – collagen 10% (Coll-10), PCL 
– collagen 20% (Coll-20) and PCL – collagen 40% (Coll-40) blends. Each solution was 
loaded into a syringe positioned on a pump and discharged through a metallic needle at a 
flow rate of 0.75 ml / hr at a potential of 10 kV. The resultant meshes were collected onto 
an earthed aluminum foil placed 15 cm below the discharge point. Once completed, the 
electrospun meshes were dried in a desiccator and sterilized via 70% ethanol treatment 







6.3.3. Collagen retention analysis 
The presence of collagen in the newly electrospun Coll-10, 20 and 40 meshes was 
validated through immunofluorescent staining against collagen I. The meshes were firstly 
fixed in methanol and blocked with 3% goat serum (Dako, Glostrup, Denmark). This was 
followed by an incubation with a mouse monoclonal antibody against collagen I (Dilution 
factor 1 : 4000) for 16 hours at 4˚C. The samples were washed with 0.05% PBS-Tween 
and visualization was accomplished by using a secondary TRITC conjugated rabbit anti-
mouse Ig antibody (Dako, Glostrup, Denmark, dilution factor 1 : 100). The specimens 
were subsequently washed and dehydrated through an ethanol series before being 
mounted and viewed with an Olympus IX81 confocal microscope (Japan). 
 
Collagen release was conducted by soaking the 1 x 1 cm2 meshes in 1 ml of PBS over a 
period of 28 days at 37˚C. 5 samples per membrane were evaluated. 100 µl of the solution 
containing the dissolved collagen was extracted per hourly for the initial 6 hours and at 1, 
2, 3, 7, 14, 21 and 28 days. The incubation volume was reconstituted back to 1 ml with the 
addition of 100 µl of fresh PBS after each extraction. Collagen quantification was done in 
accordance to the Micro BCA protein assay kit protocol (Pierce, Rockford, IL).  
 
6.3.4. Tensile test and porosity measurement   
Electrospun meshes were stretched to failure on the Intron 4302 (Norwood, MA). The set 
up was equipped with a 10 N load cell and controlled by a Series IX Automated Materials 
Tester software (version 7.43). 35 x 10 mm2 sample strips were used and they were 
preconditioned overnight in 37˚C PBS. The specimens were clamped and stretched at a 
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cross head speed of 10 mm / min in a 37˚C PBS bath. Tensile Young’s modulus, ultimate 
strength and strain were subsequently derived from the stress-strain curves. The Young’s 
modulus was calculated as the slope of the initial linear region of the curve (without the 
toe region), while the ultimate strength and strain were measured at the point of maximum 
stress. 4 samples per mesh were tested and evaluated. In order to measure the porosity of 
the mesh, 1 x 1 cm2 patches were cut and weighted. These samples were cryosectioned 
and the thickness was measured via microscopy. The porosity of the meshes was 
calculated based on the apparent volume (area x thickness), mass, density of PCL (1.11 
g/ml) and collagen (1.41 g/ml) [305].  
 
6.3.5. MSC isolation and expansion 
Human MSC was isolated and cultured as described in the materials and methods of 
chapter 4. Only passage 3 MSC was used. 
 
6.3.6. Cell cultures 
MSC was seeded at 4000 cells / mm2 on one side of the Coll-20 mesh (4 mm diameter) 
and the construct were maintained in a chondrogenic media as described in the materials 
and methods of chapter 4. These MSC mesh constructs were compared against negative 
controls consisting of uninduced samples and uninduced MSC pellet cultures while the 
induced standard MSC pellet was used as a positive control. 
 
Spontaneous MSC osteogenic differentiation on the PCL – collagen mesh was also 
evaluated. MSC was seeded at 500 cells / mm2 on one side of the Coll-20 mesh and 
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maintained in the MSC expansion media. This was compared against osteogenic induced 
(positive control) and uninduced plate cultures (negative control) which were seeded at 
the same density. Osteogenic induction was achieved as described in the materials and 
methods of chapter 4. The uninduced plate cultures were kept in the MSC expansion 
media.            
 
6.3.7. Fluorecein Diacetate (FDA) and Propidium Iodide (PI) staining  
Cell viability on the Coll-20 mesh was evaluated with FDA –PI staining at 7 and 28 days. 
The protocol was described in the materials and methods of chapter 4. 
 
6.3.8. Scanning Electron Microscopy (SEM) 
The meshes were examined via SEM as described in the materials and methods of chapter 
5. 
 
6.3.9. Real time PCR  
Osteogenic and chondrogenic gene expressions in the in vitro cultures were analyzed at 
day 28. The protocol was described in the materials and methods of chapter 4 and the 
results were either normalized to that of the osteogenic induced plate cultures or the 





6.3.10. Histology and immunostaining  
The MSC mesh, plate and pellet cultures were evaluated via histology and 
immunohistochemistry at day 28. All samples were fixed overnight in 10% neutral 
buffered formalin. The MSC mesh constructs were cryosectioned at 5 µm, while the pellet 
cultures were dehydrated, embedded in paraffin with 5 µm sections taken from the center. 
Staining was performed with HE and von Kossa (counter stained with Alcian blue) while 
immunostaining was done against collagen II, X, aggrecan, Sox9 and isotype control as 
described in the materials and methods of chapter 4.   
 
6.3.11. Statistical analysis 
The results were expressed in mean ± standard deviation and compared using student t-






Target gene Ascension 
no.  
Forward Reverse Size 
Runx2 NM_004348 5’ – AAC CCA CGA ATG 
CAC TAT CCA – 3’ 
5’ – CGG ACA TAC CGA 
GGG ACA TG – 3’ 
76 bp 
BSP NM_004967 5’ – TGC CTT GAG CCT 
GCT TCC – 3’ 
5’ – GCA AAA TTA AAG 
CAG TCT TCA TTT TG – 3’ 
78 bp 
Collagen I NM_000088 5’ – CAG CCG CTT CAC 
CTA CAG C – 3’ 
5’ – TTT TGT ATT CAA 
TCA CTG TCT TGC C – 3’ 
83 bp 
Collagen II NM_033150 5’- GGC AAT AGC AGG 
TTC ACG TAC A – 3’ 
5’- CGA TAA CAG TCT TGC 
CCC ACT T – 3’ 
79 bp 
Collagen X NM_000493 5’ – CAA GGC ACC ATC 
TCC AGG AA – 3’ 
5’ – AAA GGG TAT TTG 
TGG CAG CAT ATT – 3’ 
70 bp 
GAPDH NM_002046 5’ – ATG GGG AAG GTG 
AAG GTC G – 3’ 
5’ – TAA AAG CAG CCC 
TGG TGA CC – 3’ 
70 bp 
 




The retention of collagen within the composite meshes influences cell response. This 
retention was evaluated via immunostaining and collagen release analysis. 
Immunohistochemistry validated the presence of collagen in the newly fabricated meshes 
and the negative results in Coll-10 (figure 6.2A - C) indicated a complete loss of surface 
collagen. This could have occurred during the washing steps of the immunostaining 
procedure but it was averted when the collagen content was above 10%, thus Coll-10 was 
excluded from the following evaluations. When the collagen dissolution profile of Coll-20 
and 40 were compared (figure 6.2D), the release rate was relatively slow during the initial 
6 hours, but eventually the meshes lost 8.6 and 18.27 % of the total collagen after 28 days 
respectively. Hence a higher collagen content was accompanied by a greater collagen loss 




































Figure 6.2. Collagen retention of the electrospun meshes. Immunofluorescent staining against collagen I in 
the Coll-10 (A), Coll-20 (B) and Coll-40 (C) meshes. Coll-10 surface collagen was absent hence it was not 
subjected to any further evaluations. The percentage of collagen released was normalized to the initial 
amount in Coll-20 and 40 (D). The values of Coll-20 and 40 were significantly different at each time point 
(p < 0.05). N is 5.    
D 
A B C 
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Biomechanical competence of the electrospun meshes was important as they would be 
implanted at the load bearing regions of the knee joint. Mechanical characterization has 
shown Coll-20 to be stiffer and stronger than Coll-40. However the ultimate strain and 
porosity of the 2 meshes were equivalent (figure 6.3) and the average pore sizes were of 
the same order of magnitude. The increase in PCL content has not just conferred greater 
mechanical resilience but that has also altered the morphology of the filaments as thick 
and wavy fibers were deposited for Coll-40 as compared to slim and straight Coll-20 
filaments. The mechanical properties of Coll-20 approximated to that of hyaline cartilage 
which has a tensile modulus of 0.2 – 4.98 MPa [120, 306], ultimate strength of 1 – 8 MPa 
[307] and ultimate strain of 15 – 120% [286, 308]. The ultimate strength of Coll-20 (0.15 
MPa) was below that of cartilage, however that would still suffice given that the 
maximum applied physiological tensile stress to be 0.15 – 0.4 MPa [309]. Positive 
reference was taken from the native cartilage during mechanical characterization because 
the resurfacing membrane must recapitulate its tensile properties. However there was no 













Figure 6.3. Mechanical and architectural properties of Coll-20 and 40 meshes. Tensile Young’s modulus (A), 
ultimate strength (B), strain (C) and porosity (D) are as shown. * indicates significant difference between 
Coll-20 and 40 (p < 0.05). SEM images of Coll-20 (E and F) and Coll-40 (G and H). The Coll-20 fibers were 
slender and straight while those in Coll-40 were thick and wavy. The average pore sizes of Coll-20 and 40 















As Coll-20 excelled over Coll-10 and 40 in terms of collagen retention and mechanical 
competence, it was further screened for MSC compatibility and osteoinductivity. MSC 
remained viable on the Coll-20 mesh under all conditions. From the SEM images, MSC 
was found to reside on the mesh surface for all groups (figure 6.4). At day 7, the 
chondrogenic induced cells were ball-up as compared to the flatten morphology on the 
uninduced mesh cultures. However at day 28, the uninduced cells also began to display a 
similar rounded morphology. This might be due to the occurrence of partial chondrogenic 
differentiation in the basal chondrogenic media which lacked TGF-β1. When the unseeded 
side of the mesh was examined, it was found to be devoid of cells even after 28 days of in 
vitro culturing (figure 6.4Cand F). Hence the Coll-20 mesh was an effective porous cell 






































Figure 6.4. Cell viability and morphology during chondrogenic induction. FDA-PI staining and SEM 
imaging at day 7 and 28 for the chondrogenic induced and uninduced MSC seeded Coll-20 meshes. The 
induced samples exhibited a ball-up morphology at the early time point (D) as compared to the uninduced 
cultures which were spread out (I). It was only at day 28, that the uninduced cells were ball-up. No cells 
penetrated to the unseeded side of the Coll-20 mesh as observed on day 28 (C and F). 
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MSC were attached to the surface of the Coll-20 mesh and they did not infiltrate deep into 
the fine network (figure 6.5). There was an absence of mineralization and hypertrophy in 
the chondrogenic induced, uninduced and normal media cultures. The cells used for this 
study were able to differentiate into osteoblasts as shown by the positive von Kossa 
Alcian blue stain in the osteogenic induced plate cultures (figure 6.5D). Mineralization 
was also noted at the cell dense areas of the normal media plate cultures (figure 6.5E). 
Gene expressions of Runx2 and Bone Sialoprotein (BSP) in the normal media mesh 
cultures were below that of the osteogenic induced plate cultures and they were 
significantly lower than that of the normal media plate cultures. The collagen I gene 

















Figure 6.5. Evaluation of tissue hypertrophy on the Coll-20 mesh.Von Kossa alcian blue staining at day 28 for the 
chondrogenic induced (A) and uninduced (B) MSC mesh constructs. The seeded mesh was also maintained in normal 
media (C). There was a general absence of mineralization as compared to the plate cultures that were kept in osteogenic 
inductive (D) and normal media (E) for 28 days. Mild mineralization occurred in E at the cell dense areas. Real time PCR 
of Runx2 (F), BSP (G) and collagen I (H) of the MSC mesh culture that was maintained in normal media. The results were 
normalized against the osteogenic induced plate cultures. * indicates significant difference between the normal media Coll-
20 and osteogenic induced plate cultures (p < 0.05). # indicates significant difference between the Coll-20 and plate 












During chondrogenic induction, cell morphologies of the mesh and pellet cultures 
differed. The differentiated MSC formed distinctive chondrocyte lacunes within the 
induced pellets that were surrounded by a dense ECM matrix (figure 6.6B). Conversely, 
MSC remained as a layer of cells at the top of the Coll-20 mesh. Despite of not having the 
same morphology, cells of both cultures differentiated into chondrocytes as indicated by 
the presence of the chondrogenic markers such as Sox 9, aggrecan and collagen II. 
Furthermore the mesh cultures have a lower tendency to undergo hypertrophy as collagen 
X was not secreted. This was further reinforced by the significantly lower gene 
expressions of collagen I and X (figure 6.6K and M). The cells cultured on the Coll-20 
mesh were able to undergo chondrogenic differentiation, but it was not as effective as that 
in pellet cultures as the gene expression of collagen II was severely deficient (figure 
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Figure 6.6.  Chondrogenic differentiation of MSC seeded on the electrospun mesh at 28 days. HE (A and B) and 
immunostaining against Sox9 (C and D), aggrecan (E and F), collagen II (G and H) and collagen X (I and J) of the 
chondrogenic induced MSC Coll-20 constructs (A, C, E, G and I) and MSC pellet cultures (B, D, F, H and J). During 
induction, the differentiated MSC formed lacunes in the pellet (B) while they remained as a layer of cells at the top of 
the mesh (A). Sox9 was expressed in the induced mesh samples (C) and this was accompanied by the presence of 
aggrecan (E) and collagen II (G), but not Collagen X (I). Isotype controls and uninduced samples from both groups were 
negatively stained (results not shown). Gene expressions of collagen I (K), II (L) and X (M) at day 28. The results were 
normalized to that of the chondrogenic induced pellets. MSC chondrogenesis on the mesh was not as effective as that in 
pellet cultures. * indicates significant difference between the induced mesh and pellet cultures (p < 0.05). The sample 
size was 4 for each group.   





The periosteal flap fulfills various biomechanical and biological functions in ACI. Firstly, 
it prevents the leakage of the implanted cells. Moreover the periosteal cells are able to 
stimulate cartilage repair via the secretion of cytokines and they can also differentiate into 
chondroblasts which assist tissue restoration [109]. However, the validity of these 
assumptions was tested and it was discovered that the periosteal patch could also provoke 
cartilage hypertrophy through molecular signaling [304]. Furthermore Kajitani et al 
questioned the reparative role of the periosteal cells when there was no difference between 
the cartilage defects that were resurfaced with either fresh or frozen periosteum grafts 
[310]. The use of the graft was further complicated by its variable quality due to the 
patient’s age and surgical harvesting technique [303, 311]. In view of these shortcomings, 
other alternatives were being sought. Unfortunately, there were only a few of available 
options and one of them is the Chondro-gide membrane (Geistlich Biomaterials, 
Switzerland) which is an acellular porcine collagen I / III bilayer mesh [88, 312]. Studies 
on pure collagen patches have found the natural material to be mechanically inadequate 
and its rapid disintegration at the load bearing site have resulted in the loss of the 
transplanted cells [310]. Hence the use of synthetic polymers was encouraged given their 
stability and strength. One example would be the foam-like polyurethane membrane that 
was fabricated by Chia et al through a phase inversion process [313]. But the permeability 
of the membrane was questioned as the pore spaces might not be fully interconnected. In 
order to address these constraints, the author proposed a composite electrospun membrane 
as a physical barrier over the cartilage defect. The mesh consisted of loosely stacked ultra-
fine fibers with interconnected pores, hence the matrix is highly porous and permeable.  
Chapter 6. 
 130
Collagen I was selected as the natural biomaterial that would enhance the bioactivity of 
the mesh [314]. However this would only occur if collagen was retained in the mesh. 
When Coll-10, 20 and 40 were screened via immunostaining, it was discovered that a 
complete loss of surface collagen occurred in the Coll-10 during the washing process. 
This was averted when the collagen content was increased to 20 and 40 %. Surface 
collagen would assist in cellular interactions on the mesh. The release kinetics profile over 
a period of 28 days indicated a loss of 8.6 and 18.27 % of the total collagen content from 
Coll-20 and 40 respectively. This dissolution phenomenon is widely reported for collagen 
based electrospun meshes [315] and when modulated this gradual material loss creates 
space for cell colonization [72, 316].  
 
The surface of the articular cartilage is lined by a dense acellular network of collagen 
fibers known as the lamina splendens [317-318]. Coll-20 and 40 are morphologically 
similar to this acellular tissue, but gross resemblance must be coupled with mechanical 
suitability so as to achieve biological functionality. Tensile tests have shown Coll-20 to be 
stronger and stiffer than Coll-40. Coll-20 was comparable to hyaline cartilage in terms of 
the Young’s modulus and ultimate strain moreover its tensile strength would suffice under 
the applied physiological tensile load. Porosity could not account for the disparity in the 
mechanical properties of the 2 meshes as they were equally porous. The differential 
collagen contents were the main cause. In the composite blend, collagen existed as a 
separate phase within PCL and the transition zones between the 2 material phases served 
as stress concentrators and fracture points. Therefore an increase in collagen content 
would inevitably be accompanied by a decline in physical strength [319].  
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The MSC cultured on Coll-20 were firmly attached on the mesh and they remained viable 
under all conditions. Cell adhesion was promoted by the porous architecture and enhanced 
by the presence of bioactive collagen I. However these attached cells were unable to 
infiltrate through the porous meshwork and colonized the reverse side. The reason was 
because the 8.14 µm pores were too restrictive for cell migration. It was suspected that the 
pore size was indirectly correlated to the diameter of the electrospun fibers. When Shin et 
al experimented with 550 ± 150 nm PLGA electrospun mesh (diameter), he too noted that 
the cells aggregated on the seeded surface and they were unable to infiltrate into the 
constrictive pores channels [320]. Li et al was able to prevent this by using larger 
filaments measuring 500 – 900 nm in diameter [199]. In this current study, the unique 
architectural features of the Coll-20 mesh enabled it to serve as an effective permeable 
cell barrier that facilitates diffusion from the synovial space. 
  
The Coll-20 mesh did not elicit any hypertrophic or osteogenic response from MSC, as the 
mesh cultures did not exhibit any overt signs of mineralization. There was a low gene 
expression of collagen I and an absence of Runx2 and BSP in the normal media mesh 
cultures as compared to the normal media plate cultures which registered basal 
expressions of these osteogenic markers. It should be noted that the Coll-20 mesh and 
plate cultures were seeded at the same density with progenitor cells that were capable of 
osteogenic differentiation. Mild mineralization was even noted in the cell dense areas of 
the plate culture but this did not occur on the mesh construct. In the chondrogenic mesh 
cultures, gene expressions of collagen I and X were significantly lower than that of the 
induced pellet. Moreover collagen X was not secreted on the Coll-20 mesh. All these 
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experimental evidences pointed to the inability of Coll-20 to induce tissue hypertrophy 
and this might be attributed to its topographical cues which modulated the cell response.  
 
Cell compatibility on the Coll-20 mesh was observed under chondrogenic induction. The 
seeded MSC differentiated into chondrocytes which exhibited a ball-up morphology, they 
stained positively for Sox9 and aggrecan. Though collagen II was secreted, the gene 
expression was significantly low. This suggested that the chondrogenic differentiation 
might not be as effective as that in the induced pellets. A probable reason would be that 
MSC agglomerate best in a 3D environment before differentiating into chondrocytes [273-
274]. Cellular condensation was similarly witnessed with fibrin encapsulation in chapter 4 
as the MSC underwent chondrogenesis with a high expression of Sox9, aggrecan and 
collagen II which were equivalent to the MSC pellet. The 3D space of the cell pellet and 
the bioactive fibrin matrix facilitates the agglomeration process which is a precursor for 
chondrogenesis [273]. This was however not the case on the Coll-20 mesh as the cells 
were firmly attached to the surface of the mesh. Such cells could only cluster to a limited 
extent with those surrounding them and as a result the differentiation process was 
deficient. However this limitation was not a major concern as the research objective was 
to simply design a protective cover over the cartilage defect site with cell compatibility in 
the chondrogenic environment. In contrast, Li et al reported of comparable chondrogenic 
differentiation between induced mesh and pellets cultures as the seeded MSC has 
infiltrated deep into the sparse matrix. These progenitor cells agglomerated and 
differentiated within the meshwork and it suited Li et al’s objective of tissue engineering a 
cartilage implant [200].    
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PCL was selected as the base material for the patch because it is stable. As the polymer 
degrades slowly, the patch is able to fulfill its protective function over a longer period of 
time at the load bearing site of the knee joint. PCL breaks down via hydrolytic cleavage 
and during a 3 month in vitro degradation study, Chen et al noted an increase in the 
fractional crystallinity that accompanied the reduction in molecular weight [321]. This 
increase in fractional crystallinity was due to polymer recrystallization which in turn 
slowed down the degradation process [322-323]. The break down of the mesh was not just 
dependent on material properties but also on the site of implantation, matrix porosity and 
surface area [320].  
 
This is the first known attempt to the best of the author’s knowledge to harness an 
electrospun mesh as a protective barrier over the cartilage defect. Other applications of the 
ultra fine matrix would include bone, cardiac and dermal regeneration. Shin et al had 
demonstrated the possibility of growing woven bone within a porous PCL mesh that was 
seeded with neonatal rat MSC [324]. Cardiomyocytes cultured on electrospun meshes 
could be conditioned to express specific cardiac proteins such as connexin48 and cardiac 
troponin I [325]. Venugopal et al on the other hand was able to engineer an electrospun 
dermal graft that has the same mechanical properties as that of native skin [326]. These 
are just a few of the potential applications of the electrospun mesh and more is anticipated 







The leakage of the transplanted MSC in the preceding rabbit model has prompted the 
author to engineer a cartilage patch. This synthetic membrane would assist in cell 
retention at the defect site thus supporting tissue restoration. PCL – collagen electrospun 
meshes were evaluated as the cartilage resurfacing membrane which might potentially 
replaced the conventional periosteal flap. Material and mechanical considerations have 
indicated Coll-20 to be mechanically comparable to hyaline cartilage while having high 
collagen retention rate. In vitro studies have demonstrated MSC mesh compatibility in the 
chondrogenic environment as the seeded cells were capable of differentiating into 
chondrocytes but not with the same efficacy as that in pellet cultures. But more 
importantly, the mesh did not induce a hypertrophic or osteogenic reaction. The Coll-20 
mesh was a permeable membrane that could prevent cell leakage as the seeded MSC were 
unable to migrate through the dense ultra-fine mesh. These findings supported the use of 













Chapter 7. The evaluation of the biphasic osteochondral 





Current clinical therapies were unable to resolve osteochondral defects adequately, hence 
tissue engineering alternatives were sought to address the challenge. The author’s group 
has evaluated the use of a biphasic scaffold implant in restoring osteochondral defects and 
favorable findings have prompted an implantation trial in the pig model. This dual phase 
construct comprised of a cartilage Polycaprolactone (PCL) scaffold and a 
Polycaprolactone  - Tri Calcium Phosphate (PCL – TCP) bone scaffold. Autologous 
Mesenchymal Stem Cells (MSC) was seeded into the entire implant which was inserted 
into critically sized osteochondral defects located at the medial condyle and patellar 
groove. The cartilage defect was also resurfaced with a novel electrospun mesh that 
served as a periosteum substitute in preventing cell leakage. After 6 months, cartilaginous 
repair was observed with a low occurrence of fibrocartilage at the medial condyle. The 
enhanced defect healing has also arrested the degenerative effect in the host cartilage as 
shown by the better maintenance of Glycosaminoglycan (GAG). These positive 
morphological outcomes were supported by the higher relative Young’s modulus which 
indicated functional restoration of the cartilage zone. Bone in growth and remodeling 
occurred in all groups but a higher degree of mineralization was found in the experimental 
group. In the absence of the implanted cells or the resurfacing membrane, osteochondral 
healing was compromised. A comparison between the defect sites revealed inferior 
osteochondral healing at the patellar groove and this was attributed to the unique 





Osteochondral defects are caused by trauma or disease and it affects the cartilage and the 
underlying subchondral bone. When left on its own, self repair is inadequate and the 
injury aggravates [147]. The defect can be treated with autologous osteochondral grafts 
but this has several pitfalls such as poor healing at the donor sites and inadequate 
integration with the host tissue [91, 327]. Moreover the therapy is not feasible for patients 
who suffer from musculoskeletal diseases such as osteonecrosis [85]. Therefore tissue 
engineering solutions are explored to assist osteochondral repair. There were several 
attempts to address the issue, but most of these prove to be inconclusive. Some of the 
proposed osteochondral implants are unable to withstand the physiological loading at the 
knee joint [22]. Positive outcomes were reported from animal trials which involved 
transplantation at non-weight bearing sites or non critically sized defects [2, 154]. Though 
promising, the clinical relevance of these findings was often questioned. The author is 
mindful of these pitfalls and he proposed a large animal study so as to evaluate the 
efficacy of a biphasic osteochondral implant in the repair of critically sized defects located 
at different sites in the knee joint. The pig model was selected because it would better 
represent the human knee joint in terms of loading and anatomy [328]. The implant 
comprised of a PCL cartilage scaffold with a PCL – TCP matrix which served as the bone 
substratum. These Rapid Prototyped (RP) matrices were mechanically competent and 
porous, hence they would shield growing tissues from excessive stresses while facilitating 
tissue in growth and nutrient exchange. Autologous MSC was seeded into the biphasic 
implant via fibrin glue so as to promoted cartilage and bone regeneration. These biological 
constructs would be implanted into critically sized osteochondral defects located at the 
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medial condyle and patellar groove of pigs. The preceding rabbit study demonstrated 
compromised cartilage repair due to a probable leakage of the transplanted MSC from the 
defect site, hence efforts were undertaken to design a PCL – collagen 20% cartilage patch. 
This tissue engineered membrane would help to retain the seeded MSC at the site, 
replacing the conventional periosteum flap whose use was frequently associated with 
cartilage hypertrophy and subchondral bone sclerosis [87-88]. After 6 months, 
osteochondral repair was assessed via Micro Computed Tomography (micro CT) scans, 
mechanical testing and histological analysis. Results from the experimental group were 








































Figure 7.1. A schematic diagram of the experimental layout. 3 groups of biphasic constructs were evaluated 
: Group A – with cells and mesh, Group B – with cells without mesh and Group C – without cells with 
mesh. These were implanted into critically sized osteochondral defects located at the medial condyle and 
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7.3. Materials and methods 
 
7.3.1. Reagents and chemicals 
Unless otherwise stated, all reagents used in this study were purchased from Sigma 
Aldrich (St Louis, MO). Low glucose Dulbecco’s Modified Eagle’s Medium (low glucose 
DMEM) was from Gibco BRL (Grand Islands, NY). All labware consumables were 
purchased from Becton-Dickinson (Franklin Lakes, NJ).        
 
7.3.2. Scaffold fabrication 
The PCL and PCL – TCP scaffolds were built using the Fused Deposition Modeling 
(FDM) 3000 setup (Stratasys, Eden Prairie, MN). PCL was acquired from Birimingham 
Polymers (Pelham, AL) while TCP was purchased from Shanghai Rebone Biomaterials 
(Shanghai, China). The PCL – TCP composite was derived by blending PCL and TCP in a 
ratio of 4 : 1. The laydown patterns of the PCL and PCL – TCP scaffolds were 0 / 90 / 
180º and 0 / 60 / 120º respectively. The PCL scaffold has a porosity of 77% and it was cut 
into 8 mm diameter discs with a thickness of 2.5 mm. The compressive Young’s modulus 
and yield strength of the PCL scaffold were 15.7 MPa and 2.12 MPa respectively. The 
porosity of the PCL – TCP scaffold was 56% and it was sectioned into 8 mm diameter 
discs with a thickness of 5.5 mm. The PCL – TCP scaffold has a stiffness of 124 MPa and 
yield strength of 4.2 MPa. Prior to use, both scaffolds were rendered hydrophilic through a 
3 hour treatment in 5 M NaOH at 37 ºC. Sterilization was achieved with 70% ethanol 




7.3.3. Fabrication of the PCL – Collagen 20% electrospun mesh   
PCL – collagen 20% mesh was electrospun as described in the materials and methods of 
chapter 6. 
 
7.3.4. Bone marrow aspiration, MSC isolation and culturing 
Pig MSC was isolated from bone marrow and cultured as described in the materials and 
methods of chapter 4. Only passage 1 MSC was used in the experiment. 
  
7.3.5. Fibrin encapsulation of MSC within the biphasic construct    
Passage 1 MSC was seeded into sterile PCL and PCL – TCP scaffolds via fibrin 
encapsulation as described in the materials and methods of chapter 4. 5 million MSC were 
entrapped in the PCL cartilage scaffold while 2 million MSC were seeded into the PCL – 
TCP matrix. The cartilage and bone constructs were maintained in the MSC expansion 
media prior to implantation.  
 
7.3.6. Surgical implantation  
6 months old pigs were anesthetized and maintained in dorsal recumbency. The skin of the 
right hind knee joint was scrubbed and disinfected. Following that, a medial stifle 
arthrotomy was carried out to expose the distal femur and a manual hand drill was used to 
core out defects measuring 8 mm diameter and 8 mm depth at the medial condyle and the 
patellar groove. The biphasic osteochondral implant was inserted into the defect, secured 
through interference fit and flushed to the articulating surface. A PCL – collagen patch 
was used to resurface the cartilage defect in groups A and C. The patch was sutured down 
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onto the surrounding cartilage and secured with the application of fibrin glue at the 
peripheral. Wound closure was accomplished with bioabsorbable sutures, the animal was 
returned to the enclosure and monitored till full recovery. The pigs were allowed to move 
freely without constraints within the pens. After 6 months, the animals were euthanized 
with an overdose of barbiturates. Medial condyle and patellar groove regions of the 
operated joints were excised and kept for analysis. Native samples were also taken from 
the unoperated left limb of each animal. At the point of euthanasia, an average weight gain 
of 111.7 % was noted for every animal.   
 
7.3.7. Gross morphology and histology 
The harvested samples were photographed and fixed in 10% neutral buffered formalin. 
Decalcification in 30% formic acid, ethanol dehydration and paraffin embedding 
followed. 5 µm sections were taken from the centre of the defect site and stained for 
cartilaginous matrix distribution using 1% Toluidine blue and 0.1% Safranin O fast green. 
Morphological details were observed via Hematoxylin and Eosin (HE) and Masson’s 
trichrome staining. The stained sections were scored under blinded conditions by 3 
examiners using a modified O’Driscoll’s score (table 7.1) [329]. The specimens were 
graded for hyaline cartilage formation, structural characteristics and tissue morphology. In 
addition, immunohistology was conducted against collagen I, II and isotype control as 





























  CATEGORY            POINTS 
1. Hyaline articular cartilage, %  
 80 – 100       8 
 60 – 80       6 
 40 – 60       4 
 20 – 40       2 
 0   – 20       0 
 
2. Surface regularity  
 Smooth and intact     3 
 Superficial horizontal lamination    2 
 Fissures       1 
 Severe disruption including fibrillation   0 
 
3. Degenerative changes in repair tissue 
 Severe hypercellularity     1 
 Mild or moderate hypercellularity     2 
 Normal cellularity, no clustering, normal staining  3 
 Normal cellularity, mild clustering, moderate staining 2 
 Mild or moderate hypocellularity, slight staining  1 
 Severe hypocellularity, poor or no staining   0 
 
4. Structure integrity 
 Normal       2 
 Slight disruption including cyst    1 
 Severe disintegration     0 
 
5. Cartilage thickness % 1 
 121 – 150      1 
   81 – 120      2 
   51 – 80       1 
     0 – 50       0 
 
6. Integration with the adjacent cartilage, medially 
 Bonded       2 
 Partially bonded      1 
 Not bonded      0 
 
7. Integration with the adjacent cartilage, laterally 
 Bonded       2 
 Partially bonded      1 
 Not bonded      0 
 
8. Tidemark 
 Present       1 
 Absent       0 
 
9. Degenerative changes in the adjacent cartilage 
 Normal cellularity, no clustering, normal staining  3 
 Normal cellularity, mild clustering, moderate staining 2 
 Mild or moderate hypocellularity, slight staining  1 
 Severe hypocellularity, poor or no staining   0 
Table 7.1. Modified O’Driscoll’s histological scoring. 
1Compared with the adjacent normal cartilage thickness. The total score is 26 points. 
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7.3.8. Micro CT 
The osteochondral samples were loaded onto a Skyscan in vivo microtomograph 1076 
scanner (Belgium) for micro CT analysis. The data was acquired at a resolution of 35 µm 
and reconstructed using a modified Feldkamp algorithm as provided by Skyscan. 
Visualization and analysis were carried out with MIMICS (Materialize, Belgium). A 
threshold of -175 to 1370 HU was used to differentiate growing bone within the bone 
scaffold from the surrounding tissue. As the boundaries of the original bone defect were 
highly visible from the scans, the defect site was isolated out via the positioning of a 
cylindrical Region of Interest (ROI) measuring 8 mm in diameter. As the pigs were still 
growing with the enlargement of the joints, bone growth occurred over the top of the bone 
implant (figure 7.2). This region was also examined via micro CT. Volumetric 
measurements of bone growth were compared against that of the unoperated knee joint in 
the same animal at a similar site and they were expressed as the degree of mineralization.   
 
Figure 7.2. Spatial changes at the implant site due to joint enlargement which led to the evaluation of the 2 ROIs in the 
micro CT model. The bone growth above (grey) and within (yellow) the bone implant are as shown. The host bone is 
denoted pink.  










































7.3.9. Indentation of the repaired cartilage 
The Young’s modulus of the repaired and native cartilage was measured as described in 
the materials and methods of chapter 5. 
 
7.3.10. Statistical Analysis 
The experimental procedure was repeated for 6 pigs in each group. The results were 
expressed in mean ± standard deviation and compared using student t-test. The difference 




















7.4.1. Cartilage repair 
The animals grew over the 6 months period and gained an average of 111.7% in body 
weight. When the samples were extracted, the distal femur enlarged by an increment of 
31.5 and 22.3 % in the width of the medial condyle and patellar groove respectively 
(figure 7.3). In groups A and C, only remnants of the electrospun mesh were found with 











A smooth articulating surface was restored in all groups as shown by the gross inspection 
of the medial condyle (figure 7.4). There was varying degrees of integration between the 
repair tissue and the host cartilage with occasional fissures on the articulating surface 
(figure 7.4G and K). As the repair tissue was immature, it did not resemble the native 
hyaline cartilage with a regular cell orientation and the characteristic glass – like 
Figure 7.3. The enlargement of the distant femur over a period of 6 
months. The weight of the pigs, width of the medial condyle and patellar 
groove were increased by an average of 111.7, 31.5 and 22.3% 
respectively.    
0 months 6 months 
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appearance of the mature hyaline Extracellular Matrix (ECM). The presence of GAG in 
the neocartilage was detected via Toluidine blue and it was found that only a few of the 
samples in groups A and C have their tidemarks fully restored, while there were none in 
group B (table 7.2). Both Toluidine blue and Safrannin O detect the presence of GAG but 
the later stained negatively at low GAG levels [330]. The surface of the neocartilage in C 
contained low levels of GAG and this observation was more predominant than in the other 
groups (figure 7.4S). Furthermore, there was also an unexpected GAG reduction in the 
surrounding cartilage (5 out of 6 group C samples). The development of fibrocartilage was 
accompanied by the deposition of collagen I and this protein was mainly detected in 
groups B and C (2 and 3 out of 6 samples respectively). Group A has the least 
fibrocartilage growth. The neocartilage stained positively for collagen II in all groups 
(figure 7.4U2 – W2) and the repair cartilage bridged across the medial condyle defect for 
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Figure 7.4. Cartilage repair at the medial condyle, 6 months post implantation. Gross morphology (A- D), HE (E - L), 
Toluidine blue (M – P), Safranin O fast green (Q – X), immunostaining against collagen I (U1 – X1) and collagen II (U2 
– X2) are as shown. The inserts in E – G and Q – S are the close ups of the boxed regions while the inserts in U2 – X2 are 
the immunostaining isotype controls. The inserts in E – G show the integration between the host and new cartilage. A site 
of ligament insertion on the medial condyle is observed on the right side of the group A. Varying degrees of tissue 
bonding was noted with a cleavage occurring in group A (E). Tissue repair occurred across the 3 groups with a mix of 
immature tissue, hyaline and fibrocartilage, the general cell orientation within the neocartilage did not resemble that of the 
native cartilage (I – L). Though presented in all samples (M-P), GAG was reduced at the top region of the repair cartilage 
of group C (S). Moreover the surrounding cartilage in group C exhibited a decline in GAG for 5 out of 6 samples (W). 
Collagen II (U2 – W2) was detected in the neotissue for all groups, but collagen I (U1 – W1) was predominately observed 
at the defect site of group B (2 out of 6 samples) and C (3 out of 6 samples).  Only 1 group A sample stained positively 
for collagen I. Negative staining was observed with the isotype controls (inserts U2 – X2).     
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The patellar groove defect was barely distinguishable from the surrounding cartilage in A 
as it was resurfaced by a smooth layer of reparative tissue (figure 7.5A). When the 
sections were examined, a mix of hyaline, fibrocartilage and fibrous tissue was observed 
in all 3 groups (figure 7.5E - G). Surface restoration varied within each group as smooth 
and fibrillated morphologies were found (figure 7.5I - K). The cell orientation in the 
neocartilage differed from that of the native tissue and the repair at the defect periphery 
was better than that at the centre where fibrous tissues would usually reside. This 
observation was supported by the poor Toluidine blue staining especially so in groups B 
and C (figure 7.5M - O). GAG concentration in the neocartilage was lower than that in the 
native tissue for all samples (figure 7.5Q - S), moreover it was depleted in the surrounding 
cartilage in B and C (3 out of 6 for both groups), thus indicating degenerative changes. 
Collagen I and II were detected in all specimens except for 1 group A sample which 
stained negatively for collagen I (figure 7.5U1 – W1). A complete bridging of the patellar 
groove defect as shown by the Toluidine blue and collagen II stains was only 
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Figure 7.5. Cartilage repair at the patellar groove, 6 months post implantation. Gross morphology (A – D), HE (E - L), 
Toluidine blue (M – P), Safranin O fast green (Q – X), immunostaining against collagen I (U1 – X1) and collagen II (U2 – 
X2) are as shown. The inserts in E – G and Q – S are the close ups of the boxed regions while the inserts in U2 – X2 are the 
immunostaining isotype controls. Integration between the host and new cartilage is shown in the E – G inserts.  Cartilage 
healing was superior at the edge of the defect than at the centre (E - G) and this observation was supported by the Toluidine 
blue stain (M - O). Group A exhibited a more hyaline cartilage repair but fibrous tissue was found on the top surface (I). In 
groups B and C, a mix of fibrocartilage and fibrous tissue was noted (J and K). Surface morphology varies across the groups 
with fibrillation as shown in group C (K). Cell orientation within the repair cartilage generally did not resemble that of the 
native cartilage. GAG was either reduced or absented at the centre of the defect (Q– S), moreover there was also a reduction in 
the levels of GAG in the surrounding cartilage (V and W) especially so for groups B and C as half of the samples exhibited 
the depletion. However this was not accompanied by a distinctive change in the cell orientation of the host cartilage. Collagen 
I was noted in the repair site across all groups especially so for groups B and C (U1– W1). Collagen II was also detected (U2 
– W2) and it formed a continuous band as observed in U2, which only occurred for 2 out of 6 group A samples but none for 
groups B and C. Negative staining was noted with the isotype controls (inserts U2 – X2).     
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Observations Site A 
With cells and mesh 
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With cells without mesh 
C 
Without cells with mesh 
Medial condyle 1 / 6 2 / 6 3 / 6 Presence of Collagen I. 
Indicative of fibrocartilage. Patellar groove 5 / 6 6 / 6 6 / 6 
Medial condyle 1 / 6 3 / 6 5 / 6 Reduction of GAG in the 
surrounding cartilage. Patellar groove 2 / 6 3 / 6 3 / 6 
Medial condyle 2 / 6 0 / 6 2 / 6 Presence of the tidemark.  
Patellar groove 0 / 6 0 / 6 0 / 6 
Medial condyle 6 / 6 6 / 6 6 / 6 Continuity of the repair 
cartilage at the defect site. Patellar groove 2 / 6 0 / 6 0 / 6 
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Figure 7.6.  Mechanical evaluation and histological scoring of the repair cartilage. The relative Young’s modulus 
and total O’Driscoll’s histological scores are as shown in A and B respectively. Detailed scoring of the medial 
condyle and patellar groove are indicated in C and D respectively. * indicates significant difference between group 
A and C (P < 0.05). # indicates significant difference between group A and B (P < 0.05). ** indicates significant 
difference between group B and C (P < 0.05).  ## indicates significant difference between the medial condyle and 
the patellar groove for the same criteria within the same group (P < 0.05). N is 4 for mechanical assessment while 




Differences were noted in the cartilage repair between the 2 sites. This was validated by 
the significantly higher scores at the medial condyle as compared to the patellar groove 
(figure 7.6) and it was evident in terms of the hyaline content, cell morphology in the 
repair cartilage and cartilage thickness. Moreover there was no tidemark reconstitution in 
all the patellar groove defects (table 7.2). When the 3 groups were compared, A tended to 
register a higher total score particularly so at the medial condyle. Furthermore the 
enhanced repair is mirrored by the superior scores for the hyaline content and the tissue 
morphology. This observation was supported by the key observations as tabulated in table 
7.2 as they pointed to an improved outcome in A with a lower incident of fibrocartilage 
and better GAG maintenance in the host cartilage.  
 
The functionality of the regenerated cartilage was reflected by its Young’s modulus. The 
relative Young’s modulus of A and B at the medial condyle were significantly higher than 
that of C (figure 7.6). Furthermore, the measured A and B values were approximately 70% 
of the Young’s modulus of the native cartilage. At the patellar groove, A seemed to have a 
higher relative Young’s modulus as compared to B and C. But there was an absence of 
statistical difference due to the considerable variation within each group. A comparison of 
the 2 anatomical sites revealed better functional restoration at the medial condyle and this 
was likely attributed to the unique biomechanical cues which stimulated tissue repair.  
 
Cartilage healing was enhanced in the critically sized osteochondral defects through the 
use of the implanted MSC and electrospun mesh. Group A exhibited a reduced occurrence 
of fibrocartilage with minimal GAG depletion in the surrounding cartilage when 
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compared to B and C. Moreover the patellar groove defect could only be bridged in A (2 
out of 6 samples) while gaps persisted in B and C. Tissue repair in C was solely dependent 
on the native progenitor cells, unfortunately the quantity of these cells was insufficient to 
support an adequate repair as shown by the inferior morphological features and 
mechanical properties. To achieve optimal results, MSC implantation must be 
complemented by a resurfacing membrane as indicated by the improved outcomes in A as 
compared to B (table 7.2). The membrane helped to retain the cells at the defect by 
restricting leakage into the joint space. Healing was not just dependent on exogenous 
factors but also on the intrinsic biomechanical interactions at the defect site. This was 
shown by the better regeneration at the medial condyle as compared to the patellar groove 
in all the groups, with an obvious discrepancy in the general histological features, scores 














7.4.2. Bone repair 
Bone cavities were found in the region above the bone implant as shown in the micro CT 
models, these were directly located beneath the cartilage zone and a visual assessment 
suggested larger cavities at the patellar groove (figure 7.7). Histological evaluation of the 
bone implants indicated bone in growth within the pores of the PCL – TCP scaffold with 
dense bone infiltration in groups A and B but it was notably reduced at the patellar groove 
as compared to the medial condyle. This was because the native trabeculae networks were 
denser at the medial condyle as compared to the patellar groove, hence quantification with 
respect to the native site was required. Fibrous tissue was occasionally found in the 
implants especially so for group C (figure 7.7K and K1). In addition to the HE stain, 
Masson’s trichrome was included for an in depth assessment of bone growth as it was able 
to differentiate old (red) from new bone (green). A mixture of old and new tissues 
suggested bone remodeling within the implant and this was observed for all samples 
(figure 7.7M-O, M1-O1). The turnover process mirrored bone maturation as shown by the 
lamella rings. It appeared that the bone formation in A and B at both locations was 
accompanied by a higher proportion of old bone. When the native osteochondral tissues 
were examined (figure 7.7L and L1), skeletal growth was evident at both sites given the 
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Figure 7.7. Bone repair at the medial condyle (A – P, Q1 and R1) and patellar groove (A1 – P1). Micro CT models 
(A – D and A1 – D1), HE staining (E – H, E1 – H1 and Q1 – R1) and Masson’s trichrome staining (I – P and I1 – 
P1) are as shown. M – P and M1 – P1 are close ups of the boxed regions in I – L and I1 – L1 respectively. Bone 
growth above (grey) and within (yellow) the bone implants were isolated out in the CT models with crevices 
observed directly beneath the cartilage especially so at the patellar groove (A – C and A1 – C1). Bone in growth 
was noted in the pore spaces within the PCL- TCP scaffold (E – G and E1 – G1). With the Masson’s trichrome 
stain, old bone was stained red while new bone, fibrous tissue and cartilage were stained green. There was more old 
bone formation in groups A and B as compared to group C. At the native sites, growth and remodeling occurred 
throughout the bone tissue (L and L1) especially at the region beneath the cartilage zone (P and P1). Bone 
maturation as indicated by the lamella patterns were observed in the native bone (R1) and this could also be found 
within the implant site (Q1) of group A, similarly for the other groups located at the medial condyle and the patellar 
groove.  The arrow heads in E, F, G, E1, F1 and G1 indicate the cartilage PCL scaffold. The structure of the matrix 
has collapsed in E, F, G and F1.      
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Histological sections were taken at the centre of the defect where bone reconstitution was 
difficult hence the findings might be skewed. Therefore histology was complemented with 
a more comprehensive analysis such as the micro CT imaging. This non destructive 
technique enabled the visualization and quantification of the regenerated bone within the 
entire defect. The extent of bone restoration was derived by comparing the repair bone 
volume to that at the unoperated native site (bone volume fraction of 88.6 and 47.3% at 
the unoperated medial condyle and patellar groove respectively). When a comparison was 
made between the 3 groups, A and B were found to be more mineralized than C, above 
and within the bone implants and at both sites (figure 7.8). Bone repair in the absence of 
the implanted MSC was unsatisfactory as the native cells were inadequate to support the 
healing at the critically sized bone defects. Group A generally have a higher degree of 
mineralization with respect to B, thus it was probable that the electrospun mesh had 
helped to retain the implanted cells at the location where they were required for the 
reparative process. Mineralization above the bone implant was directly correlated to 
cavity size, hence a lower value in C would imply a larger bone cavity as compared to the 
other groups. Similarly, the craters were larger at the patellar groove as compared to the 
medial condyle for all groups. Hence the in vivo conditions at the patellar groove were not 
just adverse to cartilage repair but also to bone healing.  
 
A graphical plot between the degree of mineralization within the bone implant and the 
relative Young’s modulus of the overlying cartilage revealed a positive correlation for all 
groups implanted at both locations (figure 7.8 and table 7.3). This validated the long held 
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assumption that there was a close interaction in the healing of both tissues as cartilage 

























































Figure 7.8. Bone mineralization and correlation with cartilage repair. The degree of mineralization was measured at 
the medial condyle (A) and patellar groove (B). Measurements were taken above and within the bone scaffold 
implant.* indicates significant difference in the degree of mineralization between groups A and C at a similar site (P < 
0.05). # indicates significant difference in the degree of mineralization between groups A and B at a similar site (P < 
0.05). ** indicates significant difference in the degree of mineralization between groups B and C at a similar site (P < 
0.05). ## indicates significant difference in the degree of mineralization between the medial condyle and the patellar 
groove for the same location within the defect (P < 0.05). N is 4 for all groups. C shows the correlation between the 
degree of mineralization within the scaffold and the relative Young’s modulus of the overlying cartilage in group B at 
the medial condyle.  
 A 
With cells and mesh 
B 
With cells without mesh 
C 
Without cells with mesh 
Medial condoyle 0.86 0.93 0.96 
Patellar groove 0.84 0.86 1 
    The results were not statistically significant (P> 0.05) as N (4) was small.  
Table 7.3. Positive correlation coefficients between the degree of mineralization within 
bone implant and the relative Young’s modulus of the repair cartilage.  
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7.5. Discussion         
The implanted MSC exerted a restorative effect at the osteochondral site. At the medial 
condyle of group C where these cells were omitted, a high incidence of fibrocartilage was 
found with the positive staining of collagen I and it was accompanied by GAG depletion 
at both the repair and surrounding cartilage. These anomalies led to a lower relative 
Young’s modulus, thus compromising the load bearing function of the new cartilage. The 
implantation of MSC with the electrospun mesh supported cartilage repair in A. GAG loss 
in the host cartilage was minimized and more importantly the patellar groove defect was 
bridged by the repair cartilage for 2 out of 6 group A specimens and that did not occur in 
B and C. The enhanced cartilage healing also meant better functional restoration as shown 
by the higher relative Young’s modulus. The implanted MSC has promoted bone 
regeneration. In its absence, large bone craters above the PCL-TCP implant were found in 
C at both sites as shown by the lower degree of mineralization. In addition, there was 
limited bone in growth within the bone construct as indicated by the histological and 
radiographical evidence. In order to realize the full restorative potential of the implanted 
MSC, an adequate cell number must be maintained at the site and this was achieved with 
the electrospun mesh which prevented cell leakage. When cartilage regeneration was 
compared in A and B, the outcome in B was inferior given the prevalence of 
fibrocartilage, lower GAG distribution within and beyond the defect. Interestingly, these 
morphological observations at the patellar groove were similar for B and C despite the 
presence of implanted cells in the former (table 7.2). Thus it was probable that cartilage 
regeneration at the patellar groove was difficult and a high cell number was crucial for 
effective healing, but this was hampered by the loss of the seeded cells due to the 
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omission of the electrospun mesh. These findings were reiterated at the bone region as the 
degree of mineralization in A was generally higher than B. The use of the electrospun 
mesh was deemed promising as it did not have the associated complications of an 
autologous periosteal flap which included donor site morbidity and tissue hypertrophy 
[87]. The PCL collagen electrospun membrane might influence the friction at the 
articulating joint but given the complexity of the mechanisms involved, it would be 
explored in future studies. Firstly the surface roughness of the mesh would be measured 
via atomic force microscopy. As the mesh was implanted in the synovial space, fluid 
interaction would influence contact mechanics as observed with the boundary, hydrostatic 
and elastohydrodynamic lubrication of the native articular cartilage. The absorption and 
pressurization of synovial fluids trapped between 2 cartilage surfaces resulted in boundary 
and hydrostatic lubrication [117]. This was assisted by hyaluronan which adhered to the 
surfaces. During deformation, fluids expelled from the compressed cartilage served as 
elastohydrodynamic lubricants [117]. The reduction of friction due to the interaction 
between the solid and liquid phases might occur with the implanted mesh. This has to be 
addressed in future detailed investigations.  
 
The significance of cellular therapy towards osteochondral repair is fast gaining 
recognition. When cell free implants were evaluated in the goat model, Kangarlu et al 
discovered fibrous in growth at the defect site [331]. The results were improved in the pig 
model when Gotterbarm et al added a growth factor cocktail to the cell free construct [65]. 
Bone repair was satisfactory but it was overlaid by neocartilage with deteriorating 
mechanical properties [65]. The experiment was repeated by Zhou et al with chondrogenic 
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induced MSC. The seeded implants promoted both cartilage and bone repair as compared 
to the controls without cells that were invaded with fibrotic tissue [154]. These 
observations were also reported in other large animal models. Yamazoe et al found that 
the implantation of MSC with atelocollagen assisted bone repair in the canine 
osteochondral defect, while Guo et al reported that MSC seeded within a TCP scaffold 
was able to promote cartilage growth with high GAG content in an ovine model. The 
application of MSC in musculoskeletal medicine is increasingly popular given the 
inherent advantages. Bone marrow rich in MSC could be obtained via a simple operative 
procedure, subsequent expansion to achieve significant cell numbers for therapeutic use 
can be accomplished via monolayer culturing. Moreover the differentiation potential of 
these cells which includes osteogenic and chondrogenic lineages is maintained during the 
expansion process [332].  
 
Osteochondral defects enlarge progressively into the surrounding tissue when they fail to 
heal [51]. When an injury disrupts the normal stress distribution at the cartilage zone, an 
elevation in compressive strains and loads occurs in the surrounding tissue, triggering a 
change in chondrocyte metabolism and eventual deterioration as indicated by the loss of 
GAG [113, 333-334]. Sams et al discovered a 42% decline in the GAG content of the host 
cartilage when equine chondral defects were left to heal on their own [45]. But this loss 
was promptly reversed with cell implantation and the observation was similar to the 
current findings. It was interesting to note that severe cellular aberrations were hardly 
observed despite the reduced Safranin O stain which hinted of GAG depletion. A probable 
explanation would be that the loss of this key cartilage marker preceded critical 
Chapter 7. 
 164
abnormalities. To ensure normal load bearing at the defect site, GAG levels must not only 
be maintained but host tissue integration has to be achieved so as to prevent micro and 
macromotion that disrupt the neotissue [287]. Cartilage integration was inconsistent in 
group A, which might be attributed to the limited involvement of the native chondrocytes 
during the repair phase [155]. But bonding can be improved with an enzymatic treatment 
of the defect site prior to implant placement [335-336].  
 
The histological scores did not indicate a significantly superior cartilage repair for any one 
group at both sites though outstanding trends were highlighted by the key observations 
(table 7.2). This was attributed to several reasons. Firstly, differences based on the scoring 
criteria were hardly noticeable between the groups as the repair was barely complete since 
tissue maturation was reported to last 6 months to 2 years [296-298]. This was reinforced 
by the observation that the repair tissue resembled partially differentiated mesenchyme 
which differed from mature hyaline cartilage that was characterized by a homogeneous 
ECM [337]. Additional complications arose when tissue regeneration was found to vary 
within and between the animals despite identical treatment. This fluctuation was noted in 
the cell morphology, host tissue integration, surface and structural integrity of the repair 
cartilage at both sites.  
 
The present implant was designed as a biphasic system and it was engineered with various 
structural, material and mechanical considerations. One key structural aspect was the 
porosity of the scaffolds which facilitated tissue repair. When the osteochondral defect 
was first created, a hematoma formed and it was entrapped within the pores of the 
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matrices. The presence of growth factors within the clot would signal for the migration of 
the native progenitor cells required for tissue regeneration. Moreover the fibrin matrix 
encapsulated within the polymeric scaffolds would also exert a reparative effect as 
witnessed by Paletta et al [21]. Tissue repair was further aided by the mechanical support 
of the scaffolds. However the inferior results in group C suggested that the native cells 
were insufficient for an effective repair, hence MSC implantation was necessary. The 
main advantage of the biphasic design would be the tailoring of the specific phases so as 
to cater to the regenerative needs of the different tissues located within the osteochondral 
defect. This was currently achieved with PCL based scaffolds. PCL demonstrated 
potential in cartilage and bone tissue engineering as it is a slow degrading polymer that is 
able to provide prolong mechanical support at the load bearing site [51, 99]. This support 
is critical during the remodeling and maturation of neotissues [239, 299]. The cartilage 
phase of the biphasic implant comprised of a PCL scaffold with the incorporation of TCP 
at the bone region. This bioactive ceramic was included as it not only enhanced the 
osteoconductivity and osteoinductivity of the bone matrix [76, 247, 338], but it also 
improved the stiffness of the scaffold [299]. Schlichting et al reported that the use of soft 
matrices resulted in bone sclerosis due to the inadequate mechanical support. In contrast, 
stiff bone scaffolds supported bone in growth which enhanced the healing of the overlying 
cartilage [187]. Given the positive correlation between the degree of mineralization within 
the bone scaffold and the relative Young’s modulus of the overlying cartilage, due 
attention must be given to the design of the bone matrix so as to encourage bone in growth 




Implant degradation occurred in the in vivo environment over the 6 months period. The 
electrospun mesh was completely degraded for most specimens while the structure of the 
PCL scaffold collapsed in several samples. The electrospun mesh served the intended 
function during the initial phase given the improved results in group A over group B, but 
joint articulation would have wore it out over time. Though mechanically resilient [299], 
cyclic compressive loading would have induced fatigue damage and microcracks that 
accelerated the degradation of the cartilage PCL scaffold [339-340]. The PCL – TCP 
scaffold appeared to be intact but scaffold degradation would certainly have occurred. A 
33% degradation of a similar PCL – TCP scaffold was observed when it was implanted 
into a canine mandible defect for 6 – 9 months [341]. Polymer breakdown proceeded via 
hydrolytic surface erosion and enzymatic pathways. Furthermore the cyclic physiological 
loads would have hastened the process as a lower scaffold mass loss was observed at a 
subcutaneous site over a similar time frame [342].  
 
Young pigs were selected for the study as spontaneous healing was reported to be 
inadequate. Chang et al noted the collapse of adjacent cartilage with the formation of 
subchondral cyst when osteochondral defects were left unattended in 4 – 8 months old 
pigs [91]. Moreover a seamless self-repair has not been reported even in young animals 
except for fetal lambs [343]. With this in mind, the experimentation of adult animals 
would only be warranted when preliminary findings were promising in young animals 
[337]. Moreover the use of young animals in osteochondral regenerative studies modeled 
the condition of osteochondritis dissecans which is more prevalent among the adolescent 
than the elderly [151]. However the use of skeletally immature pigs has its drawbacks. In 
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this study, the entire biphasic implant was embedded in the subchondral bone after 6 
months as the joints enlarged during natural growth. Siegling et al has reported in his 
landmark study that the growth of the epiphysis was initiated by the cell proliferation in 
the articular cartilage and it was followed by endochondral ossification at the tidemark 
region [344]. Thus the bone growth advanced beyond the PCL – TCP scaffold into the 
cartilage PCL matrix. As a result, the PCL scaffold was not integrated into the newly 
formed cartilage but it supported its development by acting as a cellular delivery vehicle.    
 
Osteochondral restoration at the patellar groove was deficient when compared to the 
medial condyle as shown by the lower relative Young’s modulus, histological scores and 
the absence of tidemark. Furthermore all the medial condyle cartilage defects were 
bridged by the repair tissue while that only took place in 2 group A patellar groove 
samples. The degree of mineralization above the bone implant was generally poorer at the 
patellar groove and it implied a large bone crevice beneath the cartilage zone. The 
unsatisfactory osteochondral healing at the patellar groove could be attributed to the 
unfavorable in vivo loading conditions. When the human knee joint was examined during 
the walking gait, compressive loads measuring 0.2 – 0.4 times the body weight were 
observed at the patellar groove. However the force increases to 3 and 8 times the body 
weight during stairs ascent and squatting respectively [174-175]. On the other hand, the 
loading was more consistent at the medial condyle as it ranged from 2.4 to 3.4 times the 
body weight throughout the same set of activities [345-346]. This constant moderate 
loading would have favored osteochondral repair but the fluctuating stresses at the patellar 
groove might have been detrimental. The prevalence of fibrocartilage and fibrous tissue 
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hinted of high distortional shear stresses at the patellar groove which stimulated the 
fibroblastic differentiation of MSC [347]. Carter et al has also highlighted that a low 
compression, high shear stress environment would predispose pluriopotential cells to 
differentiate into fibrous tissue. Conversely, high compression and low shear encouraged 
cartilaginous development [348]. Hence these in vivo biomechanical conditions might be 
adverse to the healing at the patellar groove and this might explain the discrepancy in 
regeneration between the medial condyle and the patellar groove reported in pig, monkey 
and goat [2, 349-350]. However such findings were absent in the rabbit model due to the 
predominant squatting position [337, 351]. Hence the rabbit was not an appropriate model 
to evaluate the efficacy of the implant under the different physiological conditions as it is 
not representative of the human knee joint.       
 
The effectiveness of the cell seeded implant coupled with the electrospun mesh in 
supporting osteochondral healing was evaluated against the mesh free and cell free 
implants (groups B and C) which were employed as negative controls. But an empty 
untreated defect was omitted because the spontaneous healing response was well reported 
to be inadequate [91, 352]. Chang et al created 8 mm diameter and 5 mm deep 
osteochondral defects in the knees of 6 – 9 months old pigs [91]. The surrounding host 
cartilage collapsed into the defect site with fibrous cysts forming in the bone region at 10 
months. Subchondral bone regeneration was absent and fibrous protrusions were observed 
in some of the defects [91]. Bail et al made similar observations in his pig model and it 
was suspected that this failure was attributed to the uneven stress distribution in the 
articulating joint [91, 352]. When Jackson et al repeated the study in goats, osseous 
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resorption was noted and the lesion became sclerotic at 6 months [147]. The defect 
enlarged with the caving in of the surrounding host tissue. Nelson et al and Buckwalter et 
al conducted similar studies in dogs and monkeys [350, 353]. Fibrous tissue was noted at 
the untreated canine osteochondral defect while the modulus of the primate neocartilage 
was only 25% that of the native tissue [350, 353]. Functional restoration was clearly 
lacking and the findings highlighted the paucity of self repair in critically sized 
osteochondral defects in large animals, hence this negative control was omitted in view of 
the certain outcome. Conversely, an autograft was required as a positive experimental 
control. The graft has to be transplanted at critically sized defects, hence tissue harvesting 
would lead to severe donor site morbidity. This procedure is clinically impractical and it 
would compromise the experimental outcome with donor site deterioration. In view of this 
limitation, the characteristics of the regenerated tissue were compared against that of the 
native tissue in an unoperated joint. This approach was similar to the earlier rabbit study.                     
 
This pig study was a follow up from the previous rabbit implantation trial (chapter 5) and 
this large animal was selected given the anatomical and biomechanical similarity with the 
human knee joint. The average cartilage thickness in humans and pigs are 2.2-2.5 and 1.5 
mm respectively. Though rabbits are frequently used as animal models, their cartilage 
thickness is only 0.3 mm [82, 90, 166]. It would be challenging to suture the cartilage 
resurfacing membrane onto the thin rabbit cartilage, hence neither a PCL – collagen 
membrane nor a periosteal flap was used in preceding rabbit study. However key 
observations were made when the rabbit and pig experiments were compared. It was 
discovered that bone regeneration was equivalent with or without MSC implantation at 6 
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months in the rabbit model. In contrast, the implanted MSC exerted a notable effect in the 
pig model as the degree of bone mineralization was higher in group A as compared to C. 
Such discrepancies would caution the translation of small animal modeling to clinical 
applications. The cartilage resurfacing mesh was proposed to address the inconsistent 
cartilage repair as observed in the rabbit model. When tested in the pig model, the tissue 
engineered patch was found to enhance not only cartilage healing but also bone 
regeneration. This was likely attributed to the retention of the transplanted MSC at the 
defect which was sealed with the permeable mesh.   
 
7.6. Conclusion  
The tissue engineering of an osteochondral implant with a biphasic construct was 
investigated in the pig model and healing was found to be enhanced with seeded MSC. 
The electrospun mesh also assisted tissue regeneration by preventing cell leakage. 
Favorable outcomes in the cartilage region were noted with the reduced incidence of 
fibrocartilage and improved GAG content when both the implanted cells and mesh were 
used. The bone phase also experienced a higher degree of mineralization and that 
facilitated the functional restoration of the overlying cartilage. However, osteochondral 
healing was not just dependent on the implant design but also on the in vivo conditions at 








Chapter 8: Conclusions and Recommendations 
 
8.1. Conclusion 
An osteochondral implant was designed based on the hypothesis that a combination of 
MSC loaded hydrogel and a biomechanically competent biphasic scaffold would 
constitute a viable osteochondral implant that supports tissue regeneration. The 
investigation was initiated with the characterization of hydrogels and polymeric scaffolds 
so as to ascertain the biological and mechanical suitability. This was followed by a rabbit 
implantation study which evaluated the feasibility of the biphasic implant in supporting 
osteochondral repair. The promising outcome has encouraged a large animal trial with the 
inclusion of a tissue engineered cartilage patch.  
 
The use of fibrin and fibrin alginate composites in MSC encapsulation for the cartilage 
phase was investigated. The assessment was conducted under chondrogenic induction and 
the hydrogel matrices were found to influence chondrogenesis. When the cells were 
encapsulated in fibrin, early menchymal condensation was noted as compared to the fibrin 
alginate composites. In these composites, the expression of key cartilage markers such as 
collagen II and aggrecan declined as the alginate content increased. The differentiation of 
MSC into chondrocytes was promoted in the fibrin matrix and this observation was also 
demonstrated in the biphasic in vitro construct that mimicked the in vivo osteochondral 
environment. Enhanced cartilage development was indicated by the improved cellularity, 




Biomechanical considerations were factored into the design of the osteochondral implants 
given the in vivo load bearing demands. Therefore PCL based scaffolds were fabricated 
and structurally characterized. The resultant scaffold was found to be highly porous with 
comparable stiffness and strength with regards to cartilage and bone. It was further 
enhanced for bone regenerative applications through the incorporation of TCP. The PCL 
and PCL – TCP scaffolds were evaluated in the critically sized osteochondral defects in 
the rabbit. Prior to implantation, they were seeded with fibrin encapsulated MSC. These 
progenitor cells were later found to promote cartilage repair and the regenerative process 
was assisted with the PCL scaffold as fibrin by itself was not load-bearing. Significant 
bone regeneration was noted in the porous implant and it was supported by the inclusion 
of MSC and TCP. 
 
The regenerative outcome was promising in the rabbit model, but it was compromised by 
the loss of the implanted cells from the defect site. Hence an electrospun PCL – collagen 
mesh was devised as a cartilage patch and compositional studies were conducted in order 
to optimize the collagen retention rate and mechanical properties. PCL – collagen 20% 
was found to be optimal for the intended application and the membrane was further 
screened using in vitro cultures. Cell viability and compatibility was demonstrated in the 
chondrogenic environment with the absence of hypertrophy. Though highly porous, the 
membrane was able to prevent cell leakage as the seeded cells were unable to penetrate 




Favorable findings from the preceding in vitro and in vivo studies have prompted a 
preclinical trial involving the pig model. A biphasic construct consisting of a PCL 
cartilage scaffold with an underlying PCL-TCP bone matrix was implanted into critically 
sized osteochondral defects located at the medial condyle and patellar groove. MSC was 
seeded into the scaffolds via fibrin hydrogel and the defect was patched with the PCL – 
collagen 20% electrospun mesh which prevented cell loss. Enhanced cartilage repair was 
demonstrated by the reduced occurrence of fibrocartilage, improved GAG maintenance in 
the surrounding cartilage and higher relative Young’s modulus. This was accompanied by 
the superior bone in growth and mineralization in the subchondral defect. Conversely, 
healing was deficient when either the implanted MSC or mesh was omitted. Interestingly, 
the reparative outcomes were different between the medial condyle and patellar groove as 
cartilage healing was inferior at the later with underlying large bone cavities. These 
adverse results were attributed to the unique biomechanical conditions at the patellar 
groove.  
 
The implanted MSC supported the osteochondral regeneration as witnessed in the in vivo 
studies. Bone regeneration within the cell free implants was slower at 3 months as 
compared to the cell seeded constructs in the rabbit model (figure 5.5). MSC 
transplantation accelerated bone healing and it was also required for cartilage repair. 
Fibrous tissues developed within the cartilage defects when these reparative cells were 
omitted (figures 5.9 and 5.10). In contrast, functional restoration was achieved with the 
MSC seeded group 2 implants as the Young’s modulus of the neocartilage approached 
that of the native cartilage (figure 5.11). Native progenitor cells could have migrated to 
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the defect site to assist tissue restoration, but they were insufficient as observed in the cell 
free controls, hence cell transplantation was needed. This observation was mirrored in the 
final pig study. A higher incidence of fibrocartilage was observed in group C with the 
omission of the transplanted cells (Table 7.2). On the other hand, GAG content was higher 
within and beyond the repair tissue with cell seeded implants. Moreover this biological 
restoration has led to a higher Young’s modulus particularly so for the neocartilage of 
group A (figure 7.6A). Porcine bone repair was deficient with the omission of the 
expanded MSC as indicated by the lower degree of mineralization and the larger bone 
craters sited above the PCL – TCP implants especially so at the medial condyle (figure 
7.8). This radiographic evident was reinforced by histological findings as fibrous tissue 
predominated within the group C bone implant (figure 7.7K and O1). Hence the findings 
suggested that MSC therapy was mandatory for osteochondral repair.  
 
The outcome of this investigation is significant as the proposed osteochondral implant 
addressed material, mechanical, structural and clinical constraints which confounded 
researchers (Table 8.1.). Material incompatibility is a common concern in the design of 
biphasic osteochondral implants. Alginate, chitosan and PEO are widely used but they 
share this limitation. The author’s findings (chapter 4) highlight the inability of alginate to 
support MSC chondrogenesis as it is bioinert, while the use of chitosan is hampered by its 
attraction for neutrophils [10]. On the other hand, non-biodegradable PEO is only 
restricted to conceptual trials [50, 180]. Hence a rigorous material selection is necessary in 
the design of the osteochondral implant. PCL was chosen as the base scaffolding material 
because of its non toxic and biodegradable properties. This polymer is supplemented with 
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osteoconductive TCP for bone applications. Both materials do not elicit a foreign body 
response and the macro scaffolds are coupled with bioactive fibrin which not only 
encapsulates MSC but also supports cartilage development. Prolong mechanical support 
required in the healing process is facilitated by the slow resorption of PCL [178, 239]. 
This was lacking in Schaefer et al ‘s PGA scaffold as the polymer degrades quickly [3]. 
Mechanical competence is another key feature of the PCL and PCL-TCP scaffolds as their 
mechanical properties approximate to that of cartilage and bone. This was emphasized by 
Tanaka et al who reported tissue deterioration with the use of collagen matrices that were 
mechanically incompatible to native cartilage [12, 179]. Another pitfall encountered by 
many researchers is the reliance on foams as osteochondral biphasic scaffolds [2, 22]. 
Though porous, these foam based scaffolds may not have pores that are fully 
interconnected and the resulting dead space deters tissue development [354]. This 
structural constraint is resolved through rapid prototyping which allows the fabrication of 
scaffolds with fully interconnected pore channels. Besides material and structural 
consideration, clinical relevance must be demonstrated for the engineered implants. This 
can be achieved in large animal models which represent the human knee joint in terms of 
anatomy and loading [90, 166]. Unfortunately, this critical proof is lacking in most studies 
which are based on small or medium size animals such as mice and rabbits [8, 12]. In 
addition to that, the reparative response solicited by the biphasic osteochondral implant 
must be demonstrated in critically sized defects as self healing is inadequate. This 
standard was not met in Niederauer et al’s goat study as small osteochondral defects (2.8 
mm in diameter, 4 mm in depth) were used [2]. Consequently, the findings were 
inconclusive as healing was equally observed in both experimental and control groups. 
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The author was mindful of these concerns in the final pig model as the biphasic implants 
were tested at critically sized osteochondral defects measuring 8 mm in diameter and in 
depth. Tissue deterioration was observed by Chang et al when similarly sized defects were 
left untreated in pigs [91]. The use of biphasic osteochondral scaffolds can be coupled 
with cell therapy. The cartilage and bone phases can be reconstituted with 2 different cell 
types which include chondrocytes and osteoblasts [8, 82]. However this approach would 
entail 2 cell isolation procedures and which can be streamlined simply through the use of 
MSC which possesses both osteogenic and chondrogenic lineages. The transplanted MSC 
supported cartilage and bone healing as observed in the current rabbit and pig models. But 
to fully harness the reparative potential of the transplanted MSC, the cells must be 
retained at the defect site. This was accomplished through the use of a novel cartilage 
resurfacing membrane and it is the first attempt to the best of the author’s knowledge that 





















































Table 8.1. Limitations highlighted in literature and addressed in the current investigation.  
Highlighted constraints in biphasic implants Resolved in the present work 
Material 
         
- A chitosan cartilage matrix was proposed by Oliveira et al, 
but the natural material would provoke foreign body 
response through chemoattraction on neutrophils [9-10]. 
 
- PGA cartilage scaffold degrades rapidly and is unable to 
provide prolong mechanical support [3, 17]. 
 
- Hydroxyapatite bone scaffolds resorb poorly which results 
in stress shielding for the repair tissue [1, 9].    
  
- PCL and TCP are selected as main scaffolding 
materials. Both are biodegradable, non-toxic and do not 
elicit a foreign body response. The macro scaffold is 
coupled with bioactive fibrin which supports MSC 
chondrogenesis.       
 
- The PCL based scaffolds resorb slowly hence they 
provide prolong mechanical support at the repair site.    
 
Mechanical 
        
- Harley et al designed a biphasic osteochondral construct 
consisting of a collagen-GAG cartilage scaffold with a 
collagen-GAG-calcium phosphate osseous scaffold. The 
stiffness was 0.03 and 0.76 MPa respectively which was 
considerably lower than that of cartilage (1.36 – 39.2 MPa) 
and bone (4.4 – 229 MPa)[52].    
 
- The mechanical characteristics of PCL and PCL – TCP 
scaffolds approximate to that of cartilage and bone. 
This is necessary for mechanical support at the load 




- Foam based biphasic implants were used by Niederauer et 
al, Jiang et al and Gao et al [2, 22, 61]. The pores in these 
scaffolds may not be fully interconnected resulting in dead 
space.     
 
- Rapid prototyping allows the fabrication of scaffolds 




- Findings from small and medium animal models cannot be 
directly translated into clinical applications [8, 12]. 
 
- Inconclusive outcomes were reported by Niederauer et al 
when non-critically sized osteochondral defects were tested 
in the goat model [2]. 
 
- Schaefer et al seeded the cartilage and bone components of 
his dual phase implant with chondrocytes and periosteal 
cells respectively [17, 82]. This 2 cell type approach was 
adopted by Adachi et al with chondrocytes for the cartilage 
region and MSC for the osseous zone [85]. 
 
- Cell retention at the defect site is maintained by the 
autologous periosteal flap which is associated with a high 
incidence of cartilage hypertrophy [87-88].                
 
- A proof of concept was demonstrated by implanting 
the biphasic construct into the hind joint of pigs which 
mimic the human knee joint [90].  
 
- Critically sized osteochondral defects were evaluated. 
Tissue deterioration was observed by Chang et al when 
left untreated [91].  
 
- Autologous bone marrow MSC was used for both the 
cartilage and bone components. The stem cell is 
capable of both chondrogenic and osteogenic 
differentiation [54, 92]. 
 
- A novel electrospun PCL-collagen 20% mesh was 
tested as a cartilage resurfacing membrane. This 
synthetic mesh did not induce cartilage hypertrophy 
and it enhanced tissue repair by preventing MSC 




It is to be concluded that osteochondral regeneration is achievable with a mechanically 
competent biphasic implant that is seeded with MSC encapsulated within fibrin gel. The 
biological construct was further complemented with the use of an electrospun mesh which 
served as a cartilage patch. The concept was developed over the various stages and the 
hypothesis was validated in the animal models.       
 
8.2. Recommendations for further research 
Future work is proposed with the aim of translating the findings to clinical applications. 
To fulfill this objective, cartilage and bone repair at the osteochondral site must be further 
enhanced with due attention to the following areas: 
 
1. Growth factor supplementation. 
2. Preculturing and induction of the biphasic construct using bioreactors. 
3. The use of other MSC sources such as adipose tissue and peripheral blood [355]. 
4. A gradient cartilage scaffold that facilitates zonal repair.  
5. Validation in a skeletally mature large animal model. 
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Abstract
Computer aided technologies, medical imaging, and rapid prototyping has created new possibilities in biomedical engineering. The
systematic variation of scaffold architecture as well as the mineralization inside a scaffold/bone construct can be studied using computer
imaging technology and CAD/CAM and micro computed tomography (CT). In this paper, the potential of combining these technologies has
been exploited in the study of scaffolds and osteochondral repair. Porosity, surface area per unit volume and the degree of interconnectivity
were evaluated through imaging and computer aided manipulation of the scaffold scan data. For the osteochondral model, the spatial
distribution and the degree of bone regeneration were evaluated. In this study the versatility of two softwares Mimics (Materialize), CTan and
3D realistic visualization (Skyscan) were assessed, too.
q 2005 Elsevier Ltd. All rights reserved.
Keywords: Computer aided design; Medical imaging; Scaffolds; Bone engineering; Micro CT1. Introduction
Tissue engineering is the application of that knowledge
to the building or repairing of tissues. Generally, engineered
tissue is a combination of living cells and a support structure
called scaffolds. The scaffold, depending on the tissue or
organ in production, can be anything from a matrix of
collagen, a structural protein, to synthetic biodegradable
plastic laced with chemicals that stimulate cell growth and
multiplication. The ‘seeded’ cells that initiate regeneration
come from laboratory cultures or from the patient’s own
body.
The utilization of computer aided technologies in tissue
engineering has evolved over time and were termed by
Sun et al. as ‘computer aided tissue engineering (CATE)’
[1]. Combining computer assisted design (CAD) with
computer assisted manufacturing (CAM) is of particular0010-4485//$ - see front matter q 2005 Elsevier Ltd. All rights reserved.
doi:10.1016/j.cad.2005.02.006
* Corresponding author. Tel.: C65 874 5105; fax: C65 777 3537.
E-mail address: biedwh@nus.edu.sg (D.W. Hutmacher).interest to tissue engineers to reproduce complex scaffold
architectures without requiring the use of moulds. While
the engineering potential of various scaffold architectures
is considerable, the ability to design and optimise
structures is still very much ad hoc since local structure
and mechanical/transport properties have not been mea-
surable during tissue growth in vitro or in vivo. Hence,
computer aided design allows to design different scaffold
architectures systemically. Previous studies have primarily
used existing computer aided design (CAD) techniques to
create a specific design. Hutmacher et al. [2] used
Stratasys QuicksliceTM (QS) software to lay down
alternating material patterns that produced triangular and
polygonal pores in Polycaprolactone (PCL) scaffolds. Chu
et al. [3] created hydroxyapatite (HA) scaffolds with
interconnecting square pores using Unigraphics TM CAD
software.
Traditional methods for evaluating osseointegration of
tissue engineered scaffold/cell constructs are based on 2D
histological and radiographical techniques and in rare cases
mechanical testing. To further the development of optimal
scaffold architectures and to characterise accurately the
growth of bone into scaffolds a fast and non-destructiveComputer-Aided Design 37 (2005) 1151–1161www.elsevier.com/locate/cad
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Available online 29 August 2005Abstract
The objective of this study was to evaluate the feasibility and potential of a hybrid scaffold system in large- and high-load-bearing
osteochondral defects repair. The implants were made of medical-grade PCL (mPCL) for the bone compartment whereas ﬁbrin glue
was used for the cartilage part. Both matrices were seeded with allogenic bone marrow-derived mesenchymal cells (BMSC) and
implanted in the defect (4mm diameter 5mm depth) on medial femoral condyle of adult New Zealand White rabbits. Empty
scaffolds were used at the control side. Cell survival was tracked via ﬂuorescent labeling. The regeneration process was evaluated by
several techniques at 3 and 6 months post-implantation. Mature trabecular bone regularly formed in the mPCL scaffold at both 3
and 6 months post-operation. Micro-Computed Tomography showed progression of mineralization from the host–tissue interface
towards the inner region of the grafts. At 3 months time point, the specimens showed good cartilage repair. In contrast, the majority
of 6 months specimens revealed poor remodeling and ﬁssured integration with host cartilage while other samples could maintain
good cartilage appearance. In vivo viability of the transplanted cells was demonstrated for the duration of 5 weeks. The results
demonstrated that mPCL scaffold is a potential matrix for osteochondral bone regeneration and that ﬁbrin glue does not inherit the
physical properties to allow for cartilage regeneration in a large and high-load-bearing defect site.
r 2005 Elsevier Ltd. All rights reserved.
Keywords: Osteochondral tissue engineering; Scaffold; Bone marrow-derived precursor cells; Fibrin glue1. Introduction
Nine percent of the United States population aged 30
and older has clinical osteoarthritis (OA) of the hip or
knee, with total direct cost was estimated at $28.6 billion
dollars per year [1]. Hence in the 21st century, articulare front matter r 2005 Elsevier Ltd. All rights reserved.
omaterials.2005.07.040
ing author. Division of Bioengineering, Faculty of
ational University of Singapore, 9 Engineering Drive 1,
76, Singapore. Tel.: +65 6874 1036;
3537.
esses: shaoxin@ucalgary.ca (X.X. Shao),
u.sg (D.W. Hutmacher).
ress: Heritage Medical Research Building, Room 435,
algary, 3330 Hospital Dr. NW, Calgary, Alb., Canadaosteochondral repair remains a clinical challenge be-
cause of the increasing morbidity of traumatic injury
and arthritis while only a few of current treatments were
able to yield satisfactory clinical results from a long-
term point of view [1,2]. Although autografts or
allografts of osteochondral, periosteal and perichondrial
tissue as well as bone prosthetic replacement are the
common treatments for clinical osteochondral recon-
struction, many shortcomings limit the repair procedure
and compromise long-term results [3,4]. Hence, these
limitations have led to the development of alternative
treatment methodologies [5,6]. Tissue engineering of
osteochondral constructs might be regarded as one with
the biggest potential to make a signiﬁcant clinical impact
in the future.
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A comparison of micro CT with other techniques used in the
characterization of scaffolds
Saey Tuan Hoa, Dietmar W. Hutmachera,b,
aFaculty of Engineering, Division of Bioengineering, National University of Singapore, 10 Kent Ridge Crescent, Singapore 119280, Singapore
bFaculty of Medicine, Department of Orthopaedic Surgery, National University of Singapore, 10 Kent Ridge Crescent, Singapore 119280, Singapore
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Available online 19 September 2005Abstract
The structure and architecture of scaffolds are crucial factors in scaffold-based tissue engineering as they affect the functionality of the
tissue engineered constructs and the eventual application in health care. Therefore, effective scaffold assessment techniques are required
right at the initial stages of research and development so as to select or design scaffolds with suitable properties. Various techniques have
been developed in evaluating these important features and the outcome of the assessment is the eventual improvement on the subsequent
design of the scaffold. An effective evaluation approach should be fast, accurate and non-destructive, while providing a comprehensive
overview of the various morphological and architectural characteristics. Current assessment techniques would include theoretical
calculation, scanning electron microscopy (SEM), mercury and ﬂow porosimetry, gas pycnometry, gas adsorption and micro computed
tomography (CT). Micro CT is a more recent method of examining the characteristics of scaffolds and this review aims to highlight this
current approach while comparing it with other techniques.
r 2005 Elsevier Ltd. All rights reserved.
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Biomolecular Engineering 24 (2007) 489–495Repair and regeneration of osteochondral defects in the articular joints
Wojciech Swieszkowski a,*, Barnabas Ho Saey Tuan b,
Krzysztof J. Kurzydlowski a, Dietmar W. Hutmacher c
aWarsaw University of Technology, Faculty of Materials Science and Engineering, Woloska 141, Warszawa 02-507, Poland
bDivision of Bioengineering, National University of Singapore, Engineering Drive1, Singapore 117675, Singapore
c Institute of Health and Biomedical Innovation, Queensland University of Technology, 60 Musk Avenue, Kelvin Grove QLD 4059, AustraliaAbstractPeople suffering from pain due to osteoarthritic or rheumatoidal changes in the joints are still waiting for a better treatment. Although some
studies have achieved success in repairing small cartilage defects, there is no widely accepted method for complete repair of osteochondral defects.
Also joint replacements have not yet succeeded in replacing of natural cartilage without complications. Therefore, there is room for a new medical
approach, which outperforms currently used methods.
The aim of this study is to show potential of using a tissue engineering approach for regeneration of osteochondral defects. The critical review of
currently used methods for treatment of osteochondral defects is also provided.
In this study, two kinds of hybrid scaffolds developed in Hutmacher’s group have been analysed. The first biphasic scaffold consists of fibrin and
PCL. The fibrin serves as a cartilage phase while the porous PCL scaffold acts as the subchondral phase. The second system comprises of PCL and
PCL-TCP. The scaffolds were fabricated via fused deposition modeling which is a rapid prototyping system. Bone marrow-derived mesenchymal
cells were isolated from New Zealand White rabbits, cultured in vitro and seeded into the scaffolds. Bone regenerations of the subchondral phases
were quantified via micro CT analysis and the results demonstrated the potential of the porous PCL and PCL-TCP scaffolds in promoting bone
healing. Fibrin was found to be lacking in this aspect as it degrades rapidly. On the other hand, the porous PCL scaffold degrades slowly hence it
provides an effective mechanical support.
This study shows that in the field of cartilage repair or replacement, tissue engineering may have big impact in the future. In vivo bone and
cartilage engineering via combining a novel composite, biphasic scaffold technology with a MSC has been shown a high potential in the knee
defect regeneration in the animal models. However, the clinical application of tissue engineering requires the future research work due to several
problems, such as scaffold design, cellular delivery and implantation strategies.
# 2007 Elsevier B.V. All rights reserved.
Keywords: Osteochondral defects; Cartilage; Subchondral bone; Repair; Tissue engineering1. Introduction
In the natural joint articular cartilage and subchondral bone
form the load-bearing system that provides a large range of
joint motion with excellent lubrication, stability and uniform
distribution of high acting loads. Articular cartilage (AC)
together with subchondral bone plays a very important role in
the natural joints (Mow et al., 1993). Cartilage protects the
subchondral bone from high stresses, increases joint con-
gruence thereby reducing nominal contact pressure. Articular* Corresponding author at: Division of Materials Design, Faculty of Materials
Science and Engineering, Warsaw University of Technology, Woloska 141, 02-
507 Warsaw, Poland. Tel.: +48 222348792; fax: +48 222348750.
E-mail address: Wojciech.Swieszkowski@materials.pl (W. Swieszkowski).
1389-0344/$ – see front matter # 2007 Elsevier B.V. All rights reserved.
doi:10.1016/j.bioeng.2007.07.014cartilage also allows for low-friction movements within the
joint (Little, 1969).
Very often, articular cartilage and subchondral bone
undergoes degeneration as the result of osteoarthritis and
related disorders leading to severe pain, joint deformity and loss
of joint motion, thus requiring surgical procedures for treatment
of osteochondral defects (Redman et al., 2005). Annually, over
1 million surgical procedures involving cartilage replacement
are performed in Europe. The origin of the cartilage and
subchondral bone degradation is still unknown. One of the
scenarios could be that the subchondral bone becomes
weaker—less dense and is not able to support cartilage in
transmitting loads to the cancellous and cortical bones. As a
result of that the cartilage fracture arises.
Although some studies have achieved success in repairing
small cartilage defects, no accepted method for complete repair
